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Biocatalysis is widely accepted as a viable alternative to traditional chemical methods 
offering good chemo-, regio and stereoselectivity. The source of this selectivity is the 
chiral nature of the biocatalyst that, as a protein, is made up of naturally occurring L-
amino acids; the protein structure interacts with the substrate molecule, placing the 
substrate in a particular orientation thus conferring selectivity on the transformation. 
Biocatalysis is primarily utilised in the pharmaceutical and specialised organic sector 
due to the need to produce compounds in homochiral form and the benign conditions in 
which biocatalysts operate. An increasing number of processes combine biocatalysis 
and chemical methods into one synthetic process, with resolution by hydrolysis being 
the most common.' 
Greater understanding of enzyme function at the genetic level leading to the genomic 
based identification of novel catalytic activity and subsequent improvement of catalytic 
selectivity and efficiency through directed evolution of biocatalysts are thus likely to 
remain growth areas and increase the value and utility of biocatalysts .2,3 
Of particular interest and importance are the biocatalysts involved in hydroxylation. 
Under the control of a biocatalyst, hydroxylations that are still chemo-, regio and 
stereoselective can occur at positions remote from existing functionality. Highly 
selective hydroxylations of this type are difficult to carry out chemically. Research for 
chemical methods for non-activated carbon hydroxylation have concentrated on 
biomimetic systems. The most comprehensive to date have been the 'Gif systems 
investigated by Professor D. H. R. Barton4 and the biomimetic systems studied by 
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Professor R. Breslow.5 Although these systems go some way in terms of mimicking the 
selectivity of biological systems, they certainly do not provide a general method. 
Biocatalytic reactions therefore remain the more successful and widespread method of 
selective hydroxylation. 
As indicated, one of the key advantages of utilising biocatalysis is the selectivity 
imparted on the transformation by the biocatalyst. There are numerous cases, such as 
the hydroxylation of camphor by Pseudomonas putida (discussed in section 1.2), where 
the biocatalyst is extremely selective in the transformation of its natural substrate. More 
importantly, since the exclusive use of natural substrates would distinctly limit the 
methodology, it is encouraging that hydroxylation of non-natural substrates can also be 
carried out with good selectivity. 
Hydroxylations of steroids have historically been the most important use of whole cell 
biohydroxylation methodology. Fungi in particular have been shown to be very useful 
in selective steroid hydroxylation. Initially, Rhizopus arrhizus6'7  and Aspergillus niger8  
were shown to transform progesterone 1 t 1 la-hydroxyprogesterone 2 (figure 1). This 
discovery led to a synthesis 10-12 steps shorter than the existing chemical route in which 
the bioproduct was easily inverted to the required 13  anomer, thus allowing cost-effective 




Figure 1: Biohydroxylation of steroids 
2 
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Although this initial literature is now dated, microbial transformation remains the 
method of choice for steroid hydroxylation. Many years of research have resulted in the 
knowledge that virtually any carbon centre in the steroid nucleus can now be 
hydroxylated selectively.9 
Terpene hydroxylation products are of particular interest to the fragrance industry and as 
intermediates for the pharmaceutical industry. As for steroids, controlled chemical 
hydroxylation is difficult due to the large number of potential sites of hydroxylation and 
successful production of such compounds is mainly restricted to microbial methods. 
The indisputable success of biohydroxylation methodology in naturally occurring 
compounds, such as steroids and terpenes, has provided the basis for recent research that 
has concentrated on the microbial hydroxylation of non-natural compounds. 
1.2 Cytochrome P-450 monooxygenases 
Monooxygenases are a class of oxidoreductases that catalyse the insertion of one atom 
from molecular oxygen into the substrate, while the second atom is reduced to water. 
An important group of monooxygenases are the cytochrome P-450 monooxygenases. 
These haem-dependent monooxygenases carry out the NAD(P)H dependent oxidation of 
a diverse range of compounds. Cytochrome P-450 monooxygenases are extremely 
common in nature and are found in virtually all organisms. 
Substrates for cytochrome P-450 monooxygenases include hydrocarbons, fatty acids, 
steroids, terpenes and xenobiotic drug molecules. The enzymes perform a number of 
functions including aliphatic and aromatic hydroxylation, heteroatom oxidation and 
dealkylation and epoxidation. Perhaps most interesting is their hydroxylation of non-
functionalised hydrocarbon centres as described in figure 2, since this transformation is 
difficult to carry out chemically. 
3 
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H H 	cytochrome 	H OH 
R1 R2 	P-450 	R1 R2 
Figure 2: Hydroxylation of non-activated carbon centres by cytochrome P-450 
monooxygenases 
Mammalian cytochrome P-450 monooxygenases are particularly abundant in 
detoxification organs such as the liver, where they play an important role in the 
detoxification and excretion of xenobiotic molecules. They often catalyse initial 
hydroxylation of lipophilic compounds introducing them into breakdown pathways or 
making them more hydrophilic so facilitating excretion from the body. Perhaps due to 
this function and the need to accept a range of compounds, mammalian cytochrome 
P-450 monooxygenases tend to display wide substrate specificity that contrasts with 
their more specific prokaryotic counterparts. 
Since cytochrome P-450 monooxygenases in the liver are important in drug metabolism 
and excretion, much of the research on the mammalian enzymes has concentrated on the 
identification of inhibitors that could increase the lifetime of the drug molecule in the 
body.'° Unfortunately, drug molecules themselves may inhibit cytochrome P-450 
monooxygenases leading to potentially harmful accumulation of other lipophilic 
compounds in the body.' 
Eukaryotic cytochrome P-450 monooxygenases from fungal sources have proved very 
difficult to study due to instability of the protein and low expression levels and there 
remain few examples.'2 
Unlike their eukaryotic counterparts, prokaryotic cytochrome P-450 monooxygenases 
tend to display very strict substrate specificities that are generally confined to the natural 
substrate and its analogues. Since many monooxygenases are membrane bound, there 
are few examples of stable, isolated cytochrome P-450 monooxygenases, a problem that 
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has slowed the progress in research in human cytochrome P-450 monooxygenases. An 
unusual example of a stable isolated cytochrome P-450 monooxygenase is cytochrome 
P450cam which was originally isolated from Pseudomonas putida and has been purified 
to 	homogeneity. 1315  Cytochrome P450cam  carries out the highly regio- and 
stereoselective 5-exo hydroxylation of the monoterpene camphor 3 to 4 as shown in 
figure 3. This enzyme system typifies the prokaryotic cytochrome P-450 
monooxygenases with substrate specificity restricted to close structural analogues of 
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Figure 3: Hydroxylation of camphor by cytochrome P450cam 
Cytochrome 450cam is however a good example of the high regioselectivity possible in 
biocatalysis, where only one out of a possible of ten regioisomers is produced by 
hydroxylation. The availability of crystal structures of both free and substrate-bound 
protein 16-18 and the unusual stability of the protein mean that the enzyme has often been 
used as a model for other cytochrome P-450 monooxygenases. A recent study though 
has suggested that microbial systems such as cytochrome P450caj,, cannot be used as 
models for mammalian metabolism. 19 
1.3 	Practicalities of biohydroxylations 
Although the potential advantages to using biocatalysis such as mild temperature, pH 
and environmentally preferred solvents are widely accepted, there are also a number of 
operational features which need to be addressed when using a biocatalyst. Due to 
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difficulties in isolating many oxidoreductases and their subsequent instability, many 
biohydroxylations are carried out utilising whole-cell methodology. 
Aside from increased stability of the catalyst, the added advantage of whole-cell 
methodology is that any required co-factors and co-proteins will be provided and 
recycled by the organism. This is extremely important for biohydroxylations since 
cytochrome P-450 monooxygenases require not only a supply of oxygen but also a 
source of electrons, namely NADH or NADPH, and generally two co-proteins to deliver 
these electrons to the enzyme. Among the disadvantages are that other enzymes in the 
cell can cause undesired side-reactions. Additionally the larger volume of aqueous 
media that is required can make the product isolation laborious. 
On the other hand, the use of isolated enzymes as biocatalysts can be advantageous since 
the work-up is likely to be simpler, often with higher concentration tolerance compared 
to whole cell systems and competing side reactions are much less likely. The method is 
however severely compromised since isolation and purification of enzymes can be very 
difficult, and co-proteins also need to be produced and co-factors supplied. 
Although examples of isolated enzyme catalysis do exist, they are certainly not common 
and due to these difficulties are likely to remain so. 
Whole cell biohydroxylations are widespread in the literature mainly due to the robust 
nature of many such biocatalysts. Because the use of such biocatalysts require little 
specialist knowledge or equipment, it is likely that whole cell methodologies will remain 
the method of choice. 
M. 
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1.4 	Beauveria bassiana ATCC 7159 
Beauveria bassiana ATCC 7159 is a member of a small family of fungi and is one of the 
most frequently used whole-cell biocatalysts. It is thought to contain a number of 
hydroxylase enzymes20 and it is their function which has been most studied. Due to its 
widespread use as a biocatalyst, the literature is too wide ranging to carry out a 
comprehensive review here, but a comprehensive review of the biocatalytic reactions of 
Beauveria spp. has recently been published .21 
Among the biocatalytic reactions catalysed by Beauveria bassiana are many that are 
typically carried out by cytochrome P-450 monooxygenases such as aliphatic and 
aromatic hydroxylation; sulfoxidation and heteroatom dealkylation reactions. A number 
of other whole cell transformations such as double bond reduction 22  and Baeyer-Villiger 
oxidation 23  have also been reported. 
The bulk of the literature of Beauveria bassiana has centred on the action of its 
hydroxylase activity; some key areas of which will be discussed here. It should be noted 
when examining the literature that the species under investigation has been redesignated 
twice and that Sporotrichium sulfurescens and Beauveria sulfurescens both refer to the 
strain under study but that the ATCC strain number is constant throughout. 
1.4.1 Non-hydroxylating transformations 
In the only reports of sulfoxidation by the organism, Holland and co-workers have 
described a combination of biocatalytic and chemical routes to reach all the 
stereoisomers of some amino acid sulfoxides, affording a superior route to the existing 
resolution-based methods. 24,25 
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Heteroatom dealkylations by Beauveria bassiana also appear in the literature. 13-lactam 
5 not only undergoes hydroxylation of an ethyl side chain 6 but also yields a significant 
amount of debenzylated, non-hydroxylated product 7 (figure 4). 
OH 
0 )—N"C~Ph B. bassiana 
	
FCPh + H 
5 
	
6(10%) 	 7(20%) 
Figure 4: Incubation of J3-lactam derivative 5 with Beauveria bassiana 
This compound was the only one in a series of five structurally related compounds, 
which underwent N-debenzylation that is thought to occur via benzylic hydroxylation 
followed by hydrolysis of the resultant aminoacetal.26 Another compound in the series 
8, which did not show N-debenzylation, did undergo O-demethylation in a very high 
yield via hydroxylation of the methyl group to a hemiacetal followed again by 
hydrolysis. The difference in selectivity of hydroxylase action on these compounds 
indicates the large impact that seemingly very minor substrate alterations can have on 




1.4.2 Aryl hydroxylation 
Hydroxylation of aryl carbons by Beauveria bassiana has been widely reported for 
many different compounds. One example is the hydroxylation of pyrimidine 
heterocycles that is seen to occur only on the aromatic ring. Successful hydroxylation 
was thought to be dependent on the existence of an electron rich centre in the substrate 
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since incubation of substrate 9 and alkyl substituted analogues was unsuccessful, 
whereas pyrimidine 10 was hydroxylated successfully.27 This hydroxylase activity was 
seen however to be very limited when tested with substrate analogues. Other organisms 
such as Rhodococcus erthyropolis were, for these substrate types, found to be more 
general hydroxylation catalysts. 
We 
N NJ 
9 	 10 
Highly regioselective para-hydroxylation by Beauveria bassiana was noted to occur in 
Propham 1128  and simple derivatives, but regioselectivity was lost on substitution with 
larger alkyl carbamates 1229  yielding mixtures of alkyl hydroxylated and aryl/alkyl 
dihydroxylated compounds. 
H 
NyO (  
'JVK Cr 0 	 AVK Cr 0 
11 	 12 
It is clear from this example that prediction of hydroxylation selectivity is difficult, even 
in related compounds and that competing reactions often occur in transformations. 
1.4.3 Aliphatic hydroxylation 
Natural substrates 
Given the range of compounds that Beauveria bassiana hydroxylates with good 
selectivity, it is perhaps surprising that steroids have proved less successful as substrates 
for .Beauveria bassiana compared to other biocatalysts and there are only a few 
examples of this activity. 30 Beauveria bassiana has also been utilised in the 
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hydroxylation of hydrocarbons and alcohols 31 and terpenes32  but these substrate types 
have attracted only limited interest. 
Amide and related substrates 
By far the most prolific research in Beauveria bassiana has been in the hydroxylation of 
non-activated carbon centres in substrates containing a remote 'directing group'. This 
work was initiated by a methodical examination of hydroxylation in a long series of 
papers by Upjohn research group. The Upjohn group, in common with many others, 
have concentrated on the hydroxylation of hetero- and carbocycles often containing an 
	
electron rich substituent; typical structures being 	14 and 	31 
R 
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Since the initial reports by the Upjohn research group in the late 1960s, there have been 
many reports of aliphatic hydroxylation by Beauveria bassiana, some of which have 
been very selective. 
A study by Roberts, Willetts and co-workers demonstrates that an electron rich 
substituent is not a prerequisite for hydroxylation by the fungus and that regioselectivity 
of hydroxylation can be directed. They showed that substituting and effectively 
blocking the preferred site of hydroxylation can significantly alter the regioselectivity of 
hydroxylation of N-arylamines directing hydroxylation away from the aryl portion and 
into the aliphatic ring (figure 5)36 
Unsubstituted N-arylpiperjdine 16 was hydroxylated regioselectively to give the N-(4-
hydroxyphenyl)piperidine 17 whereas for 18, where this para position was substituted 
IN 
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and effectively blocked, hydroxylation still took place with extremely high 
regioselectivity but this time on the heterocycle rather than the aryl ring 19. Suitable 
para-substituents were found to be electron rich substituents such as nitro, cyano and 
acetate groups, which are thought to be important for recognition by the enzyme. 
Q _ Q Q 
B. bassiana 
6 	1 	 1 
	







Figure 5: Regioselective hydroxylation of N-arylpiperidines 
1.4.4 Prediction of selectivity of hydroxylation by Beauveria bassiana 
Much of the interest in aliphatic hydroxylation by Beauveria bassiana has concentrated 
on compounds with common structural motifs. Comparison of these results has helped 
to produce crude models of the hydroxylase that allow prediction of site and 
regioselectivity of hydroxylation and for the design of new substrates. Substrates for the 
hydroxylases in Beauveria bassiana are typified by structures 13 - 15 with common 
features being the electron rich linkage and an aromatic side chain. The crude model 
shown in figure 6 was initially proposed by the Upjohn group3 ' and has been widely 
used to predict the regioselectivity of hydroxylation in amide-based substrates. 
In this model, it is proposed that cyclic system C 'fits' into the enzyme region where 
hydroxylation takes place and an electron rich group E such as an alcohol or carbonyl 
moiety interacts with the enzyme in what is referred to as the binding or anchoring 
region. The model also allows for some sort of lipophilic group, which may or may not 
be part of the cyclic system. The key restraint in the model is that there is thought to be 
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an optimum distance between the electron rich binding moiety and the site of 
hydroxylation. Although this model was initially based on results from incubation of 
monocyclic alcohols and was based on very few data points, for many years this has 
been accepted as a reasonable model for the substrate-enzyme interaction and has been 
used to explain the regioselectivity of a number of compounds. 
[0] 	5.5A 
Figure 6: Crude active site model for Beauveria bassiana 
Over the years, as more substrates were investigated, it became clear that the rigid nature 
of the model was not perfect and an updated version of the same model was proposed by 
Furstoss and co-workers (figure 7)37 This model is much less rigid in substrate structure 
and allows for the electron rich substituent to be located within the cyclic system. This 
allows for variation in the optimum hydroxylation distance, which from experimental 





Figure 7: Improved model from Furstoss and co-workers where 0 is the hydroxylation 
site, C is a cyclic system and B is the bnding region. 
This updated model does offer an explanation for the analogous hydroxylation of two 
substrates, one containing an exocyclic carbonyl 21 and one a cyclic carbonyl 20 (figure 
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Figure 8: Analogous hydroxylation of a J3-lactam and an amide 
Despite many reports that the distance between an electron rich binding moiety and the 
site of hydroxylation seems to differ dramatically between substrates ranging from 3.5 to 
7 A, it has recently been reported by Pietz and co-workers that 5.5 A is indeed the 
optimum hydroxylation distance for aliphatic hydroxylation of N-phenylcarbamates by 
Beauveria bassiana. They do note however that 'induced fit' of the hydrocarbon portion 
is also important in determining the regio- and stereoselectivity of the hydroxylation.39 
Notably their conclusions are based on small number of hydroxylations and all of the 
substrates contain the same aromatic side chain (22 —24) perhaps explaining the 
13 
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Thus far, investigations and active site models have, in the main, assumed that one 
hydroxylase is responsible for all of those hydroxylations studied. Given the diversity of 
substrate structures tolerated, whilst retaining good if differing regioselectivity, it seems 
unlikely that a single enzyme carries out all the transformations. Researchers had 
largely ignored this point until a recent examination by Holland and co-workers in which 
they systematically altered substrates by stepwise atom or functional group replacements 
and investigated the effect on the regioselectivity of transformation .20 A typical set of 
substrates are shown in figure 9 and their hydroxylation sites indicated. 
aNO C 
t 	 t 
25 	 26 	 27 	 28 	 29 




Holland suggests that this particular series of substrates show that the hydroxylation of 
these compounds is not dependent on the amide since compounds 27 - 29 are 
hydroxylated in similar regions to that in amide 25. para-Hydroxylation of amine 26 is 
accounted for by the activation of this position to electrophilic attack which is perhaps a 
surprising explanation since one of the advantages of biocatalysis is that it is not usually 
dependent on activity, since non-activated groups can be transformed in the presence of 
other more chemically activated groups. A number of groups of compounds were 
similarly investigated with the results suggesting that, in some cases, regioselective 
hydroxylation did not seem to be dependent on an electron rich directing group. 
Inhibition studies were also carried out using a range of known cytochrome P-450 
monooxygenase inhibitors, which in some cases where competing hydroxylation 
reactions were taking place, produced a product array that was dependent on the 
inhibitor concentration. This combined evidence led Holland to propose that as many as 
four separate hydroxylases may exist in Beauveria bassiana. These may be responsible 
for arene hydroxylation; benzylic hydroxylation; non-activated aliphatic hydroxylation 
and the much reported hydroxylation of substrates with remote electron-rich directing 
groups. 
This study does seem to offer a more satisfactory explanation for the selectivity of 
hydroxylation in such a wide range of substrates and could offer a reason for the 
appearance of more than one 'type' of hydroxylation in particular substrates. 
1.4.5 Enantioselectivity of hydroxylation 
Although in most cases, hydroxylation by Beauveria bassiana is regioselective, it has 
been noted that enantioselectivity is not always high. One notable example is the 
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Figure 10: Regioselective hydroxylation by Beauveria bassiana 
Lactam 30 is not hydroxylated enantioselectively but small changes in the structure 
changing the J3-lactam into a benzoylamine 32 confer a large degree of enantioselectivity 
onto the hydroxylation (figure 11). From hydroxylation of optically pure starting 
material, it would seem that each of the enantiomers is hydroxylated on a different 







3O% (op 85 %)33 	 30 % (op 9O%)34 	 5 % (op 46%)35 
Figure 11: Enantioselective hydroxylation by Beauveria bassiana 
In some cases, the substrate, such as simple carbocyclic ketones and carboxylic acids, 
may not be tolerated by the organism or may be too volatile, poorly soluble and difficult 
to detect. Work is currently underway in the group of Griengl to develop a general 
method for the successful hydroxylation of such compounds.4' 	In practice, a 
'docking/protecting' group (similar to a protecting group for synthetic chemistry) 
containing functionality, which influences substrate acceptance and hydroxylation, is 
16 
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introduced prior to and removed after transformation. This approach has been extremely 
successful in some cases; the example shown in figure 12 is the b i otrans formation of 
cyclopentanone 36, which is not transformed by Beauveria bassiana in its natural state. 




36 	 37 	 38 	 3984%ee 
Figure 12: Use of a 'docking/protecting' group in biotransformation 
Although this method. is primarily aimed at increasing the types of substrates accepted 
by the enzyme, the example shown uses a chiral docking/protecting group which has the 
further advantage that it can improve the optical purity of the product, acting much like a 
chiral auxiliary. 
Although these and other cases do show that stereoselective hydroxylation is possible 
with Beauveria . bassiana, much work is needed to ascertain the requirements for 
stereoselectivity. 
As can be seen from this brief review of the literature surrounding Beauveria bassiana, 
although many substrates have been studied and many selective transformations 
identified, our understanding of the factors involved in this selectivity is limited. 
Overall, Beauveria bassiana has shown itself to be a very versatile selective whole cell 
biocatalyst. 
1.5 	Genus Rhodoou 
Actinomycetes are widely distributed in both soil and aquatic environments and have 
great metabolic diversity. The genus Rhodococcus is classified as a group of gram- 
17 
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positive bacteria belonging to the family Nocardioform Actinomycetes. Actinomycetes 
have been used for industrial processes over many years and can metabolise a wide 
range of compounds including simple hydrocarbons, aromatic compounds and steroids, 
a characteristic that has increased the awareness of this family as potential biocatalysts. 
In common with many organisms, the first step of metabolism or transformation of 
many Rhodococcus strains is oxidation. 
1.5.1 Degradation of aromatics 
The degradation of aromatic compounds by Rhodococcus species has been well 
documented. Styrene, an important industrial chemical, has been shown to be 
metabolised by Rhodococcus rhodochrous NCIMB 13259,42  an organism that can also 
oxidise a range of aromatic substrates including toluene. 
Rhodococcus chiorophenolicus PCP-1 was isolated from a pentachiorophenol (PCP) 
enriched culture inoculated from lake sediment and degrades pentachiorophenol and 
other polychlorinated phenols.43 	Pentachiorophenol is widely used as a wood 
preservative and although it is known that it is biodegradable, PCP contamination of soil 
and groundwater is a known environmental problem. 
Rhodococcus spp. are generally persistent in the environment and apparently lack 
catabolite repression, making them potential bioremediation catalysts. This use has been 
suggested for both styrene and pentachiorophenol utilising strains and indeed the 
pentachlorophenol utilising organism has already been shown to be successful in 
bioremediation tests .44'45  
Rhodococcus sp. strain C125 (Corynebacterium strain C125) has been shown to grow 
well on a range of aromatic compounds such as o-xylene, ethylbenzene and tetralin and 
contains an NAD(P)H-dependent dioxygenase activity. 46 
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The Rhodococcus spp. demonstrate large substrate diversity even within aromatic 
compounds with phenols, halogenated phenols and other substituted aromatics tolerated. 
1.5.2 Degradation of hydrocarbons 
There are numerous reports of Rhodococcus species which are able to transform 
hydrocarbons, primarily through initial terminal hydroxylation; including substrates 
ranging from propane (Rhodococcus rhodochrous ATCC 21 198)47  and octane 
(Rhodococcus rhodochrous NCIMB 9703)48  to branched long chain hydrocarbons such 
as phytane 40 49 
40 
1.5.3 Use of Rhodococcus spp. in biocatalysis 
Due to their wide metabolic diversity, Rhodococcus spp. have been investigated as 
biocatalysts for many years. Reports of the use of Rhodococcus sp. as asymmetric 
catalysts include their use in the preparation of enantiopure epoxides and as microbial 
epoxide hydrolases.5°  
The biggest application of Rhodococcus spp. is as biocatalysts for nitrile hydrolysis. 
Rhodococcus spp. have been shown to participate in two pathways in the conversion of 
nitriles to carboxylic acids; either by direct conversion using a nitrilase enzyme or via an 
amide intermediate by the action of two enzymes (figure 13). 
Me 
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The interest in these transformations results from the value of the products and the harsh 
conditions (strong acid/base under reflux) required for chemical transformation. The 
chemical transformation also produces by-products that are difficult to remove, whereas 
the biocatalytic route shows high specificity. Bioprocessing systems used in industry 
employ Rhodococcus strains for the production of acrylamide51 in one of the largest 
tonnage biocatalytic processes in operation. 
0 	 0 
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Figure 13: Biocatalytic nitrile hydrolysis 
In addition to nitrile hydrolysis being chemoselective, it has been shown that hydrolysis 
of nitriles52  and aminonitriles 4 153 can also be enantioselectjve (figure 14). Experiments 
using the amide intermediate showed that in this case the nitrile hydratase activity is not 
enantioselective whereas the amidase activity is. 
NH2 	 NH3 
cr JCN 
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Figure 14: Enantioselective hydrolysis of aminonitriles 
In a related hydrolysis reaction and in combination with another biocatalyst, a key 
problem in the synthetic route to carbovir 43 was overcome using Rhodococcus equi as a 
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Figure 15: Preparation of carbocyclic nucleoside carbovir 43 
cis-(1S, 2R)-indandiol 44 and trans-(1R, 2R)-indandiol 45 are both potential precursors 
to (-)-cis-(1R, 2R)-1-aminoindan-2.ol which is a key chiral synthon for Crixivan® 
(indinavir) 46, an orally active HIV protease inhibitor. 
Two Rhodococcus species have recently been shown to have biocatalytic activity for the 
conversion of indene to the cis- and trans-indandiols56 and it is hoped that this discovery 
could be used to provide large amounts of the enantiomerically pure intermediate and 
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These last two examples show the potential utility of microbial oxidation in the synthesis 
of enantiopure pharmaceutically important molecules. 
1.5.4 Cytochrome P-450 monooxygenases in Rhodococcus species 
It is known that many species of the actinomycetes contain at least one cytochrome 
P-450 monooxygenase.57  Investigation of such systems as biocatalysts has concentrated 
on the Streptomyces genus, although it seems likely that other species of Actinomycetes 
such as Rhodococcus, Corynebacterium and Nocardia also have potential as cytochrome 
P-450 mediated hydroxylation catalysts. It is interesting to note that, in a 40 page 
review of the biotransformations catalysed by the Rhodococcus spp. published in 
1994,124 the actions of cytochrome P-450 monooxygenases are not mentioned, despite 
their being responsible for initiating the metabolism of alkanes by hydroxylation. 
Cytochrome P-450 monooxygenases have been proposed to be involved in epoxide 
formation by Streptomyces Jlavovirens58 and O-demethylations in Streptomyces 
setonhi.59  There are also a number of cytochrome P-450 monooxygenases of 
actinomycete source, which have been isolated and characterised such as P-450 0 . from 
Streptomyces griseus ATCC 13273.60 Cytochrome P-450 0 is induced by growth on 
soybean flour enriched media and is interesting since it has a broad substrate specificity 




Although a number of Rhodococcus strains have been reported for their hydroxylating 
abilities, some of these have been shown to have non-P-450 dependent hydroxylating 
ability. An example of this is Rhodococcus erythropolis,27 where a molybdoenzyme is 
thought to be responsible for hydroxylation of pyrimidine heterocycles as determined 
through inhibition studies using known inhibitors. There are however increasing 
numbers of cytochrome P-450 monooxygenases implicated in hydroxylation by 
Rhodococcus spp. 
A single cytochrome P-450 monooxygenase system has recently been implicated in the 
degradation of herbicides such as atrazine by Rhodococcus sp. strain N186/21 and has 
been suggested as a good target for bioremediation.61'62 
Rhodococcus equi IFO 3730 has been shown to carry out the asymmetric sulfoxidation 
of 2-alkoxyethylsulfides such as 47. In the case shown the MOM group was then 
cleaved to give optically pure 2-hydroxyethyl sulfoxides that are potentially useful 
synthetic intermediates. 63 Such sulfoxidation could be carried out by monooxygenase 
enzymes including cytochrome P-450 monooxygenases. 
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As noted for Beauveria bassiana, Rhodococcus spp. have also been shown to selectively 
hydroxylate steroids. Resting cells of Rhodococcus sp. IOC-77 have been shown to 
carry out the 9(x-hydroxylation of steroids, such as 4-androstene-3, 1 7-dione 48 via a 
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Figure 16: Rhodococcus catalysed hydroxylation of steroids 
1.5.5 Rhodococcus rhodochrous NUMB 9703 
It has been reported that Rhodococcus rhodochrous ATCC 19067 (NCIMB 9703) 
(previously classified as Corynebacterium sp. strain 7E1C) grows on n-octane inducing 
a cytochrome P-450 which catalyses the NADH-dependent terminal hydroxylation of 
n-octane.48'65  This soil bacterium was originally isolated as a propane utiliser and was 
reported to carry out the diterminal oxidation of long chain (C 10 - C14) alkanes. It was 
found that growth on n-octane as the sole carbon and energy source induced a 
cytochrome P-450 system. Cell free extracts were shown to transform octane to 
1-octanol and octanoic acid requiring NADH and oxygen. The hydroxylation system 
was separated into two fractions, one containing cytochrome P-450 and one containing 
flavoprotein, both of which were necessary for activity.48'65  
Despite the ongoing interest in the omega hydroxylase from Pseudomonas oleovorans, 
which was discovered around this time and the ongoing interest in cytochrome P-450 




1.5.6 Rhodococcus sp. NUMB 9784 
Rhodococcus sp. NCIMB 9784 has been reported to perform regioselective 
hydroxylation of camphor 3 to produce 6-hydroxycamphor.66 This strain was also 
reported to catalyse the Baeyer-Villiger biooxidation of fenchone 50.67 This result in 
itself was interesting and suggested a high degree of selectivity for the enzymes present, 
since camphor and fenchone have great structural similarity and yet are degraded by 
different initial oxidative attack. 
Although hydroxylation of camphor by this organism was seen to be highly selective, 
further investigation of this organism was limited and research on camphor 
hydroxylation concentrated on cytochrome 450cam from Pseudomonas putida (section 
1.3). Recent work within our laboratories 18 has isolated the hydroxylase and confirmed 
	
its classification as a cytochrome P-450. 	Through NMR studies, the site of 
hydroxylation has been confirmed as the 6-endo position. This highly selective 
cytochrome P-450 dependent hydroxylation is very interesting, due to its contrasting 
regioselectivity with the equally selective cytochrome P450cam (figure 17). 





4  3 	 51 
Figure 17: Complementary hydroxylation of camphor by two biocatalysts 
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This complementary regioselectivity makes the camphor utilising cytochrome P-450 in 
Rhodococcus sp., an interesting target in the search for more information regarding the 
origin of selectivity of transformation by cytochrome P-450 monooxygenases. 
Another cytochrome P-450 of Actinomycete source, cytochrome P-450 0 from 
Streptomyces griseus was also shown to catalyse the hydroxylation of camphor. It is 
noted that, in this case, the regioselectivity is much lower with four products isolated.69 
This lower regioselectivity of hydroxylation is similar to the regioselectivity of 
hydroxylation of 450LM2 from rabbit liver where 5-exo, 3-endo, 5-endo and other 
minor hydroxycamphor products were produced, showing an example of the similarity 
of eukaryotic cytochrome P-450 0 to its mammalian counterparts .70 
Perhaps surprisingly, with the implication of cytochrome P-450 monooxygenases in 
hydroxylations by Rhodococcus sp., very few have been isolated and identified. One 
example is the identification of two cytochrome P-450 monooxygenases in Rhodococcus 
rhodochrous strain 116 which degrade aromatic ethers. These P-450's are induced by 
2-ethoxyphenol and 4-methoxybenzoate respectively and the compounds inducing the 
expression of each P-450 binds specifically to that enzyme, suggesting a narrow 
substrate specificity.7' Cytochrome P-450,, (induced by and binder of 2-ethoxyphenol) 
has since been purified to apparent homogeneity and fully characterised as a cytochrome 
P-450.72  
1.6 Summary 
For this brief review of some of the key literature, it should be clear to the reader that 
biohydroxylations are an important class of biocatalytic reaction and are likely to remain 
so for the foreseeable future. The key to this importance is the high selectivity that the 
enzyme catalyst imparts to the transformation and that there is, to date, no easily or 
widely acceptable chemical alternative. 
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One of the key questions in the field is the prediction .of the site and selectivity of 
hydroxylation. This issue is being addressed particularly with the Beauveria bassiana 
hydroxylase system(s) based on substrate studies, with some success; further success is 
likely to depend on the isolation of the enzymes involved. 
Although attempts have been made to utilise microbial hydroxylation systems as models 
for mammalian metabolism, it has been shown that while there are often commonalities 
between the microbial and mammalian systems, they have been found to be unreliable 
and at times can be misleading.'9 
The most important application of biocatalysis in pharmaceutical research is the use of 
these organisms to overcome synthetic problems and allow the production of selectively 
hydroxylated drug molecules. Such hydroxylated compounds are extremely important 
for use in identifying mammalian metabolites and for subsequent testing as a metabolite. 
Biocatalysis is also extremely important in the production of key chiral intermediates for 
synthesis. 
1.7 Aims 
The aims of this project were two fold. Firstly we were interested in carrying out a 
systematic study into the hydroxylation of a series of structurally related compounds by 
the well-studied Beauveria bassiana to investigate the impact of structure modifications 
on the regioselectivity of hydroxylation. 
Secondly we wanted to investigate the hitherto undetermined cytochrome P-450 
dependent hydroxylation potential of a number of Actinomycetes belonging to the 
Rhodococcus genus. Furthermore we wanted to investigate the scope and selectivity of 
any activities identified. 
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Combination of this re-investigation of a previously utilised biocatalyst with' the 
investigation of new biocatalytic activities was hoped to yield more information 
regarding cytochrome P-450 selectivity and perhaps identify routes to useful chiral 
intermediates for use in further synthesis. 
2. Beauveria bassiana ATCC 7159 
2 Biotransformations using Beauveria bassiana ATCC 
715973  
2.1 Aims 
Beauveria bassiana ATCC 7159, as discussed in the introduction, is used widely as a 
whole cell biocatalyst for hydroxylation. Attempts to model the substrate/active site of 
the hydroxylase(s) have allowed prediction of the regioselectivity of hydroxylation with 
some success. As indicated in the discussion of the active site models, the important 
factor in determining the site of hydroxylation has always been assumed to be the 
relative position of the electron rich moiety. Although apparently not necessary for 
regioselective hydroxylation, the presence of an aromatic moiety in the substrate 
molecule is noted in many good substrates for the hydroxylase(s). As an extension of 
the active site models, we were interested in the importance of this aromatic side chain, 
in particular on the regioselectivity of hydroxylation. 
An appraisal of the literature showed that N-benzoylpiperidines had been discovered in 
the late 1960s to be hydroxylated with some regioselectivity to yield, in some cases, 
optically active hydroxylated piperidine derivatives (figure 1 
OH 









Figure 18: Typical transformation yielding hydroxypiperidine derivatives 
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It has been noted previously that seemingly minor changes in substrate structure can 
have a significant effect on the selectivity of hydroxylation. We envisaged that the 
importance of the aromatic group could be investigated by the examination of analogous 
compounds to those previously studied retaining the N-heterocycle but incorporating a 
different aromatic side chain. 
Another important factor in our investigations was the utility of the hydroxylated 
products, since we wanted not only to gain further information on the structural 
requirements required for selectivity, but to investigate the potential for this biocatalytic 
route as a means of accessing selectively hydroxylated compounds. Important to this 
utility is the ease of removal of the aromatic side chain. 	Although the 
N-benzoylpiperidjne transformations could be considered a potential route to 
hydroxylated piperidines, subsequent removal of the N-benzoyl group is not trivial. 
N-benzyloxycarbonyl (Cbz) would appear to be a potentially more useful aromatic side 
chain. The group has the typical protecting group properties of ease of introduction and 
removal: the aroun is intrndiiiw 	 f 	- 
benzylchloroformate and cleaved by catalytic hydrogenation or acidolysis by 
O-dealky!ation, followed by loss of carbon dioxide. These methods of removal would 
be mild enough to leave the hydroxylated heterocycle unaffected. Most importantly for 
our studies, the group retains the electron rich carbonyl group, thought to be necessary 
for selectivity, and an aromatic group. The aromatic 'side chain' 55 is also longer than 
the benzoyl group 56 but the electron rich carbonyl is still directly attached to the 
nitrogen allowing direct comparison of the substrates (figure 19). 
NR2 	 NR2 
0 	 o 
55 	 56 
Figure 19: Comparison of aromatic side-chains studied 
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The third point under investigation is the level of substitution around the heterocycle. In 
Johnson's work, a number of alkyl substituents around the heterocycle were tolerated; 
indeed some of these alkyl side chains were actually hydroxylated. We wanted to 
investigate the incorporation of such substituents and their effect on the selectivity of 
hydroxylation. 
In summary, our aims were three-fold; namely the investigation of the effect of a longer 
aromatic side chain with different properties to that previously investigated, the effect of 
introducing alkyl substituents around the heterocycle and the use of an easily removed 
protecting group to direct hydroxylation. 
A range of N-Cbz protected alkyl piperidines were prepared from the corresponding 
commercially available alkyl piperidines by reaction with benzylchloroformate.74 
2.2 Methods 
In common with the literature, these transformations were carried out using growing 
cells. Since the hydroxylases in B. bassiana are thought to be constitutively expressed, 
growth was on glucose/corn steep solids media with no attempted induction. The 
substrate was added as a concentrated solution in ethanol to a final concentration of 0.1 
mg/ml. This low substrate tolerance is often regarded as one of the main disadvantages 
of whole-cell methodology as, in this case, conversion of 250 mg required extraction of 
2.5 L of aqueous phase. This procedure was not optimised although it was based heavily 
on literature methods. 34,75 
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2.3 Results 
Since the initial part of this work has been reported previously, 74  little detail will be 
given here, but the results are included to allow a complete comparison of results. The 
results of the biohydroxylations are summarised in table 2 (page 44) along with a 
comparison with results obtained using N-benzoyl analogues. 33  NMR experiments to 
ascertain the relative stereochemistry have not been reported previously. 
Incubation of N-Cbz-piperidine 5774 
The unsubstituted Cbz-protected piperidine 57 is hydroxylated almost exclusively at the 
4-position (58, 33 % yield) (figure 20). The structure was easily assigned from 
inspection of the 'H and ' 3C NMR spectra that showed the presence of the characteristic 




Figure 20: Transformation of alkylpiperidine 57 by Beauveria bassiana 
The regioselectivity noted was in common with results obtained with N-benzoyl 5933 
and N-phenyl36 derivatives 60 and 61. The regioselectivity in these cases is interesting 
because the substrates are all hydroxylated selectively in the same position, despite the 
common structural features, the carbonyl group and the phenyl ring, being located in 
different positions in the molecules (figure 21). 
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QQ 
OOf o a a 
57 	 59 	 60 	 61 
Figure 21: Known substrates for B. bassiana with site of hydroxylation indicated 
Amides 57 and 59 have the carbonyl substituent between heterocycle and aromatic the 
same distance from the hydroxylation site. Amine 60 is also hydroxylated with the same 
regioselectivity although the carbonyl group is in this case significantly further removed 
from the site of hydroxylation. This electron rich group appears to be required, since 
regioselectivity for hydroxylation of the heterocycle is not retained in amine 61. 
Incubation of N-Oz-4-methylpiperidine 62 74 
This high selectivity was completely conserved when the 4-methylpiperidine derivative 
62 was the substrate, with hydroxylation occurring at the tertiary carbon (63, 45 % yield) 
(figure 22). 
OH 
6  N	 B. bassiana 	 N 
oOm 	oo 
62 	 63 
Figure 22: Biohydroxylation of substituted piperidine derivative 
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Although the mechanism of hydroxylation by enzymes is currently unproven, some 
proposals have suggested that a radical mechanism is involved in a multistage process. 16 
Indeed an investigation by Fourneron has implicated the involvement of a carbon radical 
intermediate in biohydroxylations by B. bassiana.77  In light of this evidence, it is 
tempting to explain the regioselectivity of hydroxylation of the 4-methyl substituted 
piperidine 62 in terms of the stability of the tertiary radical intermediate. 
It is interesting to note that biohydroxylation of the N-benzoyl derivative 64 33 resulted in 
a mixture of the 4-hydroxy compound 65 and the 4-hydroxymethyl compound 66 as a 
result of competing hydroxylation of the alkyl side chain (figure 23). In this case, the 
insertion of a methyleneoxy unit between the aryl group and the electron rich amide 
appears to have significantly improved the regioselectivity. In the case of the analogous 
N-(4 acetylpheny1)4methy1pjperidine substitution on the heterocycle and retention of 
the aryl moiety resulted in only the 4-hydroxy-4-methyl compound in common with our 
observations. 36 
6  
OH 	 OH 
C N  B. bassiana 	 + 6  o	 O 
64 	 65 	 66 
Figure 23: Typical transformation of substituted N-benzoylpiperidines 
Incubation of N-Cbz-3-methylpiperja'jne 67 
In a departure from the high regioselectivity observed for the previous reactions, three 
products were isolated from the incubation of N-carboxybenzyl-3methyl piperidine 67 
(figure 24). 
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67 	 68 	 69 	 70 
Figure 24: Mixture of products produced by biohydroxylation of 67 
The first was identified as a 4-hydroxylated product 68 by NMR spectroscopy. 
Coupling constants for the proton attached to the hydroxylated carbon (CHOH signal) 
also allowed determination of the relative stereochemistry of the hydroxy and alkyl 
substituents. The CHOH signal showed two large and one small couplings (J 3, 12 and 
14 Hz) which were attributed to two axial-axial and one axial-equatorial coupling as 
shown in figure 25. This assignment of the coupling pattern suggests that the hydroxyl 









Figure 25: Coupling constants used in assigning hydroxylated product 68 
The remaining two products were found to be very difficult to separate either by flash 
chromatography or preparative HPLC. The mixture was therefore subjected to 
acetylation conditions under which only one of the two products was acetylated (as 
indicated by NMR spectroscopy and mass spectrometry) yielding a mixture of 
O-acetylated 69 and 70 which were then easily separated by preparative HPLC. 
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The O-acetylation of 69 to yield 69a was confirmed by NMR spectroscopy, which 
demonstrated that it was an O-acetylated stereoisomer of alcohol 68. In the case of 69a, 
the hydroxyl group was deduced to be introduced axially since the adjacent proton signal 
showed only three small couplings (J 3, 5 and 5 Hz) and therefore had no axial-axial 
interactions (figure 26). It was not possible to ascertain the relative position of the 
methyl group from simple decoupling experiments, since the C3-H signal is not easily 
identifiable. It is thought however that the methyl substituent is likely to lie in an 
equatorial position since a 3,4-diaxial conformation would be disfavoured and thus 





Figure 26: Couplings observed for CHOAc signal in 69a 
Product 70 was found to be unaltered by the acetylation conditions. Mass spectrometry 
(atmospheric pressure chemical ionisation) showed an (M + 1) peak at 250. 1, 
confirming monohydroxylation. Since the characteristic CHOH signal was missing in 
the NMR spectrum, alcohol 70 was assigned as the 3-methyl-3-hydroxy derivative. 
This example shows that ease of radical formation is certainly not always the single 
controlling factor in hydroxylation regioselectivity. In this case, alignment of the 
piperidine ring in the enzyme active site is a more significant factor. 
This transformation was reported previously 74  although the products were not separated 
and characterised. 	Biooxidation of the corresponding compound, N-benzoyl-3- 
methylpiperidine, produced a mixture of 3- and 4-hydroxy products giving a comparable 
product array. 33 
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Incubation of N-Cbz-2-methylpiperidine 7174* 
Incubation of the fungus with N-Cbz-2-methylpiperidine 71 yielded approximately equal 
amounts of two p-oducts 72 and 73 (figure 27). 
a.N 	 B. bassiana 
71 
Figure 27: B iotrans formation of 2-methylpiperidine derivative 71 
Alcohol 72 was found, by NMR spectroscopy, to be hydroxylated in the 4-position 
because the characteristic CHOH signal shows the maximum four couplings. All the 
coupling constants were shown to be small (J 3 Hz), indicating an axial positioning for 
the introduced hydroxyl group (figure 28). NOE experiments showed no enhancements 
providing evidence as to the relative stereochemistry of the methyl and hydroxyl 
substituents. It is well documented however, that for alkylpiperidine amides, 2-alkyl 
substituents favour axial rather than equatorial positioning 78,79  due to severe A"3  
interaction in the equatorial conformation. It was thus assumed that alcohol 72 has the 
2,4-diaxial arrangement. 
Biohydroxylation experiment carried out by Dr. Gideon Grogan; product characterisation carried out by 
the author. 
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Figure 28: Coupling constants used in assignment of alcohol 72 
Product 73 on the other hand was found to be hydroxylated on position 3 of the 
heterocycle. The CHOH multiplet was not sufficiently resolved to ascertain the 
axial/equatorial positioning of the introduced hydroxyl group but nOe studies suggested 
that the methyl group lies on the same side of the piperidine ring (figure 29). If we 
assume again that the 2-methyl group lies axially, due to the A'3 strain, then the 
hydroxyl group would be situated equatorially. 
Me 
Cbz. N ,LZoH 
~j 
6% 
Figure 29: nOe enhancement used in assigning 73 
The results from this incubation are again largely analogous to those observed by 
Johnson, although in this case, the authors did observe a minor 4-keto product. Their 
identification of even a small amount of ketone is interesting since in no case did we 
identify further oxidation. 
Incubation of N-Gbz-cis-2, 6-dimethylpiperidine 7474 
* 
When N-carboxybenzyl-cis-2,6-dimethylpiperjdjne 74 was incubated with Beau veria 
bassiana, one hydroxylated product was recovered. 'H and 13C NMR indicated this 
NEZ 
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compound to be the 4-hydroxy derivative 75 (figure 30), this pro.:uct has relative 
configuration 2,6-cis-4-trans (again assuming that the 2-alkyl groups adopt an axial 
positioning) (figure 31). 
,JIII1%.... 	B. bassiana 
oo 
74 75 
Figure 30: Conversion of 2,6-dimethylpiperidine 74 
4 Hz 
11 Hz 
Me 	H 	4 H 
Me H 
C b z N2 H 11 Hz 
Figure 31: Coupling constants used in assignment of 75 
Incubation of N-Cbz-2-ethylpiperidine 76 
N-Cbz-carboxybenzyl-2-ethylpiperidine 76 hydroxylation occurs almost exclusively at 
the 4-position to give the 4-hydroxypiperidine product 77 in good yield (figure 32). 
76 
B. bassiana 
Figure 32: Selective hydroxylation of 76 by Beauveria bassiana 
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From examination of the 1D proton NMR spectrum, the hydroxyl group was thought to 
lie in an equatorial orientation (figure 33). NOE studies added to this evidence showing 









Cbz HOH 11.5 Hz 
Figure 33: Coupling constants used in assigning hydroxylated product 77 
Two further substrates have been tested with the fungus, which do not correlate with the 
substrates used by Johnson, but add to the overall series and the investigation of the 
tolerance of the active site to changes in the substrate. 
Incubation of N-Cbz-3,3-dimethylpiperidine 78 
Incubation of the 3,3-dimethylpiperidine derivative 78 with the fungus provided the 4-
hydroxylated product 79, with the hydroxyl group introduced equatorially (figure 34). It 
was also noted that the rate of this hydroxylation was enhanced and that no substrate 









78 	 79 
Figure 34: Transformation of dimethyl substrate 78 
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Interestingly, this result was another case where no hydroxylation of the alkyl group was 
observed, unlike those substrates employing the N-benzoyl aromatic side chain where, in 
more than one case, the alkyl group was hydroxylated. 
Incubation of N-Cbz-2,3, 6-trihydropyridine 80 
The only result from this series that was somewhat unexpected was obtained when the 
fungus was challenged with the unsaturated piperidine derivative, N-carboxybenzyl-
2,3,6-trihydropyridine 80 where no biohydroxylation was noted and unreacted starting 
material was recovered. This result was surprising since the 3,4-alkene was envisaged to 
be ideally placed for epoxidation and because cytochrome P-450 monooxygenases, in 
particular those of Beauveria bassiana, are known to produce epoxides from alkenes 





81 	 82 
2.4 Discussion 
Degradation of substrate/hydroxylated product 
The Cbz-protecting group is potentially labile to other enzymes in the fungus and was a 
major concern when employing this series of substrates with the whole cell system. 
Microbial carbamate hydrolases have been reported in whole cell systems27 and 
degradation of alkyl substituted aromatics by benzylic hydroxylation in fungi has been 
well, studied.82  Both of these degradation pathways were potential problems with our 
substrate design. 
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The only case in which these problems arose was N-Cbz-2,6-dimethylpiperidine 74 
where the hydroxylated product 75 was isolated in very low yield (-.40 mg from 270 mg 
substrate), but a large amount of benzoic acid was also recovered (90 mg). The 
isolation of benzoic acid suggests some sort of benzylic hydroxylation, either of the 
starting material or of the hydroxylated product. Such a degradative mechanism would 
not be possible in the N-benzoyl case and is reflected in the higher yield reported. 
The yields of product recorded in these transformations are between 5 - 4.8 %, which is 
very respectable for this type of reaction (table l).333536 Unlike many literature 
examples, no starting material was recovered along with the products after three days 
incubation. It is likely that the mass balance of the conversions (greater than 50 % of 
substrate unaccounted for) is lost through degradative mechanisms. 
Substrate Substituent Yieldt 
57 None 33 
62 	
. 4-methyl 45 
67 3-methyl 24 
71 2-methyl 14 
74 2,6-dimethyl 5 
76 2-ethyl 45 
78 3,3-dimethy! 48 
Table 1: Yields of biotransformations reported for substituted N-Cbz-piperidines 
It has previously been reported that the inclusion of 'inverted' urethane linkers in 
substrates for Beauveria bassiana led to no biotransformation whatsoever; substrates of 
structure 83 where RA is aryl and RB  alkyl are successfully hydroxylated whereas the 
'inverted linker' where RA is alkyl and RB is aryl are not. Based on these results, it was 
Combined yields taken before separation of hydroxylated products 
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proposed that conjugation between the aromatic ring and the carbamate carbonyl is 
necessary for biotransformation to occur. 29 
RA N1O RB 
83 
Our observations however are contrary to these results and clearly show that conjugation 
between the aromatic moiety and the carbonyl is not a prerequisite for hydroxylation. 
Regioselectivity - effect of alkyl substitution 
The change in regioselectivity of hydroxylation around the piperidine ring from the 4- to 
the 3-position with regioisomeric alkyl substitution is difficult to rationalise in terms of 
steric restrictions. For piperidines 57 and 62, access to the favoured 4-position by the 
hydroxylating species is unrestricted, but methyl substitution at the 2- and 3-position 
must move the 4-position sufficiently far from this species that hydroxylation also 
occurs at the 3-position. One might expect that extending the 2-alkyl chain would 
therefore result in even more pronounced selectivity for the 3-position. However, 
N-carboxybenzyl-2-ethylpiperidine 76 yielded only the 4-hydroxylated compound 77. 
Although the effect of alkyl substitution is difficult to rationalise, it is noted that small 
changes in substitution can make significant differences to the regioselectivity. 
Molecular modelling of the substrates may provide further insight into the effect of 
substitution. 
Regioselectivity - effect of aryl side chain 
One of our key aims in this investigation was to gain more understanding of the factors 
involved in the regioselectivity. In order to understand these, it is important to compare 
our observations with those previously reported by the Upjohn research group.33  
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2. Beauveria bassiana ATCC 7159 
Substrate Products Products 






Et Et 	N 	Et 
76 
Table 2: Results of biohydroxylations of Cbz-alkyl piperidines including a comparison 
with the results obtained from the N-benzoyl analogues33 
The results obtained are compared in table 2 and can be summarised: 
Cbz series shows selectivity for 4- position, whereas benzoyl series 
shows product mixtures in most cases. 
Cbz series shows no side chain hydroxylation - common in benzoyl 
series 
Cbz series shows no further oxidation to ketone - noted in benzoyl series 
To compare and draw tentative conclusions from these observations, we have to assume 
that the same hydroxylase enzyme within the whole cell system carries out all the 
biohydroxylations reported. Although there is clearly more than one active hydroxylase 
in the system, the assumption is thought to be valid given the close structural similarities 
of the substrates. 
With this assumption in mind, it is difficult to explain the improvement in 
regioselectivity realised on examination of the Cbz alkylpiperidine series solely on the 
basis of the current active site model. Even in the updated models, it is assumed that the 
key restraint on the site of hydroxylation is the distance between the electron rich moiety 
and the hydroxylation site. 
45 
2. Beauveria bassiana ATCC 7159 
The hydroxylase is clearly now disposed to hydroxylation in the 4-position, except 
where there is a 2- or 3-methyl substituent when the selectivity is compromised, 
suggesting that the active site of the Beauveria hydroxylating system is very sensitive to 
relatively small changes in the nature of the protecting group. The distance from the 
carbonyl group to the putative site of hydroxylation is, of course, unchanged from N-
benzoyl to N-benzyloxycarbonyl. Our results would suggest that the more critical 
characteristic for selective hydroxylation is the distance from the carbonyl to the 
aromatic binding pocket. 
In addition, greater flexibility of the N-carboxybenzyl molecule is afforded by rotation 
around the benzylic centre. This would appear to allow improved accommodation by 
the active site and perhaps greater regioselectivity for some substrates. 
We propose that there is a defined aromatic binding pocket within the active site of the 
hydroxylase and that interaction of the substrate with the enzyme is affected sufficiently 
for the hydroxylation site to be no longer controlled solely by the site of the electron rich 
moiety in the substrate molecule. 
Stereochemistry of hydroxylation 
It has been extensively reported that, in rigid systems, the hydroxyl group is introduced 
trans with respect to the amide functional group. 35,81,83,84  By the use of proton NMR 
analysis, we have established that the hydroxyl group is introduced into the equatorial 
position in most cases. The exceptions are the 2-methyl-4-hydroxyl product 72 where 
the hydroxyl group was seen to lie in an axial position (this was shown by the lack of an 
nOe enhancement between the axial C(6)H and the C(4)H and also from the coupling 
constants of the CHOH signal, showing no axial-axial coupling) and the 3-methyl-4-
hydroxyl product (the acetylated derivative of which was isolated 69a) where the 
CHOAc signal showed no axial-axial coupling. Our results therefore show a clear 
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preference for hydroxylation trans to electron rich carbamate. It is unclear whether such 
selectivity exists in the N-benzoyl series due to assignment difficulties. 
Stereoselectivity of hydroxylation 
Unusually for flexible substrates, Johnson and co-workers reported some 
enantiodifferentiation by the Beauveria hydroxylating system when operating on 
N-benzoylalkylpiperjdines 33  On examination of the data presented, one must be 
sceptical as to the accuracy of these conclusions. The authors themselves note that their 
product isolation and purification depends on crystallisation and given that in some 
cases the crystallisation yields are as low as 6 % of the crude fraction, there is a 
likelihood that at least some resolution could have taken place. Although not all of the 
optically active products have crystallisation yields as low as this, the results should be 
examined critically. The optical purity of our products has not been determined but it 
was seen that in all cases, a 72 hour incubation of the substrate with the fungus resulted 
in complete substrate disappearance and since the yield of hydroxylated products in 
some cases was approximately 50 %, it is perhaps less likely that a resolution process is 
operating. It is likely, on the basis of previous work, 85-87 that the enantioselectivity and 
resulting enantiomeric excess (if relevant) will depend on many factors, including the 
time course of the reaction. There could be preferential hydroxylation of one 
enantiomer of the substrate at a single position as well as preferential metabolism of one 
of the product molecules, both of which would affect the enantiomeric excess of the 
final product. At this stage of the project and due to the expected low enantioselectivity 
with Beauveria bassiana, investigation of the optical purity of these products was not 
undertaken. 
2.5 Conclusions 
This study has established that the regioselectivity of hydroxylation by Beauveria 
bassiana ATCC 7159, an organism much used for biotransformatjons of this type, may 
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be significantly altered by changes to the linker between the putative site of 
hydroxylation to the aromatic group. This finding confirmed the previously noted 
observation that apparently small changes in substrate structure can significantly alter 
the regioselectivity of hydroxylation. In light of the comparison between the previously 
studied N-benzoylpiperidines and our N-benzyloxycarbonylpiperidines, it appears that 
regioselectivity is not only determined by the distance between hydroxylation site and 
carbonyl group that is constant in the molecules studied. We propose that the active site 
of the hydroxylase may contain a defined aromatic binding pocket and that the distance 
from aromatic group to site of hydroxylation may also be a contributing factor to the 
regioselectivity. The site of hydroxylation in a series of related substrates was found to 
be dependent on substitution of the heterocyclic ring and could be manipulated by 
appropriate alkyl substitution around the ring. 
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3 	Biotrans formations with Rhodococcus sp. NUMB 9784 
3.1 Aims 
The use of Rhodococcus species in biotransformations has mainly been for nitrile 
hydrolysis, indeed this use has proven the utility of Rhodococcus systems for industrial 
scale biotransformation. Bioremediation tests have also shown the adaptability of 
Rhodococcus species to changing environments. 	Although examples do exist, 
Rhodococcus spp. are not widely used for oxidative biotransformations. It is known that 
many Actinomycetes such as Streptomyces spp. can be useful for biohydroxylations and 
our aim was to investigate the utility and scope of Actinomycetes belonging to the 
family Rhodococcus for such transformations. We were particularly interested in the 
hydroxylation of non-activated carbon centres by cytochrome P-450 monooxygenases. 
The work described here was carried out as part of a larger investigation into the, as yet 
under utilised, activity of Rhodococcus species as biohydroxylation catalysts. 
Initial screening, carried out by Dr. Gideon Grogan, encompassed six Rhodococcus spp., 
which were identified from the literature as containing hydroxylating monooxygenase 
(and therefore potentially cytochrome P-450) activity. The organisms were grown on 
carbon sources reported to elicit their monooxygenase hydroxylation activities and their 
hydroxylation activity tested against a number of substrates known to be hydroxylated 
by cytochrome P-450 monooxygenases. 
One of the monooxygenase systems identified from this screening was Rhodococcus sp. 
NCIMB 9784. As highlighted in the introduction, this organism was reported to catalyse 
the regioselective hydroxylation of (+)-camphor.66 To our knowledge, there have been 
no further literature reports of the use of this organism. 
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Our aim in studying this hydroxylating organism was to investigate its activity in terms 
of substrate specificity and selectivity. Studies within our group have shown that (+)-
camphor is hydroxylated in the 6-endo position in a hydroxylation that is 
complementary to the 5-exo hydroxylation carried out by cytochrome P450cam from 
Pseudomonas putida. In light of this complementary stereoselectivity, we wanted to 
investigate the specificity and selectivity of the Rhodococcus system for comparison 
with the well-characterised cytochrome P-450cam system. 
3.2 	Growth of the organism 
Since monooxygenase activities are often substrate-inducible,57 the organism was 
initially grown on camphor in an effort to elicit the hydroxylation activity reported 
previously. 66  Growth on basal salts medium augmented with ferrous sulfate, to allow 
heme production, and (+)-camphor, as the sole carbon source, was found to be extremely 
slow. Faster, more reliable growth was obtained using starter cultures grown on sodium 
pyruvate as sole carbon source as the innoculum for larger scale growth on D-(+)-
camphor. Using pyruvate-grown starter cultures, it was found that the bacteria grew 
well in both shake flasks and in a fermenter, yielding approximately 3 - 4 g L' wet cell 
mass. SDS-PAGE of a cell extract showed that growth on camphor induces four major 
proteins. Of these, one has a molecular weight of around 45, 000 Da, 68 which is known 
to be the typical mass of cytochrome P-450 enzymes. For comparison, cells grown on 
sodium pyruvate as a general carbon source were also investigated. 
3.3 Methods 
Biotransformations using the Rhodococcus species under investigation were carried out 
using resting cells. Such transformations are carried out as whole cell systems but 
unlike growing whole cells, there are no nutrients present for cell growth. The organism 
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is grown to secondary growth phase and the cells harvested and washed. The cells are 
then re-suspended in around one-tenth growth volume of buffer ready for 
transformation. The substrate was again added as a solution in ethanol to a final 
concentration of between 0.1 and 0.5 mg mU'. The use of resting cells can be 
advantageous since purification is often simpler than for growing cell transformations. 
3.4 	Oxidation of non-camphor-like substrates 
In order to investigate the hydroxylating ability of the organism, small scale 
biotransformations 	were 	carried 	out using 	a 	range 	of substrates. 68 
N-carboxybenzylpiperidine 57, 2-methyl-5-benzyloxymethyl-tetrahydrofuran 84, indole 
85, cumene 86 and benzofuran 87 were seen to be unchanged on incubation with a 
resting cell suspension of Rhodococcus sp. NCIMB 9784. 
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These substrates had previously been reported to be hydroxylated by cytochrome P-450 
monooxygenases from various bacterial and fungal sources, but were not hydroxylated 
by this organism. 
Methyl-p-tolyl sulfide 88 was seen to be transformed by sulfoxidation to give a mixture 
of products (figure 35). Although this result did show hydroxylating abilities of the 
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organism, the transformation could have been catalysed by monooxygenase, 
dioxygenase or other oxidase activity. 






89 	 90 
Figure 35: Sulfoxidation by Rhodococcus sp. NCIMB 9784 
The most interesting results from the initial testing were that tetralin (1,2,3,4-
tetrahydronaphthalene) 91 and indene 92 were both transformed into products distinct 
from their starting materials. Indene 92 was converted into four products, three of which 
could be identified from commercially available standards, as indicated in figure 36. 
OH 	 OH 
CO Rhodococcussp. EIJj; 'OH + 	 + 14 	 NCIMB 9784 cf~— OH 
92 	 93 	 94 	 95 
Figure 36: Biotransformation of indene 92 
This transformation of indene is potentially important since trans- 93 and cis-indandiol 
94 are both potential synthons for Crixivan 46 (as discussed in section 1.5.3). Two other 
Rhodococcus species have recently been reported to have similar biocatalytic activity 
and to carry out this transformation. 56 
The transformation of tetralin 91 to one product instigated a fuller investigation because 
it is known that tetralin is transformed to (R)-1-tetralol by cytochrome P450cam88 and it 
was hoped that the transformation of this substrate might provide an interesting 
comparison between the two P-450 systems. 
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Tetralin 
A larger scale biohydroxylation of tetralin was carried out to investigate the 
transformation further, leading to identification of the product as u-tetralone 96 (figure 
37). Our interest in hydroxylation by cytochrome P-450 monooxygenases prompted us 
to ascertain whether this transformation was carried out by a cytochrome P-450 
monooxygenase or some other oxidising enzyme in the organism. 
0 
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Figure 37: Selective oxidation of tetralin 91 
The action of a cytochrome P-450 monooxygenase can be detected using an inhibition 
assay. Although this indirect evidence is not unequivocal, in the absence of the isolated 
enzyme for characterisation it can be regarded as support for cytochrome P-450 action. 
Two common inhibitors used for cytochrome P-450 monooxygenases are 
I-aminobenzotriazole 97 and metyrapone 98. l-Aminobenzotriazole 97 is a benzyne 
precursor that can strongly inactivate cytochrome P-450 monooxygenases due to the 
formation of an adduct between benzyne and two of the vicinal nitrogens of the 
porphyrin ring in the P-450.27  Metyrapone 98 can inhibit the action of cytochrome P-450 
monooxygenases by donating from one of its nitrogens to the haem centre in the 
cytochrome, rendering it catalytically inactive.89 
NH2 	 o 
N\N 	 N 
N 
97 	 98 
Analysis of incubations of tetralin 91 with Rhodococcus sp. NCIMB 9784 in the 
presence of inhibitors 97 or 98 showed no product. Since these two inhibitors act by 
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different modes of action, these studies were regarded as strong evidence that a 
cytochrome P-450 was operating in the biotransformation of tetralin. 
Tetralin like substrates 
Due to the successful transformation of tetralin, a number of commercially available 
analogues were tested as potential substrates in order to gain information about the 
specificity of the organism. 
Both a- 99 and 3-tetralol 100 were turned over by Rhodococcus sp. NICMB 9784, with 
a-tetralone 96 identified as the product of the a-tetralol transformation (figure 38). 
Although the product of the -tetralol 100 transformation was not isolated and 
identified, we speculate that it is the corresponding 3-ketone on the basis of its similarity 
to a-tetralone. 
OH 	 0 
- Rhodococcus sp. 
NCIMB 9784 	Ec::I:ItIIl 
99 	 96 
Figure 38: Biotransformation of a-tetralol 99 
Indan 101 was found to be converted to give 1-indanone 102 in the analogous 
transformation to that of tetralin, via benzylic oxidation (figure 39). 
0 
CO Rhodococcus sp. cIIIIiiiI NCIMB 9784 
101 	 102 
Figure 39: Production of indanone by Rhodococcus sp. NCIMB 9784 
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A number of other related structures were tested as substrates for the organism with little 
success. Decalin (bicyclohexyl) 103, the fully saturated derivative of tetralin, was not 
transformed, suggesting that the aromatic ring is important and perhaps that the 
organism needs the more reactive benzylic centre to be present for successful oxidation. 
Naphthalene 104, the fully unsaturated derivative is also fully recovered from the 
biotransformation mixture showing that the organism does not appear to catalyse 
aromatic hydroxylation. 1 ,2-dihydronaphthalene 105 was found to be hydroxylated to a 
mixture of many products, probably arising from epoxidation, benzylic hydroxylation 
and dihydroxylation. Incubation of a-tetralone 96 for longer periods showed that no 
further transformation took place. 
OH 
H
Ca c O CO 
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These studies have, unfortunately, shown that the oxidation capabilities of Rhodococcus 
sp. NCIMB 9784 are limited; oxidative biotransformation seems to work best on 
benzylic carbon centres or on alkene regions of the substrates and in no case was 
hydroxylation of non-activated carbon centres noted. 
Tetraljn biotransformation mechanism 
It seems likely that the transformation of tetralin by Rhodococcus sp. NCIMB 9784 
consists of more than one step and we have already shown that a-tetralol 99 is 
transformed by the resting cell system to produce x-tetralone 96. It is therefore 
proposed that initial hydroxylation of tetralin 91 is catalysed by a monooxygenase 
system yielding an alcohol, which is then transformed to the ketone by an alcohol 
dehydrogenase (ADH) (figure 40). 
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Figure 40: Proposed route to cc-tetralone from tetralin 
The transformation of 91 was followed by GC analysis and an approximately linear rate 
of substrate utilisation and product appearance with time was noted with little trace of 
the alcohol observed (figure 41). This demonstrates that, if produced as an intermediate 








Figure 41: Gas chromatograph of tetralin 91 transformation showing substrate (1.6 mins) 
and product (2.6 mins) (oven temperature 160 °C, injector temp 220 °C, FID temp 
300 °C) 
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The proposed route can be tested by inhibition of alcohol dehydrogenases. The most 
widely reported alcohol dehydrogenase inhibitors are pyrazole 106 and 
4-methylpyrazole 107. °  Unfortunately both of these compounds contain a nitrogen 
atom, which could potentially donate to the haem centre, and therefore inhibit 
cytochrome P-450 monooxygenases. 
flNf 
106 	107 
Alcohol dehydrogenase inhibition studies were carried out similarly to the cytochrome 
P-450 inhibition studies described previously. These inhibition studies indicated that 
while both l-aminobenzotriazole 97 and metyrapone 98 had no effect on the 
transformation of the tetralols, 4-methylpyrazole 107 inhibited the turnover of ct-tetralol 
99 by around 10 %. This result indicated that although no cytochrome P-450 was taking 
part in the transformation, it is likely that an alcohol dehydrogenase was involved. 
On incubation of tetralin 91 with 4-methylpyrazole in a resting cell culture of the 
bacteria no product was detected. This result was taken to confirm the hypothesis that 
4-methylpyrazole 107 would not only inhibit alcohol dehydrogenases in the system, but 
would also inhibit any P-450's present making it extremely difficult to prove whether 
tetralin 91 is converted to the tetralone 96 via the tetralol 99. 
It is interesting to note that if this is the route to the product, the transformation carried 
out by the cytochrome P-450 in this Rhodococcus sp. is the same as that carried out by 
cytochrome P450cam.88  This would be significant since it would suggest that while the 
camphor hydroxylases from Pseudomonas putida and Rhodococcus sp. NCIMB 9784 
show differing regioselectivity in their hydroxylation of camphor, they can hydroxylate 
at the same position of other substrates. 
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Nature of tetralin hydroxylase 
At this stage, it was unclear whether the transformation of tetralin and related substrates 
was being carried out by a cytochrome P-450 and if it were, whether it was the camphor 
utilising P-450 or another previously unidentified P-450 in the organism. In order to 
investigate this, cells grown on sodium pyruvate as sole carbon source were tested as 
biocatalysts to compare with previous results where the cells utilised were grown on 
D-(+)-camphor. It was found that tetralin was completely transformed by the pyruvate 
grown cells. This suggested that the transformations may have been catalysed by a 
constitutively expressed hydroxylase, rather than by the camphor hydroxylating 
cytochrome P-450. 
Binding assays were carried out with crude extracts of camphor grown cells in an 
attempt to prove this theory. These rely on the shift of the Sorét maximum of the 
cytochrome P-450 on addition of a substrate which binds to the enzyme. 91  The Sorét 
maximum depends on the environment of the iron centre, which is surrounded by the 
porphyrin group and an axial cysteine ligand. The Sorét maximum lies at 417 nm for the 
unbound protein where water acts as the sixth ligand to the haem centre (solid line) and 










Figure 42: Camphor binding assay 
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Camphor was seen to cause a complete shift from 420 nm to 390 nm (figure 42) whereas 
tetralin showed no obvious shift (figure 43).1 This lends credibility to the theory that the 
tetralin transformation may be carried out by a cytochrome P-450 but not that which is 











Figure 43: Tetralin binding assay: solid line protein only, dotted line protein plus tetralin 
3.5 	Metabolism of camphor-like substrates 
Our initial aim for the investigation of Rhodococcus sp. NCIMB 9784 was to investigate 
the utility of its cytochrome P-450 monooxygenases. It has been shown that tetralin and 
related substrates are hydroxylated, seemingly by a cytochrome P-450 but not that which 
hydroxylates camphor. We were therefore interested in investigating the scope of 
reaction of the camphor hydroxylase and chose to study the hydroxylation and 
metabolism of substrates related to camphor. The terpenoid substrates chosen were 
adamantane 108, norcamphor 109, norbornane 110 and norbornylene 111. These were 
chosen primarily due to their structural similarity with camphor but also because the 
likely hydroxylation products are all commercially available. It was found however that 
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hydroxylation of these substrates was difficult to detect. It is likely that this is due to 
further metabolism of the products through the camphor degradation pathway. Due to 
these difficulties, further work on the camphor hydroxylase in its whole cell form was 
suspended and the characterisation of substrate specificity was continued using the 
isolated camphor hydroxylase enzyme system where further metabolism is no longer an 
issue. 
108 	 109 
zb_ 
110 	 111 
Binding assays were also carried out with these substrates, with the addition of an 
ethanol solution of substrate to the crude enzyme extract from camphor grown cells and 
any shift in the Sorét maximum noted. All of the substrates tested showed some shift, 
with norcamphor 109 in particular showing a Sorét band shift (figure 44). This indicated 
that the camphor-like substrates bind to the camphor hydroxylating cytochrome P-450. 
Figure 44: Norcamphor binding assay 
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Because these binding assays showed some binding to the camphor-hydroxylating 
enzyme, they lend evidence to the supposed hydroxylation of camphor-like substrates by 
the enzyme. 
3.6 Conclusions 
Our conclusions from these studies are two fold. Although no good substrates were 
positively identified for the camphor utilising cytochrome P-450 that initially attracted 
our attention to this organism, we believe that we have identified a second cytochrome 
P-450 in the system. We have discovered that this cytochrome P-450 has narrow 
substrate specificity for tetralin 91 and related substrates. We believe that the oxidation 
to a ketone occurs via the alcohol in a two step procedure catalysed by a cytochrome 
P-450 and an alcohol dehydrogenase. It is also noted that hydroxylation of substrates 
seems to depend on the existence of a benzylic or alkene carbon within the molecule. 
Thus, the outcome of the tetralin incubation was not particularly interesting in the 
context of microbial hydroxylation of non-activated carbon centres. The transformation 
of indene 92 to yield, amongst other products, indandiols 93 and 94 is potentially 
interesting as there is known synthetic utility for such compounds in their optically pure 
form.56 
From our preliminary studies into the camphor utilising hydroxylase, it would seem that, 
like cytochrome P 450cam, the camphor monooxygenase in Rhodococcus sp. NCIMB 
9784 has narrow substrate specificity, limited to camphor-like structures. Camphor 
analogues such as norcamphor 109 were found to bind to the enzyme, as indicated by 
Sorét band shift assays. Although this may limit its use as a hydroxylation catalyst, the 
enzyme has now been isolated and could potentially be cloned for use in a suitable host 
system for hydroxylation. The enzyme could also be investigated in a manner similar to 
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cytochrome P450cam  where mutagenesis experiments have widened the substrate range 
such that larger molecules containing aromatic groups can now be hydroxylated by 
cytochrome P450cam 92'93  
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4 	Biotrans formations with Rhodococcus rhodochrous 
NCIMB 9703 
4.1 Aims 
As indicated in chapter 3, we are interested in the potential utility of Rhodococcus 
species as biohydroxylation catalysts, a property that has, as yet, not been fully 
investigated. Screening of a range of such microorganisms thought to have potentially 
cytochrome P-450 dependent hydroxylating abilities identified a number of organisms 
that warranted further investigation. One of these, Rhodococcus sp. NCIMB 9784, is 
reported in chapter 3 where we have shown that the system appears to contain at least 
two cytochrome P-450 monooxygenases which both show narrow substrate specificity. 
Another of the Rhodococcus species identified for further investigation was 
Rhodococcus rhodochrous NCIMB 9703. As highlighted in the introduction, this 
organism is reported to catalyse the terminal hydroxylation of n-octane. To our 
knowledge there have been no investigations as to the utility of this organism as a 
general biohydroxylation catalyst. 
Our aim in this investigation was to determine the existence of cytochrome P-450 
monooxygenase(s) within the organism and to investigate the scope and selectivity of 
any hydroxylation catalysed. 
4.2 	Growth of organism 
Rhodococcus rhodochrous NCIMB 9703 is reported to contain an inducible NADH 
dependent hydroxylase that catalyses the conversion of n-octane to 1 -octanol.48 Growth 
63 
4. Rhodococcus rhodochrous NCIMB 9703 
of the organism on octane was therefore attempted to induce this hydroxylating enzyme 
but growth on basal salts medium augmented with ferrous sulfate and n-octane was 
found to be extremely sluggish. In common with Rhodococcus sp. NCIMB 9784, it was 
found that initial growth on sodium pyruvate for use as innoculum for larger scale 
growth on n-octane proved a successful and reliable method for growth. Due to the 
potential experimental risks when utilising a flammable additive such as octane, 94 
fermenter growth was not attempted but growth in shake flask was found to yield 
sufficient cell mass for biotransformation. For comparison, cells were also grown on 
sodium pyruvate with no induction. Cell mass was typically greater from growth on 
pyruvate (5.5 gL1) compared with growth on octane (2.5 gU'). 
4.3 Methods 
Biotransformations using Rhodococcus rhodochrous NCIMB 9703 were carried out 
using resting cell suspensions where the, cells are live but do not have the nutrients to 
continue growing. As for Rhodococcus sp. NCIMB 9784, it was envisaged that the use 
of resting cells might ease purification. 
The organism was first grown to secondary growth phase and the cells harvested and 
washed. The cells were then re-suspended in approximately one-tenth growth volume of 
phosphate buffer (50 mM, pH 7.0) and substrate added as a solution in ethanol to a final 
concentration of 0.5 gU'. On completion, the cells were removed by centrifugation and 
the products isolated, purified by flash chromatography and identified by NMR 
spectroscopy. 
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4.4 	Initial screening 
Initial screening of the octane grown organism demonstrated that Cbz-piperidine 57 was 
oxidised selectively in the 4 position (figure 45), in a transformation analogous to that by 
Beauveria bassiana ATCC 7I59. 71 
OH 
fl Rhodococcus rhodochrous 
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N) Cbz 	 I 
Cbz 
57 	 58 
Figure 45:Transformation of 57 by Rhodococcus rhodochrous NCIMB 9703 
This selective hydroxylation of a non-activated carbon centre was encouraging and 
prompted us to challenge the octane-grown organism with a variety of new substrates. 
Oxygen heterocycles were thought to be particularly interesting since, on deprotection, 
they would yield potentially useful polyfunctionalised molecules. 
4.5 	Synthesis of substrates 
Benzyloxy substituted oxygen heterocycles were identified as potential substrates and a 
range of such substrates were synthesised. 
2-Benzyloxy-tetrahydrofurans and pyrans were synthesised from the 2-hydroxy 
heterocycle by treatment with benzyl bromide in the presence of sodium hydride (figure 
46) their carbocyclic analogues were also prepared via this route. 
IN 
4. Rhodococcus rhodochrous NUMB 9703 
~OH 	BnBr, NaH 
BuNI 	
r'(V 
Figure 46: General benzylation method, X = C or 0; n = I or 2 
Substituted aryl derivatives were prepared by treatment of the dihydropyran or furan 





n = 1 or 2; Ar = Ph, C6H4CI, 
C6H4NO2, C6H4Me. 
Figure 47: Preparation of substituted acetals: 
The substrates were all produced in moderate to good yields in unoptimised reactions. 
4.6 	Biooxidations of tetrahydropyranosyl derivatives 
General determination of regio- and stereochemistry 
In most cases, the regiochemistry and relative stereochemistry of the products could be 
determined by NMR using coupling constants, COSY and nOe/NOESY experiments. In 
all cases, it was seen that the C2-H proton was present showing two couplings consistent 
with coupling to two C3 protons suggesting that they too were unaltered by the 
hydroxylation. This left C4, C5 and C6 as the potential hydroxylation sites. Of these, 
only C6 protons have easily identifiable signals that are shifted downfield due to their 
proximity to the ring oxygen. These were important signals since, on comparison to the 
starting material, they were simplified by hydroxylation, indicating that one of their 
coupling partners had been removed (figure 48). COSY experiments confirmed that the 
CHOH proton is coupled to the C6 protons and is therefore attached to C5. 
(HO 
Not easily identified - 
overlap with C3 protons 
Identified due to downfield 
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shows two couplings 
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downfield due to adjacent 
acetal functionality 
Figure 48: Important features for stereochemical assignment from NMR analysis 
In general, the two products were identified as the 5-axial and 5-equatorial-hydroxylated 
compounds due to the coupling patterns of the C6-H signals. In the case of the 5-axial-
hydroxy product, the C6-Heq signal typically showed three or four couplings: one 
geminal, one equatorial/equatorial and one or two fine W couplings to equatorial protons 
around the ring. Additionally the C6-Hax showed one axial/equatorial and one geminal 
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Figure 49: Typical coupling patterns of hydroxylated products 
In the case of the S-equatorial-hydroxy product, the C6-Heq showed coupling to its 
geminal partner, one axial proton and one or two fine W couplings and the C6-Hax 
showed two large couplings; a diaxial coupling and a geminal coupling (figure 50). 
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Figure 50: Typical coupling patterns of hydroxylated products 
The CS-H signal, when sufficiently resolved, could also be used to identify the 
stereochemistry of the introduced hydroxyl group. Where 360 MHz 'H NMR did not 
resolve the coupling patterns, nOe experiments were used to determine the relative 
stereochemistry around the ring. 
Incubation of2-(benzyloxy)tetrahydropyran 112 
In the case of the unsubstituted substrate 112, an inseparable mixture of hydroxylated 
products was obtained upon incubation with Rhodococcus rhodochrous NCIMB 9703 
which was thought to be a mixture of 5-hydroxylated products. A small amount of one 
of these products was isolated but unfortunately, due to overlapping signals and 
unresolved multiplets, its identity could not be unequivocally determined. Acetylation 
of the product mixture failed to enable separation of the two compounds. The NMR 
spectrum did show that the C2 acetal group was in the axial position with the geminal 
proton showing only two small couplings and no axial-axial coupling. This axial 
positioning was noted throughout the series and was easily explained as a consequence 
of the anomeric effect. 
Substrate 112 has been incubated with other biocatalysts under study within our 
laboratories with interesting results: incubation with isolated enzyme preparations of 
cytochrome P450cam  (Y96A mutant) yielded no isolable hydroxylated products, 
whereas incubation with growing cell suspensions of the fungus Beau veria bassiana 
ATCC 7159 yielded a complex mixture of products. 95  These results showed that the 
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Rhodococcus species under investigation has interesting complementarity with existing 
biocatalysts (figure 51). 
Cytochrome 	no biotransformation 
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Figure 51: Incubation of 112 with different whole cell biocatalysts 
Due to the difficulties in separating the products, this result was not further investigated 
and instead a range of analogues were examined. It has been shown previously36 that 
the introduction of substituents on the aryl ring of substrates can direct hydroxylation 
away from the substituted position. Although hydroxylation of the aromatic ring was 
not noted in the biotransformation of acetal 112, the incorporation of p-substituents was 
investigated to establish any directing or yield effect. 
Incubation of 2-(4-methylbenzyloxy)tetrahydropyran 113 
On incubation of the p-methyl substituted acetal 113 with Rhodococcus rhodochrous 
NCIMB 9703, the two products were identified as the 5-axial 114 and 5-equatorial 
hydroxy 115 compounds (figure 52). The products were identified on the basis of 
'H-coupling patterns in their 'H NMR spectra. 
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Figure 52: Transformation of methyl-substituted compound 113 
The 'H NMR spectra initially showed overlapping signals but acquiring the spectrum in 
d6-benzene rather than d-chloroform was found to resolve the important signals 
sufficiently to allow coupling patterhs to be examined (figure 53). 
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Figure 53: Coupling constants used in the identification of products 114 and 115 
Incubation of 2-(4-chlorobenzyloxy)tetrahydropyran 11696 
Hydroxylation of the p-chloro analogue 116 showed little difference in regioselectivity 
to the 4-methyl substituted analogue 113 with the 5-hydroxy compounds 117 and 118 
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117 R = CI 
120 R = NO2 
116 R = CI 
119 R = NO2 
118 R = CI 
121 R = NO2 
Figure 54: Transformation of tetrahydropyranosyl derivatives 116 and 119 
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longer sited axially. The equatorial arrangement of the ether chain suggested that the 
hydroxyl group was introduced trans to the existing substituent on the ring. 
At this stage it was unclear whether the gain in regioselectivity for ether 122 was due to 
the increased length of the ether linkage or due to its spatial orientation. It had been 
assumed thus far that the ether sits in an axial position on the ring due to the influence of 
the anomeric effect. In the case of substrate 122, the insertion of the methylene 
cancelled the anomeric effect so that the ether sits in the sterically favoured equatorial 
position. 
Incubation of 2-(phenethyloxy)tetrahydropyran 124 
In order to investigate this effect, substrate 124, which combines the axial positioning 
with the longer ether chain, was synthesised and subjected to the organism. A complex 
mixture of inseparable products (total yield 40 %) was obtained. This result suggested 
that the length of the linker was not the most important factor in determining selectivity. 
"  0 -~) 
"--~O 124 
Molecular modelling was used in an attempt to explain these differences in selectivity 
based on substrate structure. The molecular modelling was carried out using 
Macromode197 and the MM2 force field implemented therein. 98 The substrates were first 
constructed and energy minimised using a chloroform solvation method" and Monte 
Carlo simulations10° were utilised to find the global energy minima rather than the local 
minimum resulting from the energy minimisation. Through this procedure, a number of 
the substrates, and their hydroxylated products, were studied. Examination of the results 
showed that the most populated lowest energy structures of each substrate had very 
similar conformations. Superimposition of these energy-minimised structures provided 
informative comparison. 
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Superimposition of the energy-minimised structures of substrates 112 (green) and 122 
(red) about the hydroxylation sites (marked as balls) showed good overlap of the 
aromatic ring, exocyclic oxygen and heterocycle (figure 56). 
Figure 56: Superimposition of energy minimised substrate structures 112 (green) and 
122 (red) 
Examination of acetal 124 (blue), where the longer ether chain was situated axially 
showed that superimposition of the aromatic and acetal linkage left the heterocycle in a 
different orientation, where no hydrogen atoms sat in analogous positions to those 
hydroxylated in the other substrates (figure 57). 
Figure 57: Superimposition of energy minimised substrate structures 124 (blue) and 122 
(red) 
This may demonstrate why substrates 112 and 122 were hydroxylated with similar 
reg io selectivity, with the longer linker compensating for the difference in orientation at 
C-2 (which is axial 112 and equatorial in 122). In contrast, acetal 124 was not 
hydroxylated with the same regioselectivity, presumably because the axial orientation of 
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the longer linker forced the heterocycle into a significantly different orientation with at 
least three possible hydroxylation sites possible. 
Although such modelling studies can provide potential explanations for regioselectivity 
of hydroxylation based on substrate structure, it should be remembered that binding to 
the enzyme could cause the substrate to sit in a conformation that is significantly 
different to its energy-minimised conformation in the absence of the enzyme. 
Yields of transformation 
The product yields for the transformation of tetrahydropyranosyl derivatives by 
Rhodococcus rhodochrous were moderate as indicated in table 3. The yields reported 
are based on conversion of 100 mg with 5 g of wet cells and it should be noted that, in 






X = Yield [an] Yield [(XD] 
Me (113) 9%(114) -210 18%(115) +7° 
Cl (116) 8%(117) -11° 12%(118) 
NO2 (119) 21 % (120) +36° 18 % (121) -44° 
Table 3: Summary of hydroxylation of tetrahydropyran derivatives where R = CH2ArX 
The conversions reported were generally found to be highly reproducible with the 
exception of the p-chloro substituted case. In this case one or two products were 
isolated depending on the experiment and the trans product was favoured. It should be 
noted that the results reported for acetals 112 and 116 are different to preliminary results 
reported previously. 96 
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The transformations reported were all carried out on racemic substrates and the optical 
activity of the products suggested a degree of stereoselectivity in the hydroxylation 
process. However, because the products described are not known compounds, the 
optical rotations give no indication of optical purity. Since less than 50 % of the mass 
balance is accounted for and no starting material was recovered, further breakdown of 
either substrate or product is possible. It was therefore not clear whether initial 
hydroxylation or further breakdown of the product was responsible for the observed 
stereoselectivity. 
Interestingly when the aromatic side chain was altered as in ether 122, the previously 
noted increase in regioselectivity was accompanied by an increased yield. Unfortunately 
the optical rotation of the product was negligible, suggesting that stereoselectivity was 
lost on insertion of the methylene unit. 
Further investigation of the stereoselectivity of selected transformations is discussed in 
section 4.8. 
Summary of biooxidation of tetrahydropyranosides 
Examination of a range of closely related structures based on six-membered oxygen 2-
alkyl heterocycles has demonstrated that Rhodococcus rhodochrous NCIMB 9703 can 
be a regioselective hydroxylation catalyst. It was observed that, irrespective of aromatic 
substituents, the enzyme has a preference for hydroxylation at C5, yielding mixtures of 
axial and equatorial substituted hydroxy products. Small structure modifications were 
seen to be potentially important in determining selectivity, leading, in some cases, to 
improved selectivity. The hydroxylations also showed a degree of stereoselectivity 
because racemic compounds were converted to optically active hydroxylated products. 
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4.7 	Biooxiciation of tetrahydrofuranosyl derivatives 
The successful hydroxylation of the tetrahydropyran acetals prompted the investigation 
of the biotransformations of the corresponding tetrahydrofuran compounds. The results 
were seen to be largely analogous to those from the tetrahydropyran series. In the case 
of the tetrahydrofuran ring systems, the site of biohydroxylation was again determined 
by NMR studies (figure 58), although here it was not possible to obtain relative 
stereochemistry determinations from 1D NMR studies alone. 
Identified due to downfield 
shift due to proximity of ring 
oxygen - coupling pattern found 
to be simplified by hydroxylation 
(HO)H 
shows 	o couplings 	
H 	
Easily identifiable - shifted 
Intact since C2-H downfield due to adjacent 
H 	H 	OCH2Ar 	
acetal functionality 
Figure 58: NMR analysis for determination of regiochemistry in products 
Incubation of 2-benzyloxytetrahydrofuran 125 
In the case of acetal 125, a single product was isolated and identified as the C4 





125 	 126 
Figure 59: Hydroxylation of 2-benzyloxytetrahydrofuran 125 
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'H-'H COSY experiments (appendix 4) showed the characteristic CHOH signal 
coupling to both C5 protons and to the multiplets corresponding to the remaining ring 
protons which did not show any shift compared to the starting material. No coupling is 
seen between the CHOH and the C2-H signal. These findings can only be explained by 
substitution at the C4 position. 
The relative stereochemistry of the two substituents on the ring cannot be identified from 
these simple experiments, since the bond angles on a five membered ring do not allow 
axial versus equatorial identifications from coupling constants. In common with the six 
membered analogues and the other compounds of the C4 ring series, the acetal existed in 
an axial orientation due to the anomeric effect. 
Notably, the regioselectivity of this reaction was improved compared to the six 
membered analogue 112 that afforded 'a mixture of products. This may be due to the 
conformation of the five membered ring which presumably only allows one CH bond to 
be sufficiently close to the hydroxylating centre in the enzyme active site. 
Incubation of 2-(4-methylbenzyloxy)tetrahydrofuran 127 
Investigation of the hydroxylation of the methyl substituted analogue 127 showed that 
regioselectivity was not compromised and the analogous C4 hydroxylated product 128 
was identified (figure 60). 
rhodochrous 
Rhodococcus 
127 	 128 
Figure 60: Biohydroxylation of substituted tetrahydrofuran 127 
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Incubation of 2-(4-chlorobenzyloxy)tetrahydrofuran 129 
In the case of the p-chloro substituted 2-benzyloxytetrahydrofuran 129, only a small 
amount of mixed hydroxylated furan derivative 130 was isolated along with around 
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Figure 61: Hydroxylation of chioro substituted tetrahydrofuranoside 129 
The isolation of the benzoic acid derivative points toward benzylic hydroxylation 
followed by cleavage of the acetal. Degradation of alkyl-substituted aromatics by 
benzylic hydroxylation has been reported previously in whole cell systems'01 but to our 
knowledge, no systematic investigation of the effect of aromatic substituents has been 
undertaken. It is not clear at this stage why this particular substrate is degraded in this 
way. At first glance one might be inclined to assume that, since none of the other 
compounds in this series are noticeably degraded in this manner, the chlorine substituent 
on the aromatic must induce this degradation. However it should be I  remembered that 
the organism successfully hydroxylated tetrahydropyran analogue 116 with no benzoic 
acid derivative recovered. This suggests that the chloro substituent itself is not sufficient 
to induce such degradation. 
Incubation of 2-(4-nitrobenzyloxy)tetrahydrofuran 132 
The most interesting hydroxylation from this series was that of 2-(4-nitrobenzyloxy)- 
tetrahydrofuran 132 leading to one optically active product 133. 	COSY, 
homodecoupling experiments and examination of the coupling patterns displayed in the 
proton NMR spectrum led to the identification of the product again hydroxylated in the 
C4 position (figure 62). 









Figure 62: Regioselective transformation by Rhodococcus rhodochrous 
Incubation of2-(benzyloxymethyl)tetrahydrofuran 134 
Following the success of the tetrahydrofuranoside 122, the organism was challenged 
with the corresponding tetrahydrofuranoside 134. In this case, the biotransformation 




Yields of transformation 
The product yields for the conversion of the tetrahydro furanos ides by Rhodococcus 
rhodochrous were moderate as indicated in Table 4. Again, the yields shown are based 
on conversion of 100 mg of starting material and were not optimised. However, it 
should be kept in mind that the oxidations appear to have occurred with concomitant 
kinetic resolution, and if this is so maximal yields would only be 50 %. 
In common with the tetrahydropyran series, the hydroxylations reported were all carried 
out on racemic substrates. Again the products described are not known compounds, so 
the optical rotations give no indication of optical purity. A further investigation of the 
enantioselectivity of selected transformations is discussed later in section 4.8. 
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Figure 62: Regioselective transformation by Rhodococcus rhodochrous 
Incubation of2-(benzyloxymethyl)tetrahydrofuran 134 
Following the success of the tetrahydrofuranoside 122, the organism was challenged 
with the corresponding tetrahydrofuranoside 134. In this case, the biotransformation 
produced only small amounts of a complex mixture of hydroxylated products that were 
not purified. 
Yields of transformation 
The product yields for the conversion of the tetrahydrofuranosides by Rhodococcus 
rhodochrous were moderate as indicated in Table 4. Again, the yields shown are based 
on conversion of 100 mg of starting material and were not optimised. However, it 
should be kept in mind that the oxidations appear to have occurred with concomitant 
kinetic resolution, and if this is so maximal yields would only be 50 %. 
In common with the tetrahydropyran series, the hydroxylations reported were all carried 
out on racemic substrates. Again the products described are not known compounds, so 
the optical rotations give no indication of optical purity. A further investigation of the 
enantioselectivity of selected transformations is discussed later in section 4.8. 
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X = Yield [aD] 
H(125) 15%(126) 450 
Me (127) 18%(128) +290 
NO2 (132) 26%(133) +800 
Table 4: Summary of hydroxylation of tetrahydrofuranosides 
Summary of biooxidation of tetrahydrofuranosides 
Investigation of a number of closely related substrates based on saturated five-membered 
oxygen heterocycles demonstrated that Rhodococcus rhodochrous NCIMB 9703 can be 
a highly regioselective hydroxylation catalyst. The biocatalyst showed a strong 
preference for hydroxylation at C4, with only one product being isolated in most cases. 
Small structure modifications were important in determining regioselectivity, although 
the organism was less tolerant to changes in the tetrahydrofuranosides than in the six 
membered analogues. The insertion of a methylene group between the heterocycle and 
aromatic side chain significantly compromised the selectivity, resulting in small amounts 
of mixed products. p-Chloro substitution was not well tolerated in the five membered 
substrates leading to a mixture of benzylic and alkyl hydroxylation. 
The fact that optical activity of products is observed suggests that the hydroxylations 
show a degree of enantioselectivity. 	In particular, incubation of 2-(4- 
nitrobenzyloxy)tetrahydrofuran 132 yielded product in higher yield and with higher 
optical rotation than the other reactions in this series and demonstrated the potential 
utility of this enzyme as a regio-, stereo- and enantioselective biohydroxylation catalyst. 
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4.8 	Stereoselectivity of hydroxylation 
The nitro substituted products (120, 121 and 133) from both series had particularly large 
values of optical rotation and were chosen as representative examples for further 
investigation. 
2-(4-Nitrobenzyloxy)-4-hydroxytetrahydrofuran 133 
We initially concentrated on the product 133 from tetrahydrofuranoside 132 and a 
number of derivatives were prepared. Many of the techniques for the determination of 
enantiomeric excess rely on the quantitative preparation of diastereomers from the 
enantiomer mixture with a chiral derivatising agent. Mosher's acid is one such 
derivatising agent and has long been the method of choice due to its stability to 
racemisation, substantial chemical shift differences between diastereomeric groups and 
the presence the trifluoromethyl group which allows the use of 19F NMR spectroscopy 
for examination of the products. 102-104 
The ct-methoxy-a-trifluoromethylphenylacetate (Mosher ester) 135 was prepared by 
reaction of alcohol 133 with R-a-methoxy-c-trifluorophenylacetic acid in the presence 
of dicyclohexylcarbodiimide (DCC) in dichioromethane. Examination of the 'H and '9F 
NMR spectra of the crude product suggested that a second product was also formed. 
This by-product was identified as the MTPA ester of 4-nitrobenzylalcohol 136, 
envisaged to be formed via acid-catalysed acetal cleavage of 133 followed by 
esterification. When the reaction was carried out under basic conditions with DCC and 
4-dimethylaminopyridine as acetylation catalyst, esterification was complete and no by-
products were identified (figure 63). The product was not purified to avoid any 
resolution occurring. 
[31 
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Figure 63: Preparation of MTPA ester 135 
Only one of the possible four diastereomers is apparent by 'H NMR spectroscopy of 
ester 135 with clear multiplets identified for C2, C3, C5 and C7 protons. Somewhat 
surprisingly, the methoxy signal was not a singlet as expected but a quartet resulting 
from long range fluorine-proton coupling (4JHF 1 Hz). Examination of the simpler '9F 
NMR spectrum (figure 64) however clearly shows two fluorine resonances from which a 
diastereomeric excess of 93% can be calculated. 
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Figure 64: Fluorine NMR spectrum of ester 135 
Enantiomeric/diastereomeric excess can also be determined using lanthanide shift 
reagents to induce a chemical shift difference between diastereomeric groups. 
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Combining the use of MTPA esters with lanthanide shift reagents has been reported to 
overcome problems of insufficient separation of signals in the 'H NMR for analysis.105 
On the basis of the positive results reported, we attempted such analysis. 
[EU 
137 
Unfortunately, stepwise addition of 5 mol % europium tris(3-heptafluoropropyl-
hydroxymethylene)camphorate (Eu(hfc)3) 137 to a sample of the MTPA ester 135 
showed no separation of signals in the 'H NMR before the increasing concentration of 
the lanthanide reagent caused significant line broadening. 
Camphanic esters prepared from optically pure camphanic acid have previously been 
utilised for the preparation of crystalline material for determination of absolute 
stereochemistry. 101,107  The S-camphanic ester 138 was successfully prepared in 76% 
yield from reaction of alcohol 133 with S-camphanic acid chloride in the presence of 











Figure 65: Preparation of camphanic ester 138 
Ester 138 appeared as only one diastereomer in the 'H NMR as indicated by three sharp 
singlets for the methyl substituents on the camphanoate portion. Camphanamides have 
previously been studied for determination of enantiomeric excess by examination of the 
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diastereotopic methylene protons108 and camphanic esters have been studied in 
conjunction with achiral shift reagents for determining enantiomeric purity.109 These 
previous studies suggest that any significant second diastereomer should be visible in the 
NMR spectrum. 
Crystals of ester 138 were obtained and re-crystallised from diethylether. The X-ray 
crystal structure showed the absolute stereochemistry of the tetrahydrofuran portion to 
be 2R, 4R as shown in figure 66. This R,R arrangement around the ring confirmed the 
tentative trans assignment of the relative ring stereochemistry based on NOESY 
experiments on the alcohol precursor. 
25 
Figure 66: X-ray crystal structure of camphanic ester 138 
From the studies undertaken, it appears that biohydroxylation of 2-(4-nitrobenzyloxy)-
tetrahydrofuran 132 by Rhodococcus rhodochrous NCIMB 9703 is a highly 
enantioselective process yielding the 2R, 4R product in circa 93 % enantiomeric excess. 
We have thus identified a route to a chiral alcohol that is known to be a useful chiral 
intermediate. It is interesting to note that the open chain triol is currently accessed from 
R-malic acid in a simple one-pot procedure. The advantage of the biocatalytic route is 
that it allows for selective reactivity at both primary centres. 
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2-(4-nitrobenzyloxy)-5-hydroxytetrahydropyrans 120 and 121 
Transformation of the 4-(nitrobenzyloxy)tetrahydropyran 119 yielded two C5 
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Figure 67: Hydroxylation of 4-nitro-substituted tetrahydropyran derivative 119 
Investigation of the enantioselectivity of hydroxylation was undertaken and esters 
prepared with the chiral derivatising agent MTPA and with camphanic acid with a view 
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Figure 68: Preparation of MTPA ester 
19F NMR analysis of Mosher's ester 139 prepared from alcohol 121 (figure 68) showed 
only one peak suggesting an enantiomeric excess of greater than 95 %. Close 
examination of the 'H NMR spectrum however cast doubt on this assignment (figure 
69). Many of the signals in the spectrum were more complicated than they ought to be. 
In particular the C8-H signals, the diastereotopic benzylic protons, which should be a 
pair of AB doublets appeared as two overlapping pairs of AB doublets. This suggested 
that there was in fact a mixture of diastereomers present in the sample. Comparison of 
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integrals of the peaks suggested that the second signals accounted for almost 25 % of the 
sample. The signal for the methoxy group was a quartet with no indication of a further 
multiplet, which was surprising since the methoxy group would normally expected to 
show good chemical shift differences between diastereomers. Examination of the 13C 
NMR agreed with the theory of a second diastereomer with a number of additional 
signals identified. 
The conclusions drawn from the NMR studies of the MTPA ester 139 are contradictory 
which emphasises the problems in utilising any single method in isolation. It is possible 
that the 19F signals for more than one of the possible diastereomers simply overlap and 
that examination of the proton NMR spectrum is more reliable. The only method of 
conclusively measuring the enantiomeric excess and determining the stereochemistry of 
the product would be comparison with authentic samples. Unfortunately, preparation of 
authentic samples of all of the possible diastereomers was outwith the scope of this 
project. 
Figure 69: Proton NMR spectrum of ester 139 in the 3 —6 ppm range 
The preparation of a camphanic ester was helpful for investigation of the five membered 
analogue and was therefore undertaken for alcohol 121 yielding camphanic ester 140 
(figure 70). 
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Figure 70: Preparation of camphanic ester 140 
Contrary to the results observed for the MTPA ester 139, both the 'H (figure 71) and '3C 
NMR spectra of the camphanic ester were easily assigned and showed no indication of 
more than one diastereomer of 140. Camphanic ester 140 has not, as yet, produced 
crystalline material. 
6 	5 	4 
Figure 71: Proton NMR expansion of ester 140 
trans-2-(4-Nitrobenzyloxy) -5-hydroxytetrahydropyran 120 
MTPA ester 141 (prepared from alcohol 120) showed two resonances in the 19F NMR of 
approximately equal peak area (figure 72). If the two peaks present in the fluorine NMR 
spectrum were due to diastereomers, this would give a diastereomeric excess of only 7 
%. However, since both the ester and its alcohol precursor had large optical rotations, it 
seemed unlikely that the ester was a near equal mixture of diastereomers. 
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Figure 72: Fluorine NMR spectrum of ester 141 
Examination of the 'H NMR spectrum clearly showed a mixture of compounds in the 
sample, in particular the methoxy and C6-Heq and C6-Hax signals clearly showed 
multiplets for different molecules and other signals in the spectrum were much broader 
than would be expected. Carbon-13 NMR spectroscopy also showed the existence of 
more than one compound with secondary peaks identified at similar chemical shift to the 
main peak. 
We suggest that the product is not a mixture of diastereomers but that, on formation of 
the bulky ester from the axial hydroxyl group, the diaxial ring strain is increased 
sufficiently that the energy of the system can overcome the anomeric effect and cause 
the ring to flip to produce the more favourable diequatorial arrangement around the 





Figure 73: Possible ring flipping to produce a mixture of conformers 
M. 
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This effect would not be expected for ester 139 where the bulky ester group already 
exists in the equatorial position on the ring. NMR experiments at elevated temperatures 
(323 and 343 K) were carried out in order to investigate whether there was an 
equilibrium effect but at the temperatures which we could raise the sample to, no change 
was noted and these experiments provided no further evidence to explain this result. 
In common with the other alcohols under study, the camphanate derivative 142 was also 
prepared by reaction with camphanic acid chloride (figure 74) and the resultant ester 142 
analysed. 
OH 






Figure 74: Preparation of camphanic ester 142 
Carbon-13 NMR spectroscopy showed a number of additional peaks and 'H NMR 
spectrum clearly showed that the methyl signals were not singlets. Crystallisation has as 
yet been unsuccessful, further suggesting a mixture of compounds. 
4.9 	Biooxidations of carbocyclic ethers 
After successful investigation of the five and six membered oxygen heterocycles showed 
the potential of Rhodococcus rhodochrous NCIMB 9703 as a regio and enantioselective 
hydroxylation catalyst, the obvious substrates to investigate next were the corresponding 
carbocycles. Not only would this yield information as to the importance of the cyclic 
oxygen for selectivity but it is also envisaged that the hydroxylated carbocyclic 
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compounds could be synthetically useful. Thus carbocycles of similar structure were 
prepared and examined as hydroxylation substrates for the organism. Unfortunately, the. 
results from this series were less promising than the corresponding heterocycles with the 
incubations leading to mixtures of products. 
Incubation of benzyloxycyclohexane 143 
Rhodococcus rhodochrous NCIMB 9703 converted the simple benzyloxycyclohexane 
143 to two inseparable hydroxylated products in good combined yield (35 %). 
Acetylation of the product mixture failed to improve the separation of the two products. 
Based on the results from the oxygen heterocycles and those reported previously,96 it is 
thought likely that these were the C4 hydroxylated compounds (C4 is analogous to the 
CS position in the tetrahydropyranosides). 
143 
Incubation of benzyloxycyclohexene derivatives 
The organism was challenged with cyclohexenol derivatives with the aim of accessing 
intermediates which could be further functionalised, however these transformations 
proved to be rather unsuccessful. 4-Benzyloxycyclohex-1,2-ene 144 was found to yield 
the corresponding epoxide 145 in good yield (figure 75). Unfortunately, the epoxide 
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Figure 75: Production of epoxide by Rhodococcus rhodochrous 
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Three products were isolated on incubation of 3-benzyloxycyclohex- 1 ,2-ene 146 (figure 
76). The 3-ketone derivative 147 was isolated, presumably due to hydroxylation of an 
alkene carbon and subsequent rearrangement. 125,126  Two saturated alcohols 148 and 149 
were also identified in the product mixture suggesting that reduction of the double bond 
was taking place in addition to the expected hydroxylation. 
OH OH 
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Figure 76: Mixture of products isolated from incubation of cyclohexenol derivative 146 
It should be noted that the results reported for alkenes 144 and 146 do not agree with 
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Figure 77: Proposed route to saturated products 
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Allylic alcohols are possible products from initial hydroxylation of alkenes and are 
known to be substrates for enoate reductases, which carry out the reduction of activated 
double bonds"° and may provide a route to the saturated alcohols isolated (figure 77). 
This reduction of the double bond in addition to the desired hydroxylation emphasises 
the potential problems in utilising whole cell systems since side reactions are often 
unpredictable. 
Summary of biooxidation of carbo cyclic ethers 
Investigation of the carbocyclic compounds showed less selective conversion than the 
analogous oxygen heterocycles. Most notable is that the anomeric effect cannot operate 
for these compounds so that the spatial orientation of the aromatic side-chain is 
different. This factor has already been shown to have an important effect on the 
selectivity of hydroxylation. 
Investigation of the unsaturated carbocycles 144 and 146 showed other competing 
reactions that were not relevant for the saturated substrates. Interestingly no benzylic 
hydroxylation, the only side reaction previously noted with the organism, was observed. 
The isolated products were found to have negligible optical rotations suggesting minimal 
enantioselectivity. 	This result, in conjunction with our results from the 
tetrahydropyranosides, points toward an important role for the orientation of the 
aromatic side-chain in determining the enantioselectivity, with axial positioning leading 
to improved enantioselectivity. 
4.10 Biooxidations of nitrogen heterocycles 
Enzymatic hydroxylation of protected nitrogen heterocycles have previously been 
studied and found to be an important route to optically active hydroxylated nitrogen 
heterocycles. A recent report by Witholt and co-workers described the production of 
optically active N-benzyl-3-hydroxypyrrolidine by Pseudomonas oleovorans.' 1 ' 
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Optically active hydroxypyrrolidines are important intermediates in the synthesis of a 
number of biologically important molecules and although a number of synthetic routes 
exist, each has drawbacks such as expensive chiral starting materials or low yielding 
resolution steps. 
Due to the structural similarities to our previously studied substrates (figure 78), we 
prepared N-benzylpyrrolidine for testing with Rhodococcus rhodochrous. It was found 
that incubation of the substrate with resting cell cultures of the organism resulted in no 
hydroxylation and the starting material was recovered unchanged. 
Qo 	cr 
125 	 150 
Figure 78 :Comparison of two compounds under study 
Since this transformation was unsuccessful, no further nitrogen heterocycles were tested 
as substrates for the biocatalyst although further investigation of this substrate type, 
perhaps employing a longer aromatic chain, could be interesting. 
4.11 Biooxidations of carbocyclic nucleoside precursor 
Carbocyclic nucleosides show biological activity particularly as antiviral and antitumour 
agents and possess greater metabolic stability to phosphorylase enzymes that cleave the 
linkage between the heterocyclic base and sugar molecule in the corresponding 
nucleosides. Two carbocyclic analogues, Carbovir 43 and Abacavir 151, are of 
particular interest due to their anti-HIV activity. Carbovir"2 is already in clinical use 
and Abacavir"3 has recently completed clinical trials. 
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There are many routes to carbocyclic nucleosides, some of which require initial 
formation of an appropriately functionalised carbocycle followed by coupling of the 
required base. 	This method requires enantiomerically pure cyclopentane and 
cyclopentene units and biocatalytic routes have been employed in their preparation. 
We were aware that the carbocyclic analogues of the compounds under study were 
structurally related to such carbocyclic nucleoside precursors. We therefore sought to 
investigate whether the substrate range of the enantioselective hydroxylating activity 
could be extended to include compounds such as 152. 
Incubation of ether 152 resulted in the isolation and identification of one hydroxylated 
product 153 in around 20 % yield. The product was identified as the C5 hydroxylated 
product (figure 79) on consideration of a number of factors. Examination of proton and 
carbon NMR spectrum showed that the alkene portion was intact in the product 
molecule. C3 was also intact but its complicated coupling pattern did not allow 
determination of substitution at C4. Importantly, the alkene signals were noticeably 





152 	 153 
Figure 79: Hydroxylation of ether 152 by Rhodococcus rhodochrous 
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Two-dimensional NOESY experiments were carried out in an attempt to determine the 
relative stereochemistry around the ring. The two important signals for investigation of 
the relative stereochemistry around the ring are those for Hi and H4, the protons 
adjacent to the ring substituents. As indicated in figure 80, Hi shows nOe crosspeaks to 
the opposite alkenè proton and to the opposite C4 proton to H4 and the two signals 
under study do not show an nOe to each other. This analysis of the crosspeaks in the 
NOESY spectrum suggests a trans arrangement around the ring. 
Figure 80: nOe crosspeaks indicated by arrows 
It was envisaged that this trans hydroxylated product could be easily converted to the 







Figure 81: Proposed route to carbocyclic nucleoside derivatives 154 
The product was seen to have a significant optical rotation triggering an investigation 
into the enantioselectivity of the biohydroxylation. Since little product was available in 
this initial phase of the project only the camphanic ester was prepared. Proton and 
carbon NMR analysis showed more peaks than would be expected and thus suggested 
that the reaction might not be 100 % stereoselective. Crystallisation studies have, as yet, 
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been unsuccessful. 	Clearly further investigation of the enantioselectivity of 
hydroxylation is necessary. 
Work is currently underway within the group to determine the enantioselectivity of 
transformation, confirm the relative stereochemistry and utilise the biotransformation 
product as a chiral intermediate in the synthesis of carbocyclic nucleosides. 
Allylic hydroxylation is not uncommon in microorganisms and although many of the 
reports involve rigid steroid molecules, there are also examples of extremely selective 
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Figure 82: Microbial allylic hydroxylation 
4.12 Nature of the hydroxylating enzyme 
Rhodococcal hydroxylases have been reported previously and it is clear that at least one 
is functioning in the organism under study. Rhodococcus erythropolis DSM 6138 has 
recently been shown by Gotor and co-workers to contain a molybdate dependent 
oxygenase that is responsible for the hydroxylation of, for example, pyrimidine 
heterocycles. 27 	Cytochrome P-450 monooxygenases are also widespread in 
Rhodococcus species: a cytochrome P-450 responsible for the 6-endo-hydroxylation of 
camphor has recently been identified and purified from Rhodococcus sp. NCIMB 
9784.68 As part of our investigation into the use of cytochrome P-450 monooxygenases 
in biocatalysis, we were interested to examine the nature of the hydroxylase. 
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Alkane hydroxylators have previously been shown to hydroxylate non-natural 
substrates. Another octane utilising enzyme, Pseudomonas óleovorans is known to 
contain a cytoplasmic membrane monooxygenase, which carries out the 00-
hydroxylation of octane. A recent publication by Witholt et a!" has shown the utility 
of the alkane hydroxylase system by preparing optically active hydroxylated N-
benzylpyrrolidine (as described in section 4.8). 
Initial literature reports suggested that terminal hydroxylation of n-octane by 
Rhodococcus rhodochrous NCIMB 9703 is catalysed by an inducible cytochrome 
P-450.48'65 In this work we hoped to utilise this cytochrome P-450 as a biohydroxylation 
catalyst. The reactions reported here were carried out using cells grown on octane as the 
sole carbon source, but cells grown on sodium pyruvate were also tested in an attempt to 
establish the nature of the hydroxylase. Comparable yields and optical activities of 
products were observed utilising both octane and pyruvate grown cells, suggesting that 
these reactions do not utilise the octane-hydroxylating enzyme, or that there is an 
unknown limiting factor in operation. Such a limiting factor could render the expression 
level of the protein insignificant and could be NADH supply, substrate diffusion or 
oxygen transfer into the cell. 
Inhibition studies using 1 -aminobenzotriazole and metyrapone showed that 
hydroxylation was inhibited by both of these compounds. Because these cytochrome 
P-450 inhibitors inhibit the enzyme by different mechanisms,27'89 these studies were 
taken to be evidence that a cytochrome P-450 system was operating in these 
transformations. 
Thus far, these studies have yielded only limited information about the hydroxylase 
under study but it is clear that the hydroxylations reported are cytochrome P-450 
catalysed. As in chapter 3, it is unclear whether the hydroxylase operating is the induced 
cytochrome P-450 or another constitutively expressed enzyme. 
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4.13 Optimisation of transformations 
Although some studies have been undertaken to improve the biotransformation, there are 
many avenues for optimisation of the whole cell system as a hydroxylation catalyst. The 
effect of substrate concentration has been investigated and the optimum concentration 
found to be around 0.5 gU', with higher concentrations of up to 0.6 and 0.7 gU' 
tolerated for some substrates. The exact concentration tolerance seems to be substrate 
dependent and would require further investigation for larger scale preparations. 
Another extremely important variable is cell concentration. In some studies, the authors 
report extensive investigation to optimise this parameter."' In our case, the growth of 
the organism was the slowest stage in the testing of substrates and we therefore sought to 
minimise the cell mass used for each reaction. We found that the use of 5 g wet cell 
mass for transformation of 100 mg substrate (200 mL volume) was the minimum cell 
mass that did not increase the required time unnecessarily. 
The time of transformation is an important factor, both in terms of practicality and 
selectivity. In the hydroxylations described, optically active products were isolated in 
yields of up to 40 %. The mass balance of the reaction is thought to be lost through 
degradation pathways from the substrate or the hydroxylated product. The enantiomeric 
excess of the isolated product is likely to be dependent on a number of factors including 
further degradation of the desired product. In future, periodic sampling of aliquots 
should provide data to optimise this. 
Co-metabolism of a co-substrate such as glucose could also be advantageous since this 
provides energy for the reaction and the recycling of co-factors that could increase the 
rate sufficiently to impact on the yield or selectivity of hydroxylation. 
Work is currently underway on the optimisation of conditions for the preparation of 
carbocyclic nucleoside precursors. 
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4.14 Conclusions 
This study has established that Rhodococcus rhodochrous NCIMB 9703, an organism 
not previously reported for biotransformations of non-natural substrates, can be used to 
regioselectively and enantioselectively hydroxylate a range of oxygen heterocycles. It 
was also noted that the regio- and enantioselectivity of reaction was significantly altered 
by changes to the p-substituent on the benzyloxy group or by extension of the ether 
linkage. It is envisaged that this biocatalyst could be used to produce hydroxylated, 
polyfunctionalised chiral intermediates for use in asymmetric synthesis. 
2-Benzyloxytetrahydropyrans were substrates for resting cell suspensions of the bacteria 
yielding predominantly 5-hydroxylated products in combined yields of up to 40 %. 
Corresponding tetrahydrofuranosides were also hydroxylated, mainly to 4-hydroxy 
compounds in yields of up to 26 %. Most interestingly, 2-(4-nitrobenzyloxy)-
tetrahydrofuran 125 was transformed exclusively to the 4-hydroxylated product 130 with 
an optical rotation of +80° in 93 % enantiomeric excess and the 2-(4-nitrobenzyloxy)-
tetrahydropyran 115 was hydroxylated exclusively in the 5-position giving two products 
with optical rotation +36° and -44°. 
The transformation of a carbocyclic nucleoside precursor 152 was investigated with the 
desired trans product identified as the only product. The hydroxylation was found to be 
enantioselective in addition to its high regiospecificity. This particularly positive result 
is currently under further study within the group. 
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5 	Experimental 
5.1 	Apparatus and chemicals 
All chemicals were purchased from the Aldrich Chemical Company, Poole, Dorset U.K. 
or Acros Organics, Loughborough, U.K.. 'H and '3C NMR analysis was performed on 
Bruker AC250 (250 MHz and 63MHz respectively) and WH-360 (360 MHz and 90 
MHz) spectrometers. 19F NMR analysis was performed on a Bruker AC250 
spectrometer at 235 MHz. Unless otherwise specified, spectra were recorded in 
deuterochloroform at ambient temperature. Chemical shifts are quoted. in parts per 
million (ppm) and were referenced internally ('H, CHC13, 7.27 ppm; 13CHC13, 77.0 
ppm). Carbon multiplicity was established by DEPT (distortionless enhancement by 
polarisation transfer). 
Infra-red spectra were recorded on a Perkin-Elmer FT-JR spectrometer (Paragon 1000) 
as thin films with frequencies (v) measured in wavenumbers (cm'). Mass spectra were 
run using electron impact (El) on Finnigan 4500 or 4600 instruments. Thin layer 
chromatography was performed on glass sheets coated with silica gel Merck 60E-254 
(0.24 mm, Art. 5715). Components were detected by UV (254 nm) and visualised by 
treating the plate with ammonium molybdate solution and heating. Wet flash 
chromatography was carried out on silica gel (Merck 9385, Kieselgel 60). 
Optical rotations [aD] were measured on an Optical Activity AA-1000 polarimeter with 
a cell path length of 1 dm at a temperature of 25 °C and concentrations (c) quoted in 
g/100 mL in methanol (sodium 589 nm detection). Unless otherwise stated, the 
compounds reported have been prepared in racemic form. 
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Gas chromatography (GC) was carried out using a Hewlett-Packard 6890 series GC 
system with flame ionisation detection or mass selective detection (HP 5973) employing 
a HP-5MS 5% phenyl methyl siloxane capillary column (30.Om x 320tm x 0.25 jtm). 
The HPLC analysis was carried out on a Waters 486 system employing Millennium 
software using a Sphericlone® 5 t ODS-2, 250 x 4.6 mm column (Phenomenex). 
Preparative scale HPLC was carried out on an equivalent column with an internal 
diameter of 10.0 mm at a flow-rate of 4.5 mL/min. 
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5.2 	Beauveria bassiana ATCC 7159 
5.2.1 Maintenance and growth of microorganism 
Beauveria bassiana ATCC 7159 was obtained from the American Type Culture 
Collection, U.S.A.. The organism was maintained on malt extract agar plates at room 
temperature and these were subcultured at regular intervals. A loop of fungus was used 
to inoculate 60 mL of sterile medium containing 7.5 g U' corn steep solids and 10 g U' 
glucose in distilled water adjusted to pH 4.85 in a 250 mL Erlenmeyer flask. After three 
days growth on an orbital shaker at 200 r.p.m. at 25° C, the culture was used to inoculate 
600 mL of the same medium in a 2 L Erlenmeyer flask. This culture was again grown 
for three days. 
5.2.2 General biotransformation procedure 
A solution of 66 mg substrate in 1 mL ethanol was prepared and added to a three day old 
660 mL culture of Beauveria bassiana ATCC 7159. After a further three days 
incubation as above, the fungal cells were removed from the broth by centrifugation and 
the supernatant extracted into ethyl acetate. Purification of metabolites was routinely 




5.2.3 Results of biotransformations 
Typical numbering scheme used for substituted piperidines under study 
Biohydroxylation of N-carboxybenzylpiperidine 5774  produced hydroxylated product 58 
that was isolated as a colourless oil (100 mg, 33 %). This piperidinol has been reported 
and characterised previously.' 15,116 
Biohydroxylation of N-carboxybenzyl-4-methylpiperidine 62 74 
N-carboxybenzyl-4-methyl-4-hydroxy-piperidine 63 was isolated as a pale yellow solid 
(130 mg, 45 %); mp 76 °C; oH (250 MHz) 1.24 (3H, s, CH3); 1.45 - 1.56 (5H, in, 
C(3)H2, C(5)H2 & C(4)OH), 3.23 - 3.34 (2H, dt, C(2)Hax & C(6)Hax, J 7 & 13), 3.80 
(2H, br. d, C(2)Heq & C(6)Heq, 1 13), 5.11 (2H, s, CH2Ph), 7.25 - 7.36 (5H, in, 
aromatic); 0c  (63 MHz) 30.0 (q, CH3), 38.2 (t, C3 & CS), 40.2 (t, C2 & C6), 66.9 (t, 
CH2Ph), 67.7 (s, C4), 127.7 (d, aromatic), 127.8 (d, aromatic), 128.3 (d, aromatic), 136.7 
(s), 155.1 (s); m/z (El) required 249.13649, found 249.13637; 249 (44 %, Mt), 158 (14, 
M - PhCH2), 142 (16, M - PhCH20), 91(100, PhCH2). 
Biohydroxylation of N-carboxybenzyl-3-methylpiperidine 67 
Three products were isolated from this biohydroxylation, two of which were found to be• 
difficult to separate and were thus separated by subjecting the mixture to acetylation 
conditions (10 mol equivalents acetic anhydride, 5 mol equivalents pyridine and 
catalytic dimethylaminopyridine) under which conditions one of the products was 
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acetylated 69 and one was left untouched 70. The products were then separated by 
preparative HPLC 
N-carboxybenzyl-trans-3-methyl-4-hydroxypiperidine 68 was isolated as a colourless oil 
(10 mg, 3 %); oH (360 MHz) 0.99 (3H, d, CH3, J 6.5), 1.43 - 1.59 (3H, br. m) & 1.91 
(1H, br. dd, J 3.& 13) (C(3)H, C(4)OH or C(5)H2), 2.53 (1H, br. s, C(2)Hax or 
C(6)Hax), 2.90 (1H, ddd, C(4)H, J 3, 12 & 14), 3.30 (1H, br. m, C(2)Hax or C(6)Hax), 
4.05 - 4.13 (2H, br. m, C(2)Heq & C(6)Heq), 5.11 (1H, s, CHAHBPh), 5.12 (1H, s, 
CHAHBPh), 7.28 - 7.36 (5H, m, aromatic); m/z (El) required 249.13649, found 
249.13616; 249 (8 %, Mt), 158 (11, M - PhCH2), 142 (6, M - PhCH20), 91(100, 
PhCH2). 
N-carboxybenzyl-cis-3-methyl-4-hydroxypiperidine was isolated as its acetylated 
derivative 69a as a colourless oil (5 mg); oH  (360 MHz): 0.88 (3H, d, CH3, J 7). 1.67 - 
1.93 (3H, br. m, C(3)H & C(5)H2), 2.07 (3H, s, acetyl CH3), 3.00 - 3.15 (1H, br. m, 
C(2)Hax or C(6)Hax), 3.25 - 3.28 (1H, br. rn, C(2)Hax or C(6)Hax), 3.70 (1H, br. 5, 
C(2)Heq), 3.75 (1H, ddd, C(6)Heq,J4.5, 4.5 & 13.5), 5.01 (1H, ddd, C(4)Heq,J3, 3 & 
5), 5.12 (2H, d, CH2Ph, J2), 7.28 - 7.39 (5H, m, aromatic); m/z (El) required 29 1.14706, 
found 291.14768; 291 (3 %. M), 200 (11, M - PhCH2), 91(100, PhCH2). 
N-carboxybenzyl-3-methyl-3-hydroxypiperidine 70 was isolated as a colourless oil (10 
mg, 3 %); 0H  (360 MHz) 1.21 (3H, s, CH3), 1.49 - 1.79 (5H, m, C(3)OH, C(4)H2 & 
C(5)H2). 2.96 - 3.03 (2H, br. m, C(2)Hax & C(6)Hax), 3.68 (1H, br.s, C(2)Heq), 3.84 
(1H, ddd, C(6)Heq, J4.5, 4.5 & 13), 5.13 (2H, s, CH2Ph), 7.28 - 7.35 (5H, m, aromatic); 
m/z (El) required 249.13649, found 249.13725; 249 (5 %, Mt), 114 (26, M - 
PhCH2000), 91(100, PhCH2). 
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Biohydroxylalion of N-carboxybenzyl-2-methylpiperidine 71 
N-carboxybenzyl-cis-2-methyl-4-hydroxy-piperidine 72 was isolated as a colourless oil 
(20 mg, 7%); oH (250 MHz) 1.35 (3H, d, CH3, J 7),1.46- 1.91 (5H, m, C(3)H2, C(4)OH 
& C(5)H2), 3.34 (1H, ddd, C(6)Hax, J 3.5 & 12.5), 3.90 (1H, ddd, C(6)Heq, J 3.5, 4 & 
12.5), 4.16 (1H, q, C(4)H, J3), 4.31 -4.42 (1H, m, C(2)Heq), 5.12 (2H, s, CH2Ph), 7.25 
- 7.36 (5H, m, aromatic); 6c  (90 MHz) 19.1 (q, CH3), 32.2, 33.5 (t, C3 & C5), 36.4 (t, 
C6), 45.7 (d, C2), 64.7 (d, C4), 66.8 (t, CH2Ph), 127.7 (d, aromatic), 127.8 (d, aromatic), 
128.4 (d, aromatic), 136.9 (s), 155.2 (s); m/z (El) required 249.13649, found 
249.136337, (FAB) 234 (4 %, M - CH3), 158 (15, M - PhCH2), 142 (31, M - PhCH20), 
114 (2, M - PhCH2CO2), 91(100, PhCH2). 
Figure 83: nOe enhancements and coupling constants used in assigning relative 
stereochemistry in product 72 
N-carboxybenzyl-cis-2-methyl-3-hydroxy-piperidine 73 was isolated as a colourless oil 
(20 mg, 7 %); 011 (360 MHz) 1.12 (3H, d, CH3, J7), 1.43 - 1.78 (SH, m, C(3)OH, C(4)H2 
& C(5)H2), 2.79 (1H, ddd, C(6)Hax, J3, 13 & 13.5), 3.77 (1H, m, C(3)H), 3.95 (1H, br 
d, C(6)Heq, J 12.5), 4.51 (1H, q, C(2)Heq, J6.5), 5.12 (2H, s, CH2Ph), 7.25 - 7.38 (5H, 
m, aromatic); Oc  (90 MHz) 9.2 (q, CH3), 24.0 (t, C4 or CS), 27. 1, (t, C4 or CS), 37.6 (t, 
C6), 51.0 (d, C2), 67.0 (t, CH2Ph), 69.0 (d, 0), 127.7 (d, aromatic), 127.9 (d, aromatic), 
128.4 (d, aromatic), 136.7 (s), 155.3 (s); m/z (El) required 249.13649, found 249.13637, 
(APCi) 250 (100 %, MH), 158 (7, M - PhCH2). 
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Figure 84: nOe enhancements used in assigning the relative stereochemistry in product 
73 
Biohydroxylation of N-carboxybenzyl-cis-2, 6-dimethylpiperidine 74 
N-carboxybenzyl-cis-2, 6-dimethyl-trans-4-hydroxypiperidine 75 was isolated as a 
colourless oil (10 mg, 5 %); oH (360 MHz) 1.25 (6H, d, 2 x CH3, J7), 1.42- 1.60 & 1.86 
- 1.90 (5H, in, C(3)H2, C(4)OH & C(5)H2), 4.20 (1H, tt, C(4)H, J4 & 11), 4.49 -4.57 
(2H, in, C(2)Heq & C(6)Heq), 5.14 (2H, s, CH2Ph), 7.23 - 7.38 (5H, in, aromatic); 0c 
(63 MHz, DEPT) 21.7 (q, 2 x CH3), 39.4 (t, C3 & CS), 47.2 (d, C2 & C6), 61.4 (d, C4), 
66.9 (t, CH2Ph), 127.7 (d, aromatic), 127.8 (d, aromatic), 128.4 (d, aromatic); m/z (El) 
required 263.152 14, found 263.15203, (FAB) 264 (MH). 
Biohydroxylation of N-carboxybenzyl-2-ethylpiperidine 76 
N-carboxybenzyl-trans-2-ethyl-4-hydroxypiperidine 77 was isolated as a colourless oil 
(130 mg, 45 %); OH (360 MHz) 0.85 (3H, t, C(8)H3, J7.5), 1.23 - 1.66 (5H, in, C(3)H, 
C(4)OH, C(5)H &C(7)H2), 1.92 (2H, dd, C(3)H & C(5)H,J2.5 & 12.5,), 2.85 (1H, ddd, 
C(6)Hax, J 2.5, 13.5 & 13.5), 3.91 (1H, tt, C(4)H, J 4.5 & 11.5), 4.16 (1H, br. d, 
C(6)Heq, J 12.5), 4.33 (1H, br. in, C(2)Heq), 5.10 (2H, d, CHAHBPh, J 12.5), 5.13 (2H, 
d, CHAHBPh, J 12.5), 7.25 - 7.37 (5H, in, aromatic); Oc  (90 MHz) 10.7 (q, C8), 23.8 (t, 
C7), 35.0 (C3 & C5), 37.6 (t, C6), 52.8 (d, C2), 65.0 (d, C4), 67.0 (t, CH2Ph), 127.6 (d, 
aromatic), 127.8 (d, aromatic), 128.3 (d, aromatic), 136.8 (s), 155.4 (s); m/z (El) required 
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263.15214, found 263.15253, (APCi) 264 (12, MH), 172 (7, M - PhCH2), 156 (23, M - 
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Figure 85: nOe enhancements and coupling constants used in assigning relative 
stereochemistry in product 77 
Biohydroxylation of N-carboxybenzyl-3,3-dimethylpiperidine 78 
N-carboxybenzyl-3,3-dimethyl-4-hydroxypiperidine 79 was isolated as a colourless oil 
(134 mg, 48 %); 8H (250 MHz @ 345K) 0.89 (3H, s) & 0.95 (3H, s) (C(7)H3 & C(8)H3), 
1.51 - 1.64 (2H, m, C(5)H & C(4)OH), 1.71 - 1.82 (1H, m, C(5)H), 2.85 (1H, d, 
C(2)Hax, J 13.5), 3.12 - 3.23 (1H, m, C(6)Hax), 3.40 (1H, dd, C(4)H, J4.0 & 8.5), 3.56 
(1H, dd, C(2)Heq, J 1.5 & 13.5), 3.81 - 3.91 (1H, m, C(6)Heq), 5.13 (2H, s, CH2Ph), 
7.24 - 7.36 (5H, m, aromatic); 6H  (63 MHz) 18.4 (q, C7 or C8), 24.2 (q, C7 or C8), 29.5 
(s, 0), 35.8 (t, CS), 41.5 (t, C2 or C6), 52.6 (t, C2 or C6), 66.9 (t, CH2Ph), 74.7 (d, C4), 
127.7 (d, aromatic), 127.8 (d, aromatic), 128.3 (d, aromatic), 136.7 (s), 155.4 (s); m/z 
(El) required 263.15214, found 263.15254, 263 (10 %, M), 172 (5, M - PhCH2), 128 (3, 
M -0O2CH2Ph), 91(100, CH2Ph), 77 (4, Ph). 
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5.3 	Rhodococcus sp. NCIMB 9784 
5.3.1 Maintenance and growth of microorganism 
Rhodococcus sp. NCIMB 9784 was obtained from the National Collection of Industrial 
and Marine Bacteria, Aberdeen, U.K.. The organism was maintained on agar plates at 
4 °C and these were subcultured at regular intervals. A loop of bacteria was used to 
inoculate 100 mL of sterile basal salts medium§ with 0.5 g U' ferrous sulfate 
heptahydrate and 4 g U' sodium pyruvate added through sterile filters, in a 250 mL 
Erlenmeyer flask. After three days growth on an orbital shaker at 250 r.p.m. at 30 °C, 
five such cultures were used to inoculate 8 L sterile basal salts media in a 10 L fermenter 
with 0.05 g U' ferrous sulfate heptahydrate and 1 g L' (+)-camphor added. The culture 
was grown for three days at 30 °C with aeration and stirring (200 rpm), with additional 
(+)-camphor (1 g L') added after two days growth. The cells were harvested by 
centrifugation (11K r.p.m. for 30 minutes) and washed with phosphate buffer (50 MM, 
pH 7.4) to remove excess camphor. 
5.3.2 General biotransformation procedure 
Resting cell transformations were carried out by resuspending cell mass in one-tenth 
growth volume of phosphate buffer (50 mM, pH 7.0), the substrate added as a solution 
in ethanol to 0.5 mg mL-1 and the suspension incubated at 30 °C with shaking (250 
§ Solution A: ammonium chloride 2.0 g U'; potassium dihydrogen phosphate 3.1 g U', dipotassium 
hydrogen phosphate 8.2 g U', yeast extract 0.1 g U', tryptone 0.1 g L 1 ; Solution B: magnesium sulfate 
0.05 g U', manganese sulfate 0.05 g U', calcium chloride 0.01 g U', ammonium molybdate 0.01 g U'. 
Solutions autoclaved separately and mixed when cool. 
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r.p.m.). The reaction was monitored by GC analysis until utilisation of substrate ceased. 
The cells were removed from the suspension by centrifugation (1 1K r.p.m. for 30 
minutes) and the supernatant extracted with ethyl acetate. The combined organic 
extracts were dried over magnesium sulfate and the resultant oil purified by wet flash 
chromatography using petroleum ether/ethyl acetate mixtures as eluent. 
5.3.3 Inhibition experiments 
In these experiments, an aliquot of inhibitor solution was added to the resting cell 
suspension at the same time as the substrate. For such small scale experiments, substrate 
was added to 0.1 mg per mL and inhibitor added to 2.5 mM concentration in an attempt 
to saturate the system with inhibitor. The suspension was incubated at 30 °C for 14 
hours and extracted with ethyl acetate for GC analysis. 
5.3.4 Biotransformation of 1,2,3,4-tetrahydronaphthalene (tetralin) 91 
0 
8 3  
3 
6 	4 
cz-Tetralone 96 was isolated as a pale yellow oil 23 (81 mg, 37 %); 6H (250 MHz): 2.06 - 
2.16 (21-1, m, C(2)H2 or C(3)H2), 2.60 - 2.65 (2H, m, C(2)H2 or C(3)H2), 2.94 (21-1, dd, 
C(4)H2, J6 & 6,), 7.20 - 7.31 (21-1, m, C(7)H & C(8)H), 7.44 (1H, ddd, C(6)H, J 1. 5, 7.5 
& 7.5), 7.99-8.02 (1H, m, C(9)H), 8c(63  MHz): 23.1 (t, C3). 29.5 (t, C2), 39.0 (t, C4), 
126.4 (d, C7 or C8), 127.0 (d, C7 or C8), 128.6 (d, C6), 132.4 (s, C5), 133.2 (d, C9), 
144.3 (s, CIO), 198.3 (s, Cl); m/z (El) required 146.07317, found 146.07271; 146 (65 




5.4 	Rhodococcus rhodochrous NCIMB 9703 
5.4.1 Substrate synthesis 
General benzylation procedure (A) 
Alcohol (1 mot eq.) and tetrabutylammonium iodide (trace) were added to a solution of 
sodium hydride (60 % suspension in mineral oil; 1.33 mot eq.) and freshly distilled 
benzyl bromide (1.67 mot eq.) in anhydrous THF under an atmosphere of argon at 0 C. 
On complete utilisation of the alcohol, the reaction mixture was diluted with diethyl 
ether and washed with saturated sodium hydrogen carbonate, saturated brine and water. 
The organic extracts were dried over anhydrous MgSO4, filtered, concentrated under 
reduced pressure and purified by flash chromatography. 
General preparation of 2-oxy-substituted oxygen heterocycles (B) 
The dihydroheterocycle (1.5 mot eq.) was added to a stirred solution of alcohol (1 mot 
eq.) and 4-toluenesulfonic acid (4 mot %) in anhydrous dichloromethane under an 
atmosphere of argon. On complete consumption of the alcohol, the reaction mixture was 
diluted with diethylether and washed with saturated brine, saturated sodium hydrogen 
carbonate and water. The organic extracts were then dried over anhydrous MgSO4, 
filtered, concentrated under reduced pressure and purified by flash chromatography. 
General esterijication procedure using acid chloride (C) 
Acid chloride (1.2 mot eq.) and pyridine (2 mot eq.) were added to a stirred solution of 
the alcohol (1 mot eq.) in anhydrous dichloromethane under an atmosphere of argon. 
Dimethylaminopyridine (trace) was also added if reaction was sluggish. On complete 
consumption of alcohol, the reaction mixture was diluted with dichloromethane and 
washed with citric acid (5 % aqueous solution), saturated sodium hydrogen carbonate 
solution, saturated brine and water. The organic extracts were dried over anhydrous 




General esterification procedure using DCC coupling method (D) 
DCC (1 mot eq.) and acid (1.5 mot eq.) were added to a stirred solution of the alcohol (1 
mot eq.), pyridine (1.5 mot eq.) and dimethylaminopyridine (catalytic) in anhydrous 
dichloromethane under an atmosphere of argon. On complete consumption of alcohol, 
the reaction mixture was diluted with ethyl acetate and filtered through cotton wool to 
remove dicyclohexylurea and the filtrate evaporated. The dilution, filtration and 
evaporation cycle was repeated twice to remove traces of DCU. The filtrate was then 
washed with citric acid (5 % aqueous solution), saturated sodium hydrogen carbonate 
solution, saturated brine and water. The organic extracts were dried over anhydrous 
MgSO4, filtered and concentrated under reduced pressure. 
Typical numbering scheme of six membered oxygen heterocycles 
6 
tLZIr  x 
8 
2-benzyloxy-tetrahydropyran 112117 
Acetal 112 was prepared using the general procedure B from benzylalcohol and 
dihydropyran.** 
Vmax 1120.3 (CO), 2867.8 & 2939.3 (CH stretch); 6H (250 MHz) 1.50 - 
1.91 (6H, m, C(3)H2, C(4)H2 & C(5)H2), 3.55 (1H, m, C(6)HA), 3.94 (1H, m, C(6)1-10, 
4.51 (1H, d, C(8)HA, J 12), 4.72 (1H, dd, C(2)H, J 3.5 & 3.5), 4.80 (1H, d, C(8)HB, J 
12), 7.32 (5H, m, aromatic); 8c (63 MHz) 19.2 (t, C3, C4 or CS), 25.3 (t, C3, C4 or CS), 
30.4 (t, C3, C4 or CS), 61.9 (t, C6 or C8), 68.6 (t, C6 or C8), 97.5 (d, C2), 127.3 (d, 
aromatic), 127.6 (d, aromatic), 128.2 (d, aromatic), 138.1 (s); m/z (El) requires 
192.11503, found 192.11517; 192(3%, M), 107 (16, PhCH20), 101 (39, M—PhCH2), 
91(100, PhCH2), 85 (43, M - PhCH20). 




Acetal 113 was prepared following the general procedure from 4-methylbenzylalcohol 
and dihydropyran.** 
Vmax 1118.7 (CO), 2869.3 & 2490.5 (CH stretch); S (250 MHz) 
1.51 - 1.91 (6H, m, C(3)H2, C(4)H2 & C(5)H2), 2.36 (3H, s, Me), 3.56 (1H, m, C(6)HA), 
3.95 (1H, m, C(6)HB), 4.49 (1H, d, C(8)HA, J 12), 4.72 (1H, dd, C(2)H, J 3.5 & 3.5), 
4.76 (1H, d, C(8)HB, J 12), 7.17 (2H, d, aromatic, J 8), 7.28 (2H, d, aromatic, J 8); öc 
(63 MHz) 19.2 (t), 21.0 (q, Me), 25.3 (t), 30.4 (t), 61.9 (t, C6 or C8), 68.5 (t, C6 or C8), 
97.3 (d, C2), 127.8 (d, aromatic), 128.8 (d, aromatic), 135.1 (s), 136.9 (s); m/z (El) 
requires 206.13068 found 206.11321; 206 (2 %, M), 105 (100, CH3C6H4CH2), 91(16, 
PhCH2), 85 (29, M - CH3C6H4CH20). 
2-(4-chlorobenzyloxy)-tetrahydropyran 116 
Acetal 116 prepared following the general method B from dihydropyran and 4-
chlorobenzylalcohol.** 
Vmax 1089.5 (CO), 2880.9 & 2978.1 (CH); 6H  (250 MHz) 1.49 - 
1.87 (6H, m, C(3)H2, C(4)H2 & C(5)H2), 3.53 (1H, m, C(6)HA), 3.88 (1H, m, C(6)HB), 
4.45 (1H, d, C(8)HA, J 12), 4.68 (1H, dd, C(2)H, J 3 & 3), 4.73 (1H, d, C(8)HB, J 12), 
7.27 (4H, m, aromatic); öc  (63 MHz) 19.1 (t, C3, C4 or CS), 25.3 (t, C3,C4 or CS), 30.3 
(t, C3, C4 or CS), 62.0 (t, C6 or C8), 67.8 (t, C6 or C8), 97.6 (d, C2), 128.3 (d, 
aromatic), 128.9 (d, aromatic), 133.0 (s), 136.6 (s); m/z (El) requires 226.07606 and 
228.073 11, found 226.07604 and 228.07357; 228 (2%, 37C1 M), 226 (7, 35C1, M), 127 
(47, 37C1C6H4CH2), 125 (100, 35C1C6H4CH2), 101 (27, M - C1C6H4CH2). Although this 





Acetal 119 was prepared following the general procedure C from 4-nitrobenzylalcohol 
and dihydropyran in 72 % yield (2.90 g). Vmax 1125.8 (CO), 1344.8 & 1520.8 (NO), 
2866.1 & 2942.3 (CH stretch); 6H  (250 MHz) 1.50 - 1.90 (6H, m, C(3)H2, C(4)H2 & 
C(5)H2), 3.52 (1H, m, C(6)HA), 3.85 (1H, m, C(6)HB), 4.57 (1H, d, C(8)HA, J 13.5), 
4.70 (1H, dd, C(2)H, J3.5 & 3.5), 4.84 (1H, d, C(8)HB, J 13.5), 7.50 (2H, d, aromatic, J 
9), 8.16 (2H, d, aromatic, J 9); 6c  (63 MHz) 19.1 (t, C3, C4 or C5), 25.1 (t, C3, C4 or 
C5), 30.2 (t, C3, C4 or CS), 62.1 (t, C6 or C8), 67.4 (t, C6 or C8), 98.1 (d, C2), 123.3 (d, 
aromatic), 127.5 (d, aromatic), 145.9 (s), 147.0 (s); m/z (El) requires 237.10011, found 
237.10016; 237 (3 %, M), 136 (46, 02NC6H4CH2), 101 (34, M - 02NC6H4CH2), 85 
(100, M - 02NC6H4CH2O). 
2-benzyloxymethyl-tetrahydropyran 122118 
5 0  7 9 
4 	2 
Ether 122 was prepared following the general benzylation procedure from (±)-
tetrahydropyran-2-methanol and benzyl bromide.** Vmax 1090.9 (CO), 2849.8 & 2933.5 
(CH stretch); oH (250 MHz) 1.45 - 1.62 & 1.83 (6H, m, C(3)H2, C(4)H2 & C(5)H2), 3.45 
(4H, m, C(6)H2 & C(7)H2), 4.03 (1H, m, C(2)H), 4.53 (1H, d, C(9)HA, J 12), 4.60 (1H, 
d, C(9)H,3, J 12), 7.29 (5H, m, aromatic); oc  (63 MHz) 23.0 (t, C3, C4 or CS), 25.8 (t, 
C3, C4 or CS), 28.1 (t, C3, C4 or CS), 68.3 (t, C6, C7 or C9), 73.2 (C6, C7 or C9), 73.6 
(t, C6, C7 or C9), 76.7 (d, C2), 127.4 (d, aromatic), 127.6 (d, aromatic), 128.2 (d, 
aromatic), 138.1 (s); m/z (El) required 206.13068, found 206.13064; 206 (3 %, M), 91 
(23, PhCH2), 85 (34, M - PhCH20CH2), 77 (14, Ph). 
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2-ph enethyloxy-tetrahydropyran 124 
6 
o c  
Acetal 124 was prepared following the general procedure B from 2-phenylethanol and 
dihydropyran in 65 % yield (1.65 g). Vmax 1070.9 (CO), 2867.0 & 2937.4 (CH stretch); 
H (250 MHz) 1.46— 1.85 (6H, in, C(3)H2, C(4)H2 & C(5)H2), 2.92 (2H, dd, C(8)H2, J7 
&7), 3.45 (1H, in, C(6)HA), 3.62 (1H, ddd, C(9)HA, J7, 7 & 9.5), 3.75 (1H, m, C(6)HB), 
3.94 (1H, ddd, C(9)HB,J7, 7 & 9.5), 4.60 (1H, dd, C(2)H,J3 & 4), 7.16-7.32 (5H, m, 
aromatic); 8c  (63 MHz) 19.4 (t), 25.3 (t), 30.5 (t), 36.2 (t), 62.1(t), 68.1 (t), 98.6 (d, C2), 
126.0 (d, aromatic), 128.1 (d, aromatic), 128.9 (d, aromatic), 140.0 (s); m/z (El) required 
206.13068,, found 206.13097; 206 (0.2 %, M), 105 (73, PhCH2CH2), 101 (21, M - 
PhCH2CH2), 91(16, PhCH2), 85 (100, M - PhCH2CH20). Although this compound has 
been described previously in the literature, its characterisation has not been reported. 





Acetal 125 was prepared following the general method from benzylalcohol and 
dihydrofuran in 86 % yield (2.14 g). Vmax 1090.1 (CO), 2880.2 & 2977.1 (CH stretch); 
H (250 MHz) 1.80 - 2.09 (4H, m, C(3)H2 & C(4)H2)5 3.93 (2H, in, C(5)H2), 4.48 (1H, 
d, C(7)HA5 J 12)5 4.71 (1H, d, C(7)HB5 J 12), 5.22 (1H, dd, C(2)H2, J 2 & 3.5), 7.31 
(5H, m, aromatic); & (63 MHz) 23.3 (t, C3 or C4), 32.2 (t, C3 or C4), 66.9 (t, C5 or 
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C7), 68.6 (t, CS or C7), 103.0 (d, C2), 127.4 (d, aromatic), 127.7 (d, aromatic), 128.2 (d, 
aromatic), 138.2 (s); m/z (El) requires 178.09938, found 178.09973; 178 (11 %, M), 
107 (21, PhCH20), 91(100, PhCH2), 87 (25, M - PhCH2), 77 (25, Ph), 71(80, M - 
PhCH2O). 
2-(4-methylbenzyloxy)-tetrahydrofuran 127 
Acetal 127 was prepared following the general procedure B from 4-rnethylbenzylalcohol 
and dihydroftlran.** 
Vmax 1118.4 (CO), 2878.7 & 2976.7 (CH stretching); 6H  (250 MHz) 
1.83 - 2.08 (4H, m, C(3)H2 & C(4)H2), 2.36 (3H, s, Me), 3.94 (2H, m, C(5)H2), 4.47 
(1H, d, C(7)HA, J 11.5), 4.70 (1H, d, C(7)HB, J 11.5), 5.25 (1H, dd, C(2)H, J2 & 3.5), 
7.17 (2H, d, aromatic, J8), 7.26 (2H, d, aromatic, J8); oc (63 MHz) 20.9 (q, Me), 23.3 
(t, C3 or C4), 32.1 (t, C3 or C4), 66.7 (t, CS or C7), 68.4 (t, CS or C7), 102.7 (d, C2), 
127.8 (d, aromatic), 128.8 (d, aromatic), 135.1 (s), 136.9 (s); m/z (El) required 
192.11503 found 192.11500; 192 (8 %, M), 105 (100, CH3C6H4CH2), 91(23, PhCH2). 
2-(4-chlorobenzyloxy)-tetrahydrofuran 129 
Acetal 129 was prepared following the general method C from 4-chlorobenzylalcohol 
and dihydrofuran.** 
Vmax 806.3 (CC1), 1117.2 (CO), 2881.1 & 2977.5 (CH); 6H (250 
MHz) 1.80 - 2.05 (4H, m, C(3)H2 & C(4)H2), 3.90 (2H, m, C(5)H2), 4.43 (1H, d, 
C(7)HA, J 12), 4.66 (1H, d, C(7)HB, J 12), 5.18 (1H, dd, C(2)H, J 2.5 & 3.5), 7.27 (4H, 
m, aromatic); öc (63 MHz) 23.3 (t, C3 or C4), 32.2 (t, C3 or C4), 66.9 (t, CS or C7), 67.8 
(t, CS or C7), 103.1 (d, C2), 128.3 (d, aromatic), 129.0 (d, aromatic), 133.0 (s), 136.8 
(s); m/z (El) requires 212.06041 & 2 14.05746, found 212.06038 & 214.05747; 214 (7 %, 
37C1 Mt), 212 (17, 35C1 M), 127(48, 37C1C6H4CH2), 125 (90, 35C1C6H4CH2), 87 (27, M 




Acetal 132 was prepared following the general procedure C from 4-nitrobenzylalcohol 
and dihydrofuran in 71 % yield (2.69 g). Vmax 1110.3 (CO), 1344.9 & 1520.0 (NO), 
2884.3 & 2978.0 (CH stretch); oH (200 MHz) 1.82 - 2.10 (4H, m, C(3)H2 & C(4)H2), 
3.91 (2H, m, C(5)H2), 4.56 (1H, d, C(7)HA, J 13.5), 4.78 (1H, d, C(7)H8, J 13.5), 5.22 
(1H, m, C(2)H), 7.47 (2H, d, aromatic, J 9), 8.17 (2H, d, aromatic, J 9); 8c  (50 MHz) 
23.3 (t, C3 or C4), 32.3 (t, C3 or C4), 67.1 (t, C5 or C7), 67.4 (t, C5 or C7), 103.5 (d, 
C2), 123.4 (d, aromatic), 127.6 (d, aromatic), 146.1 (s), 147.1 (s); m/z (El) requires 




Ether 134 was prepared following the general benzylation procedure A using 
tetrahydrofurfuryl alcohol and benzyl bromide in a 46 % yield (0.87 g). Vmax 1083.9 
(CO), 2858.7 & 2697.2 (CH stretch); 0H  (250 MHz) 1.62 (1H, m) & 1.90 (3H, m) 
(C(3)H2 & C(4)H2), 3.47 (2H, d, C(6)H2, J 5), 3.76 (1H, m, G(5)HA), 3.88 (1H, m, 
G(5)HB), 4.07 (1H, m, C(2)H), 4.55 (1H, d, G(8)HA, J 12), 4.59 (1H, d, G(8)HB, J 12), 
7.30 (5H, m, aromatic); oc  (63 MHz) 25.5 (t, C3 or C4), 28.0 (t, C3 or C4), 68.1 (t), 72.6 
(t), 73.2 (t),77.7 (d, C2), 127.4 (d, aromatic), 127.5 (d, aromatic), 128.2 (d, aromatic), 
138.2 (s); m/z (El) required 192.11503 found 192.11516; 192 (M+), 107 (PhCH20), 101 
(M - PhCH2), 91 (PhCH2), 71 (M - PhGH20GH2). 
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Preparation of cyclohex-3,4-enol' 21  
1,4-cyclohexanediol (15 g, 0.13 mol) and concentrated sulphuric acid (0.05 mL) were 
heated to 200 °C. The distillate collected was diluted with diethylether and dried over 
MgSO4. The product was then purified by distillation at reduced pressure yielding 
alcohol (10 %). 5H (200 MHz) 1.46 - 2.31 (6H, m, C(2)H2, C(5)H2 & C(6)H2), 3.01 




Ether 144 was prepared in a 75 % yield (1.56 g) following the general benzylation 
procedure A from cyclohex-3,4-en-1-ol. 6H  (250 MHz) 1.66 (1H, m), 1.94 - 2.26 (4H, 
m) & 2.40 (1H, m) (C(2)H2, C(5)H2 & C(6)H2), 3.66 (1H, m, C(1)H), 4.58 (1H, d, 
C(8)HA, J 12), 4.61 (1H, d, C(8)H,3, J 12), 5.62 (2H, m, C(3)H & C4(H)), 7.31 (5H, m, 
aromatic); oc (63 MHz) 23.9 (t, C2, CS or C6), 27.7 (t, C2, CS or C6), 31.6 (t, C2, CS or 
C6), 69.8 (t, C8), 73.7 (d, Cl), 124.2 (d), 126.7 (d), 127.3 (d), 127.4 (d), 128.2 (d), 138.9 










Ether 146 was prepared in a 60 % yield (1.15 g) following the general benzylation 
procedure from cyclohex-2,3-en-1-ol. Vmax 1650.5 (C=C stretch), 2861.2 & 2933.3 (CH 
stretch), 3023.8 (C=CH stretch); 6H (250 MHz) 1.57 - 2.07 (6H, m, C(4)H2, C(5)H2 & 
C(6)H2), 3.97 (1H, m, C(1)H), 4.57 (1H, d, C(8)HA, J 12), 4.63 (1H, d, C(8)HB, J 12), 
5.86 (2H, m, C(2)H & C(3)H), 7.32 (5H, m, aromatic); 8c (63 MHz) 19.1 (t, C4, C5 or 
C6), 25.1 (t, C4, CS or C6), 28.2 (t, C4, C5 or C6), 69.8 (t, C8), 72.0 (d, Cl), 127.2 (d), 
127.4 (d), 127.6 (d), 128.1 (d), 130.8 (d), 138.9 (s); m/z (El) required 188.12012, found 
188.12058; 188(10%,M), 107(14,PhCH20),91 (100,PhCH2),81 (32,M—PhCH20) 
N-benzylpyrrolidine 150" 
Amine 150 was prepared in 72 % yield (0.65 g) from pyrrolidine (1 mol eq.), benzyl 
bromide (1.1 mol eq.) and potassium hydroxide (1.1 mol eq.) in ethanol. Vmax 2961.0 
(CH), 2781.4 (NCH2); ö,j (250 MHz) 1.78 (4H, m, C(3)H2 & C(4)H2), 3.52 (4H, m, 
C(2)H2 & C(5)H2), 3.62 (2H, s, C(6)H2), 7.29 (5H, m, aromatic); 6c (63 MHz) 23.3 (t, 
C3 & C4), 54.0 (t, C2 & C5), 60.6 (t, C6), 126.7 (d, aromatic), 128.0 (d, aromatic), 
128.8 (d, aromatic), 139.2 (s); m/z (El) requires 161.12045, found 161.11994; 161 (65 
%, M), 91(100, PhCH2), 70 (67, M - PhCH2). 
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5.4.2 Maintenance and growth of microorganism 
Rhodococcus rhodochrous NCIMB 9703 was obtained from the National Collection of 
Industrial and Marine Bacteria, Aberdeen, U.K. The organism was maintained on agar 
plates at 4 °C and these were subcultured at regular intervals. A loop of bacteria was 
used to inoculate 50 mL of sterile basal salts mediumtt with 0.05 g U' ferrous sulfate 
heptahydrate and 4 g U' sodium pyruvate added via sterile filters, in a 250 mL 
Erlenmeyer flask. After three days agitation on an orbital shaker at 250 r.p.m. at 30° C, 
each culture was used to inoculate 500 mL of the same medium with 0.05 g U' ferrous 
sulfate heptahydrate and 5 mL octane per 500 mL culture added, in a 2 L Erlenmeyer 
flask. This culture was grown for five to seven days. The cells were harvested by 
centrifugation (10 000 rpm for 30 minutes) and washed with phosphate buffer (50 mM, 
pH 7.0). 
5.4.3 General biotransformation procedure 
Resting cell transformations were carried out by re-suspending washed cells in one-tenth 
growth volume of phosphate buffer (50 mM, pH 7.0). A solution of 100 mg substrate in 
1 mL ethanol was prepared and this was added to the resting cell culture (200 mL) of 
Rhodococcus rhodochrous NCIMB 9703. After 16 hours incubation as above, the cells 
were removed by centrifugation and the supernatant extracted into ethyl acetate. 
Purification of metabolites was routinely carried out using flash silica chromatography 
with petroleum ether/ethyl acetate or dichloromethane/ethyl acetate as eluent. 
tt Solution A: ammonium chloride 2.0 g U'; potassium dihydrogen phosphate 3.1 g U', dipotassium 
hydrogen phosphate 8.2 g U', yeast extract 0.1 g U', tryptone 0.1 g L'; Solution B: magnesium sulfate 
0.05 g U', manganese sulfate 0.05 g U', calcium chloride 0.01 g U', ammonium molybdate 0.01 g U'. 
Solutions autoclaved separately and mixed when cool. 
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5.4.4 Biohydroxylation results 









Typical products identified from biohydroxylation with Rhodococcus rhodochrous 
NCIMB 9703: trans-2-aryl-5-hydroxytetrahydropyran A and cis-2-aryl-5-
hydroxytetrahydropyran B. 
Biohydroxylation of2-(4-methylbenzyloxy)tetrahydropyran 113 
trans-2-(4-methylbenzyloxy)-5-hydroxytetrahydropyran 114 was isolated as a colourless 
Oil (10 mg, 9 %). [aD] -21° (c 1.4); 8H  (360 MHz) 1.60 (2H, in, C(3)HA & C(4)HA), 
2.04 (2H, in, C(3)HB & C(4)HB), 2.34 (3H, s, Me), 3.47 (1H, dddd, C(6)Heq, J 0.5, 2, 
3.5 & 12), 3.80 (1H, hr. s, C(5)H), 4.00 (1H, dd, C(6)Hax, J 2 & 12), 4.46 (1H, d, 
C(8)HA, J 12), 4.70 (1H, d, C(8)HB5  J 12)5 4.78 (1H, dd, C(2)H, .10.5 & 2.5), 7.18 (4H, 
in, aromatic), 6c (90 MHz) 21.6 (q, CH3), 25.6 (t, C3 or C4), 26.2 (t, C3 or C4), 65.4 (d, 
C5), 65.6 (t, C6 or C8), 76.4 (t, C6 or C8), 97.0 (d, C2), 128.4 (d, aromatic), 129.5 (d, 
aromatic), 135.3 (s), 137.8 (s); m/z (El) required 222.12559, found 222.12559; 222 (0.8 
%, M), 121 (100, CH3PhCH20), 91(58, PhCH2). 
cis-2-(4-methylbenzyloxy)-5-hydroxytetrahydropyran 115 was isolated as a colourless oil 
(20 mg, 18 %). [aD] +7° (c 1.0); oH (360 MHz, C6D6) 1.44 (3H, in, C(5)OH, C(3)HA, 
C(4)HB), 1.70 (2H, in, C(3)HB, C(4)HB), 2.11 (3H, s, CH3), 3.39 (1H, in, C(5)H), 3.48 
(1H, ddd, C(6)Heq,.1 1.7, 4.3 & 10.7), 3.54 (1H, dd, C(6)Hax, J 8.8 & 10.7), 4.37 (1H, 
d, C(8)HA5 .112), 4.59 (1H, dd, C(2)H, .1 2.6 & 3), 4.71 (1H, d, C(8)HB, J 12), 7.01 (2H5 
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d, aromatic, J 8), 7.25 (2H, d, aromatic, J 8); öc (93 MHz) 21.6 (q, CH3), 28.6 (t, C3 or 
C4), 30.1 (t, C3 or C4), 66.0 (d, C5), 66.5 (t, C6 or C8), 69.3 (t, C6 or C8), 96.7 (d, C2), 
128.5 (d, aromatic), 129.5 (d, aromatic), 135.2 (s, C12), 137.9 (s, C9); m/z (El) required 
222.12559, found 222.12634; 222(8%, M), 121 (4, M - OH), 118 (12, M—CH3PhCH), 
105 (45, CH3PhCH2). 
Biohydroxylation of 2-(4-chlorobenzyloxy)tetrahydropyran 116 
trans-2-(4-chlorobenzyloxy)-5-hydroxytetrahydropyran 117 was isolated as a colourless 
Oil (9 Mg, 8%). {a0] —11 (c 1.6); 6H(2SO  MHz) 1.60 (2H, m, C(3)HA & C(4)HA), 2.04 
(2H, m, C(3)HB & C(4)HB), 3.48 (1H, m, C(6)Heq), 3.81 (1H, br. m, C(5)H), 3.97 (1H, 
dd, C(6)Hax, J 2 & 12), 4.47 (1H, d, C(8)HA, J 12), 4.70 (1H, d, C(8)HB, J 12), 4.77 
(1H, dd, C(2)H, J 2.5 & 2.5), 7.25 - 7.33 (4H, m, aromatic); 6c  (63 MHz) 25.0 (t, C3 or 
C4), 25.6 (t, C3 or C4), 64.8 (d, CS), 65.1 (t, C6 or C8), 68.1 (t, C6 or C8), 96.6 (d, C2), 
128.4 (d, aromatic), 129.0 (d, aromatic), 133.3 (s), 136.3 (s); m/z (El) required 
242.07097 and 244.06802, found 242.07065 and 244.06782; 244 (0.1 %, M 37C1), 242 
(0.5 %, M "Cl), 127 (52, 37C1C6H4CH2), 125 (100, 35C1C6H4CH2), 91(15, PhCH2). 
cis-2-(4-chlorobenzyloxy)-5-hydroxytetrahydropyran 118 was isolated as a colourless oil 
(13 mg, 12%). 6H(360  MHz) 1.71 - 1.95 (5H, m, C(3)H2, C(4)H2 & C(5)OH), 3.67 (2H, 
hr. m, C(6)H2), 3.79 (1H, br. m, C(5)H), 4.50 (1H, d, C(8)HA, J 12.2), 4.72 (1H, m, 
C(2)H), 4.77 (1H, d, C(8)HB, J 12.2), 7.28 - 7.38 (4H, m, aromatic); 6c  (63 MHz) 27.9 
(t, C3 & C4), 65.3 (d, CS), 66.0 (t, C6 or C8), 68.0 (t, C6 or C8), 96.3 (d, C2), 128.4 (d, 
aromatic), 129.0 (d, aromatic), 133.3 (s), 136.2 (s); m/z 242 (M). 
Biohydroxylation of2-(4-nitrobenzyloxy)tetrahydropyran 119 
trans-2- (4-nitrobenzyloxy)-5-hydroxytetrahydropyran 120 was isolated a colourless oil 
(22 mg, 21 %). [aD] +36 (c 1.15); 8H  (360 MHz) 1.70 (2H, m, C(3)HA & C(4)HA), 1.70 
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(1H, br. s, C(5)OH), 2.13 (2H, m, C(3)HB & C(4)HB), 3.53 (1H, m, C(6)Heq), 3.99 (1H, 
dd, C(6)Hax, J2.2 & 11.8), 4.65 (1H, d, C8-HA, J 13.5), 4.85 (1H, m, C(2)H), 4.89 (1H, 
d, C(8)HB, J 13.5), 7.55 (2H, d, aromatic, J 8.8), 8.24 (2H, d, aromatic, J 8.8); 8c (90 
MHz) 25.5 (t, C3 or C4), 26.2 (t, C3 or C4), 65.2 (d, C5), 65.7 (t, C6 or C8), 68.3 (t, C6 
or C8), 97.7 (d, C2), 124.1 (d, aromatic), 128.2 (d, aromatic), 146.1 (s), 147.8 (s); m/z 
(El) required 253.09502, found 253.09509; 253 (1%, M), 236 (4, M - OH), 153 (92, 
02NC6H4CH20H), 152 (44, 02NC6H4CH20). 
cis-2-(4-nitrobenzyloxy)-5-hydroxytetrahydropyran 121 was isolated as a pale yellow oil 
(19 mg, 18 %). [aD] -44 (c 0.7); oH (360 MHz) 1.88 (5H, m, C(3)H2, C(4)H2 & 
C(5)OH), 3.63 (1H, dd, C(6)Hax, J 8 & 11), 3.70 (1H, ddd, C(6)Heq, J 1.2, 4 & 11), 
3.80 (1H, m, C(5)H), 4.63 (1H, d, C(8)HA, J 13.4), 4.76 (1H, dd, C(2)H, J 3.1 & 3.3), 
4.90 (1H, d, C(8)HB, J 13.4), 7.55 (2H, m, aromatic), 8.24 (2H, m, aromatic); oc  (63 
MHz) 27.8 (t, C3 or C4), 29.5 (t, C3 or C4), 65.2 (d, CS), 66.0 (t, C6 or C8), 67.6 (t, C6 
or C8), 96.8 (d, C2), 123.5 (d, aromatic), 127.7 (d, aromatic), 145.5 (s), 147.7 (s); m/z 
(El) required 253.09502, found 253.09501; 253 (0.1 %, M), 153 (21, 
02NC6H4CH20H). 
Biohydroxylation of2-(benzyloxymethyl)tetrahydropyran  122 
07 	9 
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trans-2-(benzylmethyloxy)-5-hydroxytetrahydropyran 123 was isolated as a colourless 
oil (38 mg, 35 %). [aD] +2.9 (c 1.0); 8H  (360 MHz) 1.38 - 1.72 (4H, m) & 2.12 (1H, m) 
(C(5)OH, C(3)H2 & C(4)H2), 3.13 (1H, dd, C(6)Hax, J 10.4 & 10.6), 3.39 - 3.50 (3H, 
overlapping m, C(7)H2 & C(2)H), 3.70 (1H, m, C(5)H), 4.03 (1H, ddd, C(6)Heq, J 2.2, 
4.8 & 10.6), 4.53 (1H, d, C(8)HA, J 12.2), 4.58 (1H, d, C(8)HB, J 12.2), 7.29 (5H, m, 
aromatic); Oc  (90 MHz) 27.0 (t, C3 or C4), 32.4 (t, C3 or C4), 66.2 (d, C2), 72.6 (t, C6, 
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C7 or C8), 72.7 (t, C6, C7 or C8), 73.3 (t, C6, C7 or C8), 76.4 (d, C5), 127.5 (d, 
aromatic), 127.7 (d, aromatic), 128.8 (d, aromatic), 138.0 (s); m/z (El) required 
222.12559, found 222.12568; 222 (20%, M), 205 (2, M - OH), 107 (30, PhCH20), 91 
(62, PhCH2). 
Biohydroxylation of2-(benzyloxy)tetrahydrofuran 125 
5 
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2-(benzyloxy)-4-hydroxytetrahydrofuran 126 was isolated as colourless oil (16 mg, 
15 %). [aD] +45 (c 0.6); oH (360 MHz) 1.95 (1H, br.s, C(4)OH), 2.14 (1H, dddd, 
C(3)HA, J 1, 2.2, 5.5 & 14.4). 2.29 (1H, ddd, C(3)HB, J 2.6, 6.4 & 14.4), 3.87 (1H, d, 
C(5)H, J9.8), 4.04 (1H, dd, C(5)H, J4.2 & 9.8), 4.53 (1H, d, C(7)HA, J 11.8), 4.59 (1H, 
br. m, C(4)H), 4.77 (1H, d, C(7)HB, J 11.8), 5.43 (1H, dd, C(2)H, J2.5 & 5.5), 7.34 (5H, 
m, aromatic); oc (90 MHz) 43.3 (t, 0), 69.9 (t, CS or C7), 72.1 (d, C4), 74.3 (t, CS or 
C7), 103.6 (d, C2), 128.1 (d, aromatic), 128.3 (d, aromatic), 128.8 (d, aromatic), 138.3 
(s); m/z (El) required 194.09429, found 194.09434; 194 (0.7 %, M), 177 (0.9, M - OH), 
107 (16, PhCH20), 103 (20, M - PhCH2), 91(100, PhCH2), 77 (20, Ph). 
Biohydroxylation of2-(4-methylbenzyloxy)tetrahydrofuran 127 
2-(4-methylbenzyloxy)-4-hydroxytetrahydrofuran 128 was isolated as a colourless oil (19 
Mg, 18 %). [CCD] +290 (c 0.25); 0H (360 MHz) 2.13 (1H, dddd, C(3)HA, J 1.5, 2.5, 5.5 & 
14.5), 2.27 (1H, dddd, C(3)HB, J 0.5, 2.5, 6 & 14.5), 2.37 (3H, s, CH3), 3.87 (1H, dddd, 
C(5)HA, J 0.5, 1.5, 1.5 & 10), 4.04 (1H, ddd, C(5)HB, J 0.5, 4 & 10), 4.49 (1H, d, 
C(7)HA, J 11.5), 4.60 (1H, m, C(4)H), 4.72 (1H, d, C(7)HB, J 11.5), 5.42 (1H, dddd, 
C(2)H, J 0.5, 0.5, 2.5 & 5.5), 7.18 (2H, m, aromatic), 7.25 (2H, m, aromatic); oc (93 
MHz) 21.0 (q, CH3), 42.8 (t, 0), 69.2 (t, CS or C7), 71.7 (d, C4), 73.7 (t, CS or C7), 
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102.8 (d, C2-H), 127.9 (d, aromatic), 128.9 (d, aromatic), 134.7 (s), 137.3 (s); m/z (El) 
required 208.10994, found 208.11008; 208 (8%, M), 191 (4, M - OH), 92 (35, PhCH3), 
91(83, PhCH2). 
Biohydroxylation of 2-(4-nitrobenzyloxy)tetrahydrofuran 132 
2-(4-nitrobenzyloxy)-4-hydroxytetrahydrofuran 133 was isolated as a pale yellow oil (28 
mg, 26 %). [(XD] +80 (c 1.5); oH (250 MHz, CDC13) 1.97 (1H, br in, C(4)OH), 2.15 (1H, 
dddd, C(3)HA, J 1.2, 2.6, 5.4 & 14.4), 2.27 (1H, ddd, C(3)HB, J 2.6, 6.0 & 14.4), 3.83 
(1H, ddd, C(5)HA, J 1.5, 1.5 & 10), 3.96 (1H, ddd, C(5)HB, J0.5, 4 & 10), 4.57 (1H, d, 
C(7)HA, J 13), 4.58 (1H, in, C(4)H), 4.80 (1H, d, C(7)HB, J 13), 5.38 (1H, dd, C(2)H, J 
2.5 & 5.5), 7.46 (2H, d, J 8.8, aromatic), 8.17 (2H, d, J 8.8, aromatic); 6c  (63 MHz) 42.7 
(t, 0), 68.1 (t, CS or C7), 71.4 (d, C4), 73.9 (t, CS or C7), 103.6 (d, C2-H), 123.5 (d, 
aromatic), 127.7 (d, aromatic), 145.6 (s), 147.2 (s); m/z (El) required 239.07937, found 
239.07941; 239(4%, M), 136 (22, 02NC6H4CH2), 107 (31, PhCH20). 
2-(4-nitrobenzyloxy)-tetrahydrofur-4-yl-(ci-trifluoromethyl- ci-methoxyphenylacetate) 






Ester 135 prepared following esterification method D from alcohol 133 and a-
trifluoromethyl-a-methoxyphenyl acetic acid. [(XD] +37 (c 1.2); oH  (250 MHz) 2.23 (1H, 
dddd, C(3)HA, J 1, 2.5, 5.5, 15), 2.42 (1H, ddd, C(3)HB, J 2.5, 7.0 & 15), 3.54 (3H, ddd, 
OMe, JHF  1), 4.07 (2H, overlapping in, C(5)H2), 4.58 (1H, d, C(7)HA, J 13), 4.80 (1H, d, 
C(7)Hs, J 13), 5.35 (1H, dd, C(2)H, J 2.5 & 5.5), 5.58 (1H, in, C(4)H), 7.25 - 7.52 (7H, 
in, aromatic), 8.18 (2H, d, aromatic, J 8.8); Oc  (90 MHz) 39.8 (t, 0), 55.8 (q, OMe), 
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68.7 (t, CS or C7), 71.3 (t, C5 or C7), 76.9 (d, C4), 103.7 (d, C2), 120.0 (s), 124.1 (d, 
aromatic), 125.2 (s), 127.6 (d, aromatic), 128.3 (d, aromatic), 129.0 (d, aromatic), 130.2 
(d, aromatic), 132.3 (s), 145.7 (s), 147.8 (s), 166.8 (s); 6F  (235 MHz) —76.1 & -76.2, mlz 
(El) required 455.11919 found 455.11922; 455(0.2%, M+), 319 (1, M—O2NC6H4CH2), 
222 (4, M - PhC(CF3)(OMe)CO2), 189 (100, PhC(CF3)OMe), 136 (53, 02NC6H4CH2). 





Ester 136 was prepared following the DCC coupling method D from a-trifluoromethyl-
c-methoxypheny1acetic acid and 4-nitrobenzylalcohol in 90 % yield (50 mg). E- (250 
MHz) 3.52 (3H, ddd, OMe, JHF  1.5), 5.38 (1H, d, PhCHA, J 13), 5.45 (1H, d, PhCHB, J 
13), 7.25 - 7.48 (7H, m, aromatic), 8.20 (2H, d, aromatic, J 9); 5c (63 MHz) 55.4 (q, 
OMe), 66.1 (t, PhCH20), 120.8 (s), 123.8 (d, aromatic), 125.4 (s), 127.1 (d, aromatic), 
128.4 (d, aromatic), 129.7 (d, aromatic), 131.6 (s), 141.5 (s), 166.1 (s); 6F  (235 MHz) 
-75.9, m/z (FAB) 370 (3 %, MH), 189 (100, PhC(CF3)(OMe)), 136 (50, 02NC6H4CH2), 
91(48, PhCH2), 77 (65, Ph). 
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Ester 138 prepared following esterification method C from alcohol 133 and camphanic 
acid chloride (76 %). Found C, 60.0; H, 6.2; N, 3.2. C12H25N08 requires C, 60.1; H, 6.0; 
N, 3.3; 8H (360 MHz) 0.99 (3H, s, Me), 1.08 (3H, s, Me), 1.15 (3H, s, Me), 1.72 (1H, 
m), 1.95 (1H, m), 2.06 (1H, m), 2.32 - 2.51 (3H, m)(C(3)H2, 2 x camphane CH2), 3.98 
(1H, d, C(5)HA, J 10.8), 4.14 (1H, dd, C(5)HB, J4.5 & 10.8), 4.64 (1H, d, C(7)HA, J 
13.2), 4.85 (1H, d, C(7)HB, .1 13.2), 5.44 (1H, dd, C(2)H, J 2.3 & 5.5), 5.53 (1H, m, 
C(4)H), 7.51 (2H, m, aromatic), 8.25 (2H, m, aromatic); m/z (El) required 419.15802, 









Ester 139 was prepared following the DCC coupling method D from alcohol 121 and 
a-trifluoromethyl-a-methoxyphenylacetic acid. [CCD]  +8° (c 0.65) 6H (250 MHz) 1.93 
(4H, m, C(3)H2 & C(4)H2), 3.54 (3H, ddd, OMe, JHF  1.2), 3.77 (2H, m, C(6)H2), 4.58 (d, 
C(8)HA', J 13.5), 4.60 (d, C(8)HA, J 13.5), 4.75 (1H, m, C(2)H or C(5)H), 4.85 (1H, m, 
C(8)HB), 5.07 (1H, m, C(2)H or C(5)H), 7.46 (7H, m, aromatic), 8.19 (2H, d, aromatic, J 
8.8); oc (63 MHz) 24.3 (t, C3 or C4), 27.7 (t, C3 or C4), 27.9 (t, C3' or C4'), 55.3 (q, 
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OMe), 61.5 (t, C6' or C8'), 62.3 (t, C6 or C8), 67.6 (t, C6' or C8'), 67.7 (t, C6 or C8), 
69.6 (d, C2 or CS), 96.3 (s), 96.9 (d, C2 or C5), 120.8 (s), 123.5 (d, aromatic), 125.6 (s), 
127.1 (d, aromatic), 127.6 (d, aromatic), 128.4 (d, aromatic), 129.6 (d, aromatic), 131.9 
(s), 145.2 (s), 147.2 (s), 165.7 (s); 8F (235 MHz) —72.1; m/z (El) requires 470.14266, 
found 470.14267; 470 (0.6 %, M), 217 (56, PhC(OMe)(CF3)C(0)), 189 (26, 
PhC(OMe)(CF3)), 91(86, PhCH2). 






Ester 140 was prepared following the acid chloride method C from alcohol 121 and 
camphanic acid chloride.(61 %) oH (360 MHz) 0.95 (3H, s, CH3), 1.04 (3H, s, CH3), 
1.11 (3H, s, CH3), 1.68 (2H, m), 1.79 —2.06 (5H, m) & 2.41 (1H, m) (C(3)H2, C(4)H2 & 
2 x camphane CH2), 3.74 (2H, m, C(6)H2), 4.60 (IH, d, C(8)HA, J 13.4), 4.76 (1H, m, 
C(2)H or C(5)H), 4.85 (1H, d, C(8)HB, J 13.4), 4.97 (1H, m, C(2)H or C(5)H), 7.51 (2H, 
d, aromatic, J 8.8), 8.21 (2H, d, aromatic, J 8.8); Oc (90 MHz) 10.1 (q, CH3), 17.2 (q, 
CH3), 17.3 (q, CH3), 25.0 (t), 28.5 (t), 29.3 (t), 31.0 (t), 54.6 (s), 55.2 (s), 62.7 (t, C6 or 
C8), 68.3 (t, C6 or C8), 69.2 (d, C2 or CS), 91.4 (s), 97.2 (d, C2 or CS), 124.1 (d, 








Ester 141 was prepared following the DCC coupling method D from alcohol 120 and 
a-trifluoromethyl-ct-methoxyphenylacetic acid. [cD] +38°(c 1.55) oH (250 MHz) 1.58 - 
2.06 (3H, m) & 2.12 - 2.36 (1H, m) (C(3)H2 & C(4)H2), 3.53 (ddd, OMe, JHF  1), 3.59 
(ddd, OMe', JHF  1), 3.70 (ddd, C(6)Heq, J2.0, 2.0 & 13), 3.78 (ddd, C(6)Heq', J2.0, 2.0 
& 13), 3.95 (1H, dd, C(6)H, J2 & 13), 3.97 (1H, dd, C(6)H', J2 & 13), 4.60 (1H, d, 
C(8)HA, J 13.5), 4.61 (1H, d, C(8)HA', J 13.5), 4.83 (2H, m, C(8)HB & C(2)H or C(5)H), 
5.28 (1H, br. m, C(2)H or C(5)H), 7.37 - 7.88 (7H, m, aromatic); Oc  (63 MHz) 21.9 (t, 
C3 or C4), 22.2 (t, C3' or C4'), 24.6 (t, C3 or C4), 24.8 (t, C3' or C4'), 55.1 (q, OMe'), 
55.3 (q, OMe), 61.0 (t, C6 or C8), 61.2 (t, C6' or C8'), 67.6 (t, C6 or C8), 69.9 (d, C2 or 
CS), 96.2 (d, C2 or CS), 96.3 (d, C2' or CS'), 121.0 (s), 123.6 (d), 125.6 (s), 127.1 (d), 
127.4 (d), 127.7 (d), 128.3 (d), 129.5 (d), 131.8(s), 132.2 (s'), 145.3 (s), 147.3 (s), 
165.9(s); 166.0 (s'); 8F  (235 MHz) —72.1 & -72.3; m/z (El) requires 470.14266, found 




trans-2-(4-nitrobenzyloxy)-tetrahydropyr-5-y1 camphanate 142 
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Ester 142 was prepared following the acid chloride method C from alcohol 120 and 
camphanic acid chloride (58 %). oH (360 MHz) 0.97 (3H, s, CH3 ), 0.99 (3H, s, CH3), 
1.06 (3H, s, CH3'), 1.09 (3H, s, CH3), 1.11 (3H, s, CH3), 1.62 —2.25 (7H, m) & 2.44 
(1H, m) (C(3)H2, C(4)H2 & 2 x camphane CH2), 3.68 (1H, ddd, C(6)HA, J 2.2, 2.2 & 
12.8), 3.94 (1H, ddd, C(6)HB, J 1. 8, 1.8 & 12.8), 4.61 (1H, d, C(8)HA, J 13.4), 4.82 (1H, 
d, C(8)HB, J 13.4), 4.83 (1H, d, C(8)HB', J 13.4), 4.88 (1H, m, C(2)H or C(5)H), 4.98 
(1H, br. m, C(2)H or C(5)H), 7.50 (2H, d, aromatic, J 8.6), 8.20 (2H, d, aromatic, J 8.6); 
0c (90 MHz) 10.14 (q, CH3), 10.18 (q, CH31), 17.1 (q, CH3), 17.2 (q, CH3), 22.7 (t), 25.5 
(t), 29.3 (t), 29.4 (t'), 30.9 (t), 31.1 (t'), 54.6 (s'), 54.7 (s), 55.2 (s'), 55.3 (s), 62.0 (t, C6 or 
C8), 68.2 (t, C6 or C8), 69.3 (d, C2' or CS'), 69.4 (d, C2 or CS), 91.5 (s'), 91.6 (s), 96.9 
(d, C2 or CS), 124.1 (d, aromatic), 128.2 (d, aromatic), 145.9 (s), 147.8 (s), 167.4 (s'), 
167.5 (s), 178.5 (s'), 178.7 (s). 
Biohydroxylation of4-benzyloxycyclohex-1,2-ene  144 
oC 
trans-4-benzyloxy-1,2-epoxycyclohexane 145121  was isolated as a colourless oil (40 %, 
43 mg). [aD] 3 (c 1.5); OH  (250 MHz) 1.49 - 1.68 (2H, m) & 1.88 - 2.25 (4H, m) 
(C(2)H2, C(5)H2 & C(6)H2 protons), 3.17 (2H, m, C(l)H & C(2)H), 3.53 (1H, m, 
C(4)H), 4.43 (1H, d, C(8)HA, J 12), 4.52 (1H, d, C(8)HB, J 12), 7.30 (5H, m, aromatic); 
Oc (63 MHz) 20.5 (t, CS or C6), 23.4 (t, CS or C6), 30.4 (t, 0), 51.5 (d, Cl or C2), 52.0 
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(d, Cl or C2), 69.9 (t, C8), 70.5 (d, C4), 127.3 (d, aromatic), 128.3 (d, aromatic), 138.6 
(s); m/z (El) 204 (M). 
Biohydroxylation of 4-benzy1oxycyc1ohex-1,2-ene 146 
oOm 
3-(benzyloxy)-cyclohexanone 147123  was isolated as a colourless oil (36 mg, 33 %). [cLD] 
0 (c 1); oH (250 MHz) 1.89 - 2.01 (2H, m, C(5)H2), 2.09 - 2.31 (4H, m, C(4)H2 & 
C(6)H2), 2.62 (2H, m, C(2)H2), 3.82 (1H, dddd, C(3)H, J 3, 3, 5.5 & 5.5), 4.60 (2H, s, 
C(8)H2), 7.31 (5H, m, aromatic); 0c  (63 MHz) 30.4 (t, CS & C6), 37.1 (t, C2 & C4), 
70.1 (t, C8), 72.1 (d, 0), 127.3 (d, aromatic), 127.5 (d, aromatic), 128.3 (d, aromatic), 
138.3 (s), 211.1 (s); m/z (El) required 204.11503, found 204.11532; 204 (9%, M), 91 
(100, PhCH2). 
HO ,aO,-,,C 
4-(benzyloxy)-cyclohexan-1-ol 148123  was isolated as a colourless oil (7 mg, 6 %). [aD] 
0 (c 0.5); 6H  (600 MHz) 1.57 (3H, m, C(1)OH & CH2), 1.65 (2H, m, CH2), 1.72 (2H, m, 
CH2), 1.89 (2H, m, CH2), 3.48 (1H, dddd, C(1)H or C(4)H, J 3.1, 3.1, 6.2 & 6.2), 3.73 
(1H, dddd, C(1)H or C(4)H, J4.0, 4.0, 8.0, 8.0), 4.52 (2H, s, C(8)H2), 7.25 & 7.23 (5H, 
m, aromatic); oc  (63 MHz) 27.4 (t, C2 & C6), 30.4 (t, C3 & C5), 68.4 (d, Cl or C4), 
69.5 (t, C8), 73.3 (d, Cl or C4), 127.2 (d, aromatic), 127.3 (d, aromatic), 128.2 (d, 
aromatic), 139.0 (s); m/z (El) required 206.13068, found 206.13070; 206 (Mt, 5 %), 205 




(Benzyloxy)-cyclohexan-1-ol 149 was isolated as a colourless oil (15 mg, 13 %). [(XD] 0 
(c 0.5); 8H (600 MHz) 1.23 - 1.61 (5H, m, C(1)OH, 2 x CH2), 1.97 (2H, m, CH2), 2.05 
(2H, m, CH2), 3.38 (1H, dddd, C(1)H or CHOCH2), J4.0,4.0, 9.7 & 9.7), 3.68 (1H, m, 
C(1)H or CHOCH2), 4.53 (2H, s, C(8)H2), 7.26 & 7.33 (5H, m, aromatic); öc (63 MHz) 
29.2 (t, C2 & C6), 32.6 (t, C3 & C5), 69.5 (d, C4), 70.0 (t, C8), 76.0 (d, Cl), 127.3 (d, 
aromatic), 127.4 (d, aromatic), 128.2 (d, aromatic), 138.8 (s); m/z (El) required 
206.13068, found 206.13072; 206 (1 %, Mt), 205 (4, M-H), 91(100, PhCH2). 
Biohydroxylation of3-benzyloxymethyl-cyclopent-1,2-ene 152 
5 	6 	8 
-!~~O--- 01 --,  
1-hydroxy-4-benzyloxymethyl-cyclopent-2,3-ene 153 was isolated as a colourless oil (19 
%, 21 mg). [aD] -25° (c 1.0); oH (360 MHz) 1.91 (1H, ddd, C(5)HA, J3.2, 7.8 & 14.2), 
2.00 (1H, ddd, C(5)HB, J 5, 7.2 & 14.2), 3.23 (1H, m, C(4)H), 3.39 (2H, m, C(6)H2), 
4.55 (2H, s, C(8)H2), 4.92 (1H, m, C(1)H), 5.93 (1H, m, C(2)H or C(3)H), 6.04 (1H, 
ddd, C(2)H or C(3)H, J 0.8, 2 & 5.6), 7.39 (5H, m, aromatic); Oc (90 MHz) 37.9 (t, CS), 
45.3 (d, C4), 73.5 (t, C6 or C8), 74.4 (t, C6 or C8), 77.5 (d, Cl), 128.0 (2 x d), 128.8 (d), 
134.8 (d), 137.4 (d), 138.8 (s); m/z (El) 204 (M), 113 (M—PhCH2), 107 (PhCH20), 91 
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A. CRYSTAL DATA 
Empirical formula C20 H26 N 08 
Formula weight 408.42 
Wavelength 0.71073 A 
Temperature 150(2) K 
Crystal system Monoclinic 
Space group P21 
Unit cell dimensions a= 11.423(5) A 
= 6.727(3) A 
c= 13.889(6)A 
Volume 1027.3(8) A3 
Number of reflections for cell 515 (2.5 <0< 19.50) 
Z 	 2 
Density (calculated) 	 1.320 Mg/M3 
Absorption coefficient 	 0.102 mm- 
F(O00) 	 434 
= 105.732(8) 
= 90° 
B. DATA COLLECTION 
Crystal description 
Crystal size 






0.26 x 0.02 x 0.02 mm 
1.52 to 25.01° 
-13<=h<=13, -7<=k<=8, -13<=l<=16 
5229 




Absorption correction 	 Sadabs 
(Tmin 0.588, Tmax 1.000) 
C. SOLUTION AND REFINEMENT 
Solution 	 direct (SHELXS-97 (Sheidrick, 1990)) 
Refinement type 	 Full-matrix least-squares on F2 
Program used for refinement 	SHELXL-97 
Hydrogen atom placement 	geometric 
Hydrogen atom treatment 	riding 
Data / restraints / parameters 	3161/1/272 
Goodness-of-fit on F2 	 0.871 
Conventional R [F>4c(F)] 	RI = 0.0571 [2003 data] 
Weighted R (F2 and all data) 	wR2 = 0.1340 
Absolute structure parameter 	-0.1(18) 
Extinction coefficient 	 0.014(3) 
Final maximum delta/sigma 	0.001 
Weighting scheme 	 calc w=1/[\s2"(Fo2)+(0.0737P)2+0.0000P] where 
P=(Fo2+2Fc2)/3 
Largest diff. peak and hole 	0.272 and -0.247 e. A 
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Table 1. Atomic coordinates ( x 10) and equivalent isotropic displacement parameters 
(A2 x 10). U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
Atom x y z U(eq) 
0(1) 1643(2) 6139(4) 3 136(2) 39(1) 
 2700(3) 4890(7) 3658(3) 31(1) 
 3783(4) 6341(7) 3902(3) 38(1) 
 3486(4) 7650(7) 4710(3) 38(1) 
 2289(3) 6804(7) 4842(3) 31(1) 
0(6) 572(3) 8516(6) 3651(2) 50(1) 
 1375(4) 7309(7) 3847(3) 35(1) 
 2416(3) 4569(7) 4676(3) 31(1) 
0(8) 3543(3) 1828(5) 3395(2) 48(1) 
 2848(4) 3167(8) 3056(3) 38(1) 
0(9) 2204(2) 3259(5) 2091(2) 42(1) 
 2487(4) 1727(7) 1435(3) 42(1) 
 2094(4) 2573(7) 367(3) 45(1) 
 1314(4) 935(8) -212(3) 45(1) 
0(13) 776(3) -11(5) 465(2) 50(1) 
C(14) 1733(4) -120(8) 1402(3) 50(1) 
0(15) 2067(3) -343(5) -573(2) 46(1) 
 1405(4) -1928(7) -1182(3) 51(1) 
 2238(4) -3472(7) -1367(3) 39(1) 
 1738(4) -5111(8) -1937(3) 42(1) 
 2444(4) -6642(9) -2113(3) 49(1) 
 3705(4) -6553(9) -1701(3) 45(1) 
 4226(4) -4918(8) -1144(3) 49(1) 
 3499(4) -3399(8) -968(3) 46(1) 
N(23) 4464(5) -8150(8) -1885(3) 59(1) 
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0(24) 5570(4) -8024(7) -1510(3) 86(1) 
0(25) 3987(4) -9563(6) -2413(3) 70(1) 
C(51) 1931(4) 7508(7) 5760(3) 44(1) 
 1258(3) 3381(8) 4581(3) 42(1) 
 3454(4) 3589(8) 5483(3) 40(1) 
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0(9)-C(10)-C(1 1) 106.5(4) 
C(14)-C(10)-C(11) 105.1(4) 
C(12)-C(1 1)-C(1O) 102.8(4) 
O(15)-C(12)-O(13) 112.6(4) 












C(2 I)-C(20)-N(23) 120.1(4) 
C(19)-C(20)-N(23) 119.7(5) 
C(22)-C(2 l)-C(20) 120.0(4) 




Symmetry transformations used to generate equivalent atoms 
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Table 3. 	Anisotropic displacement parameters (A2 x 10). 	The anisotropic 
displacement factor exponent takes the form: -2 it2 [ h 
2 a*2  Ui 1 +... + 2 h k a* b* U12] 
Ull U22 U33 U23 U13 U12 
0(1) 33(2) 50(2) 27(2) 7(2) -4(1) 11(2) 
 23(2) 38(3) 28(2) 11(2) 1(2) 7(2) 
 30(2) 46(3) 36(2) 3(2) 6(2) -6(2) 
 30(2) 43(3) 33(2) 2(2) -2(2) 5(2) 
 28(2) 40(3) 20(2) 10(2) -3(2) 9(2) 
0(6) 40(2) 62(2) 39(2) 5(2) -5(2) 19(2) 
 30(3) 38(3) 3 1(2) 4(2) -1(2) 5(2) 
 21(2) 42(3) 27(2) 6(2) 0(2) 0(2) 
0(8) 55(2) 48(2) 32(2) -1(2) -1(2) 15(2) 
 39(3) 43(3) 29(2) 1(2) 7(2) -5(3) 
0(9) 40(2) 57(2) 23(2) -3(2) -3(1) 6(2) 
 41(3) 54(3) 28(2) 0(3) 4(2) 11(3) 
 54(3) 48(3) 30(2) 5(2) 7(2) 1(3) 
 50(3) 57(3) 23(2) -2(2) 5(2) -4(3) 
0(13) 45(2) 67(2) 31(2) -3(2) 1(2) -8(2) 
C(14) 65(3) 56(3) 27(2) 2(2) 9(2) 4(3) 
0(15) 46(2) 58(2) 29(2) -7(2) 3(1) -5(2) 
 56(3) 52(4) 33(3) -8(3) -7(2) -13(3) 
 44(3) 43(3) 24(2) -3(2) 1(2) -8(3) 
 42(3) 53(3) 26(2) -3(2) 1(2) -5(3) 
 57(3) 64(4) 18(2) -6(2) -1(2) -17(3) 
 52(3) 60(4) 22(2) 2(3) 6(2) -4(3) 
 41(3) 70(4) 30(2) 1(3) 3(2) -6(3) 
 48(3) 57(4) 28(2) -6(2) 5(2) -10(3) 
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N(23) 76(3) 69(4) 30(2) 4(2) 13(2) 12(3) 
0(24) 63(2) 132(4) 54(2) -11(2) 4(2) 26(3) 
0(25) 90(3) 59(3) 60(3) -9(2) 17(2) 3(2) 
C(51) 39(3) 55(3) 33(2) 5(2) 0(2) 13(2) 
 35(2) 48(3) 40(3) 7(2) 8(2) -2(2) 
 40(2) 49(3) 27(2) 8(2) 1(2) 7(2) 
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Table 4. Hydrogen coordinates ( x 10) and isotropic displacement parameters (A2 x 
1O). 
X y z U(eq) 
H(3A) 4564 5631 4162 46 
H(313) 3814 7132 3308 46 
H(4A) 3384 9055 4492 45 
H(4B) 4141 7568 5344 45 
H(10) 3375 1404 1635 51 
H(11A) 1623 3816 340 54 
H(11B) 2806 2834 108 54 
H(12) 671 1508 -783 53 
H(14A) 2236 -1325 1418 60 
H(14B) 1380 -159 1979 60 
H(1 6A) 920 -1380 -1829 61 
H(1 6B) 835 -2533 -841 61 
 881 -5174 -2213 50 
 2083 -7748 -2509 58 
 5084 -4842 -882 58 
 3859 -2293 -572 55 
H(51A) 2560 7120 6364 66 
H(51B) 1154 6901 5771 66 
H(51C) 1847 8959 5740 66 
H(71A) 1415 1973 4485 62 
H(71B) 621 3866 4005 62 
H(71C) 992 3540 5190 62 
H(72A) 3491 2170 5335 60 
H(7213) 3303 3753 6140 60 
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N-Benzyloxycarbonyl (Cbz) protected piperidines are hydroxylated with greater regioselectivity than the 
corresponding N-benzoyl analogues when incubated with the fungus Beauveria bassiana ATCC 7159. Cbz-protected 
piperidines 1-3, 5-7, have been biotransformed by growing cell suspensions of this fungus to yield predominantly 
4-hydroxylated products in up to 48% yield. The regiospecificity of hydroxylation was only compromised significantly 
with N-Cbz-3-methylpiperidine 3 and N-Cbz-2-methylpiperidine 4 where hydroxylation occurred in both the 
3 and 4 positions. 
Introduction 
The hydroxylation of non-activated carbon centres remains a 
challenge in organic synthesis. In most cases, a biocatalytic 
route is favoured, most notably in the industrial conversion of 
steroids by fungi.' Such biocatalytic methods are preferred for 
reasons of both regio- and stereoselectivity and the technique 
of fungal biohydroxylation has now been applied to the produc-
tion of a wide range of hydroxylated derivatives of xenobiotic 
compounds. Most notable of these is the use of the entomo-
pathogen Beauveria bassiana to selectively hydroxylate a wide 
range of organic compounds including N-containing hetero-
cycles.' Pioneering work by the group of Fonken and Johnson 
at the Upjohn company established that the biohydroxylation 
of N-heterocycles was much improved by their conjugation to 
an aromatic moiety linked to the heterocycle via a bridge with 
an electron rich centre.' Detailed studies revealed that Sporo-
trichum suiflirescens ATCC 7159, now redesignated Beauveria 
bassiana, would selectively hydroxylate N-benzoylalkylpiper-
idines to give optically active hydroxypiperidines.4 Hydroxy-
piperidines are constituents of many pharmacologically and 
biochemically important natural products including pseudo-
conhydrine 5 and esters of 1-methylpiperidin-3-o16 which have 
cholinergic or anticholinergic properties. 
A particular feature of biohydroxylations reactions is the 
possible formation of a large number of reaction products 
given that the reaction is not generally directed by a particular 
functional group. For example, N-benzoylpiperidine studied by 
Johnson can potentially lead to six different hydroxylation 
products, and the number increases dramatically with substitu-
tion within the piperidine ring. It is therefore of great interest to 
understand how to direct regio- and stereoselectivity of 
hydroxylation to give the desired alcohol. Changes in selectivity 
can either be achieved by using a different biocatalyst or by 
temporarily changing the structural characteristics of the sub-
strate using protecting groups.' Here we show that the selectiv-
ity of biohydroxylation by Beauveria bassiana can be modified 
by using benzyloxycarbonyl (Cbz) instead of benzoyl protected 
piperidines. The Cbz-group has the additional advantage that it 
is more amenable to facile removal than a benzoyl group.' A 
number of Cbz-protected alkylpiperidines 1-8 were therefore 
synthesised and incubated with Beauveria bassiana ATCC 7159 
and the results of biotransformation compared with those 
obtained with the corresponding N-benzoyl analogues. 
R,h W 
ooC ooc 
I R =H 
2 R'H,R4 =Me 
3 RH,R3 =Me 
4 R0 =H,R2=Me 
5 R"H,R2,R6 Me 
6 R0 =H,R2 =Et 
7 RH,R3,R3 =Me 
Results and discussion 
Cbz-protected alkylpiperidines 1-8 were synthesised from the 
unprotected piperidines by treatment with benzyl chloroform-
ate in the presence of potassium carbonate. The results of the 
biohydroxylations are summarised in Table 1, including a com-
parison with those obtained using the N-benzoyl analogues, as 
reported previously' The unsubstituted Cbz-protected piperi-
dine 1 is hydroxylated almost exclusively at the 4-position to 
give 9 (33% yield), in common with results obtained with N-
benzoyl 4 and N-phenyl 9 derivatives. The structure was easily 
assigned from inspection of the '3C NMR spectrum which 
clearly showed no loss of symmetry in the hydroxylated 
product. This selectivity was completely conserved when the 
4-methylpiperidine derivative 2 was the substrate, with hydroxy-
lation occurring at the tertiary carbon to give 10 (45% yield). 
This is not surprising as the radical mechanism by which 
hydroxylation by Beauveria bassiana is proposed to occur" 
would favour this product due to the stability of the tertiary 
radical intermediate. It is interesting to note that biohydroxyl-
ation of the N-benzoyl derivative' resulted in a 1:2 mixture of 
the 4-hydroxy compound and the 4-hydroxymethyl compound 
as a result of competing hydroxylation of the C-4 methyl group. 
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Table I Comparison of biohydroxylation of N-benzoyl and N-Cbz 
protected alkylpiperidines by Beauveria bassiana ATCC 7159 
Major 
Combined yield products 
Hydroxylated R = PhCO 
products (%) Major products 	(data taken 
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Combined yields calculated prior to separation. Preparation of 
substrates 4 and 8 where R = Cbz have been reported previously. 21'22 
The insertion of an O—CH, into the protecting group appears 
to have improved the regioselectivity of hydroxylation. 
Three products (ha—c) were isolated from the transformation 
of N-benzyloxycarbonyl-3-methylpiperidine 3, of which ha 
and He were very difficult to separate by either chromato-
graphy on silica or preparative HPLC. The mixture of ha 
and lie was therefore subjected to acetylation conditions in an 
attempt to ease separation. Only one of the two products was 
acetylated (as shown by NMR and mass spectrometry) result-
ing in a mixture of ha and O-acetylated lie, which were then 
easily separated by preparative HPLC. 
Product ha was found to be unaltered by the acetylation 
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Fig. I NOE enhancements and coupling constants used in assigning 
hydroxylated products 12a and 12b. 
conditions. Mass spectrometry (atmospheric pressure chemical 
ionisation) showed an (M + 1) peak at 250. 1, confirming that 
ha is a monohydroxylated product. Since the characteristic 
CHOH signal was missing in the NMR spectrum, ha was 
assigned as the 3-methyl-3-hydroxy derivative, 
The structure of He was confirmed by NMR spectroscopy 
of the O-acetylated derivative. From the coupling pattern, it 
was possible to deduce that the hydroxy moiety was introduced 
in the axial position since the adjacent proton signal showed 
only three small couplings (J 3, 5 and 5 Hz). It was however not 
possible to establish the relative position of the methyl group 
from simple decoupling experiments since the C3-H signal is 
not easily identifiable. It is thought however that the methyl is 
most likely to lie in the equatorial position since a 3,4-diaxial 
conformation would be disfavoured and thus prone to ring-flip 
to give the 3,4-diequatorial conformation. 
Product lib was identified by NMR spectroscopy as the iso-
mer of lie, the 4-hydroxy-3-methyl derivative with the hydroxy 
group located equatorially. The signal due to the C-4 proton 
showed two large and one small couplings (J 3, 12, and 14 Hz) 
implying that the methyl group also adopts an equatorial 
position. The regioselectivity obtained in the biohydroxylation 
of 3 is the same as that observed for the N-benzoylpiperidine.4 
Evidently in this case, alignment of the piperidine ring in the 
enzyme active site is a more significant factor for hydroxylation 
regioselectivity than ease of radical formation which would 
favour formation of 11 a. When the fungus was challenged with 
the 2-methylpiperidine derivative 4 as substrate, equal amounts 
of products hydroxylated in the 3 (12b) and 4 (12a) positions 
but no 2-hydroxylated products were obtained. The structures 
of 12a and 12b were confirmed by NOE experiments, as shown 
in Fig. 1. The preference of 2-alkyl substituents for axial rather 
than equatorial positions is well documented in alkylpiperidine 
amides ."2 These conformational effects favour the 2,4-diaxial 
chair over the diequatorial conformation of 12a. 
One major concern about employing this series of substrates 
with a whole cell biotransformation system was the potential 
lability of the Cbz-protecting group to other enzymes in the 
fungus. Microbial carbamate hydrolases have been reported '3 
and degradation of alkyl substituted aromatics by benzylic 
hydroxylation has been well studied.'4 It had also been reported 
that the inclusion of inverted urethane-type linkers in hydroxy-
lation substrates for this fungus led to no biotransformation 
whatsoever.'5 In only one case were these possibilities impli-
cated by results. When N-benzyloxycarbonyl-cis-2,6-dimethyl-
piperidine 5 (270 mg) was incubated with Beauveria bassiana 
only 10 mg of hydroxylated product was recovered. 'H and '3C 
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Fig. 2 NOE enhancements and coupling constants used in assigning 
4-hydroxylated product 14 of biotransformation of 6. 
derivative 13. However, a large amount of benzoic acid (92 mg) 
was also recovered from the reaction mixture suggesting a 
degradative mechanism involving a benzylic hydroxylase as has 
been previously described. 14  This degradation pathway is not 
relevant in the N-benzoyl analogues which is reflected in the 
better yield reported. 
Although no active cell-free extract, nor pure enzyme 
work has been successfully conducted using preparations from 
Beau veria bassiana ATCC 7159, the results of the numerous 
whole-cell studies have been used to construct a crude model for 
the active site of what is assumed to be the sole hydroxylating 
species in this fungus.t5t6 This model suggests an optimum 
distance from the electron-rich site of attachment to the site 
of hydroxylation of between 3.3 and 6.2 A.t6  The results with 
N-benzyloxycarbonylalkylpiperidines suggest that the active 
site of the Beau veria hydroxylating system is very sensitive to 
relatively small changes in the nature of the protecting group. 
The hydroxylase is clearly now disposed to hydroxylation in the 
4-position, except where there is a 2- or 3-methyl substituent, 
when the selectivity is compromised. The distance from the 
carbonyl group to the putative site of hydroxylation is, of 
course, unchanged from N-benzoyl to N-benzyloxycarbonyl 
substrate. The results presented herein would suggest that the 
more critical characteristic for selective hydroxylation is the 
distance from carbonyl to an aromatic binding pocket. In 
addition, greater flexibility of the N-benzyloxycarbonyl mole-
cule is afforded by rotation around the benzylic centre. This 
would appear to allow improved accommodation by the 
active site and therefore greater regioselectivity for some 
substrates. 
The change in regioselectivity of hydroxylation around the 
piperidine ring from the 4- to the 3-position with regioisomeric 
alkyl substitution is difficult to rationalise in terms of steric 
restrictions in the active site of the hydroxylase. For piperidines 
1 and -2 access to the favoured 4-position by the hydroxylating 
species is unrestricted, but methyl substitution at the 2- and 
3-position must move the 4-position sufficiently far from this 
species that hydroxylation also occurs at the 3-position. One 
would expect that an extension to the 2-alkyl chain would 
therefore result in even more pronounced selectivity for the 
3-position. However, when N-benzyloxycarbonyl-2-ethylpiper-
idine 6 is the substrate, hydroxylation occurs almost exclusively 
at the 4-position to give the 4-hydroxypiperidine derivative 14 
(Fig. 2) in good yield. 
In Johnson's work,' the relative position of the hydroxy 
group in the hydroxylated products from the 2-alkylpiperidines 
was assigned by analogy to the products of the 2-ethyl trans-
formation and it has been well reported that, in rigid systems, 
the hydroxy group is introduced in a trans orientation with 
respect to the amide functional group.' By the use of NMR 
analysis we have established that the hydroxy group is also 
introduced into the equatorial position in most cases, with the 
exceptions of the 2-methyl-4-hydroxy product 12a where the 
OH was in an axial position (this was shown by the lack of an 
NOE enhancement between the axial C2-H and the C4-H and 
also from the coupling constants of the CHOH signal, showing 
no axial—axial coupling) and the 3-methyl-4-hydroxy product  
(the acetylated derivative of which was isolated) 11  where the 
CHOAc signal showed no diaxial couplings. 
It is interesting to note that Johnson and co-workers 
observed some enantiodifferentiation by the Beau veria hydroxy-
lating system when operating on N-benzoalkylpiperidines.4 The 
optical purity of our products has not been determined but it 
was seen that in all cases, a 72 hour incubation of the substrate 
with the fungus resulted in complete substrate disappearance 
implying that no substrate enantiomer (where relevant) is pre-
ferred to any great extent. It is likely, on the basis of previous 
work,' that the enantioselectivity and resulting enantiomeric 
excess (if relevant) will depend on many factors, including the 
time course of the reaction. There could be preferential 
hydroxylation of one enantiomer of the substrate at a single 
position as well as preferential metabolism of one of the 
product molecules, both of these examples would effect the 
enantiomeric excess of the identified product. An investigation 
into these factors is currently underway in our laboratories and 
will be published at a later date. Since the yield of hydroxylated 
products was approximately 50% it is unlikely that .a resolution 
process is operating. 
Two further substrates have been tested with the fungus 
which do not correlate with the substrate used by Fonken but 
add to the overall series and the investigation of the tolerance 
of the active site to changes in the substrate. It was found on 
incubation of the 3,3-dimethylpiperidine derivative 7 with the 
fungus that the 4-hydroxylated product 15 was produced. It was 
also noted that the rate of this hydroxylation was enhanced and 
that no substrate remained after two days, whereas other reac-
tions required three days for complete substrate disappearance. 
This is likely to be a consequence of the reaction being directed 
by the two methyl groups. 
Somewhat unexpectedly, when the fungus was challenged 
with the unsaturated piperidine derivative, N-benzyloxy-
carbonyl- 1 ,2,3,6-tetrahydropyridine 8, no biohydroxylation was 
noted but unreacted starting material was recovered. This result 
was surprising since both allylic hydroxylation and epoxid-
ations'7 are known to be catalysed by P-450 monoxygenases. 
Conclusion 
This study has established that the regioselectivity of hydroxyl-
ation by Beauveria bassiana ATCC 7159, an organism much 
used for biotransformations of this type, may be significantly 
altered by changes to the linker attaching the putative hydroxy-
lation site to the aromatic recognition group. It appears that 
regioselectivity is not only determined by distance of hydroxy-
lation site to the carbonyl group, which is the same for both 
N-benzoyl and N-Cbz protected piperidines. The distance to the 
aromatic sidechain is also important, suggesting that the active 
site of the enzyme contains a defined aromatic binding pocket. 
Experimental 
Apparatus and chemicals 
All chemicals were purchased from Aldrich Chemical Com-
pany, Poole, Dorset UK unless specified otherwise. tH  and  tsC 
NMR analysis was performed on a Bruker AC250 spectrometer 
(at 250 MHz and 63 MHz respectively) and on a WH-360 spec-
trometer (at 360 MHz and 90 MHz). Spectra were recorded in 
deuterochloroform. Chemical shifts are quoted in parts per mil-
lion (ppm) and these chemical shifts were referenced internally 
(t H, CHC13, 7.62 ppm; '3CHCI3, 77.0 ppm). Coupling constants 
(J) are quoted in Hz. Carbon multiplicity was established by 
DEPT (distortionless enhancement by polarisation transfer). 
Infra-red spectra were recorded on a Perkin-Elmer FT-IR spec-
trometer (Paragon 1000) as thin films. Mass spectra were run 
using electron impact (El) on a Finnigan 4600 instrument for 
nominal mass and a Kratos MS50TC instrument for high 
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resolution spectra. Thin layer chromatography was performed 
on glass sheets coated with silica gel Merck 60E-254 (0.24 mm, 
Art. 5715). Components were detected by UV (254 nm) and 
visualised by treating the plate with ammonium molybdate 
solution and heating. Wet flash chromatography was carried 
out on silica gel (Merck 9385, Kieselgel 60). Gas chrom-
atography was carried out using a Hewlett-Packard 6890 series 
GC system (employing a HP-5 5% phenyl methyl siloxane capil-
lary column (30.0 m x  320 I.tm x 0.25 pm)). Oven temperature 
gradient from 200'C (2 mm) ramp to 250'C (20°C min'; 
10 mm); inlet temperature 200°C and detector temperature 
300 °C. The HPLC system used was a Waters 486 controller 
using Millenium software using Phenomenex ODS-2 5 ii column 
(25 cm x  4.6 mm) using CH3CN-0.1% NH4OAc solution as 
eluent. 
General method for the preparation of Cbz-protected 
alkylpiperidines 
The substituted piperidine (0.010 mol) and benzyl chlorofor-
mate (0.012 mol) were added to a stirred solution of potassium 
carbonate (0.030 mol) in tetrahydrofuran (50 cm') under an 
atmosphere of argon. After stirring for 1 h, water (10 cm') was 
added and the solution was stirred for I h. Water (150 cm') was 
then added and the mixture extracted with ethyl acetate 
(3 x  150 cm'). The combined organic extracts were washed with 
saturated sodium carbonate solution (160 cm') and brine 
(2 x 120 cm') and dried over anhydrous MgSO4. After 
filtration, the solvent was removed in vacuo and the residue 
purified by wet flash chromatography using petroleum ether-
ethyl acetate mixture as eluent. 
N-Benzyloxycarbonylpiperidine 1.18 Carbamate (1) was iso-
lated as a colourless oil (2.04 g, 93%); Vmx 1701 cm; oH 1.46-
1.63 (6H, m, C(3)H21  C(4)H2 and C(5)H2), 3.41-3.46 (4H, m, 
C(2)H2 and C(6)H2), 5.12 (2H, s, CH2Ph), 7.25-7.38 (5H, m, 
aromatic); Oc 24.1 (t, C3 and CS), 25.4 (t, C4), 44.6 (t, C2 and 
C6), 66.6 (t, CH2Ph), 127.6 (d, aromatic), 127.6 (d, aromatic), 
128.2 (d, aromatic), 136.8 (s, aromatic), 155.1 (s, C=O); m/z 
(El) required 219.12593, found 219.12558, 219 (14%, M), 
128 (12, M - CH2Ph), 91 (100, PhCH2), 84 (10, M - 
CO2CH2Ph). 
N-Benzytoxycarbonyl4-methylpiperidine 2. Carbamate (2) 
was isolated as a colourless oil (2.08 g, 89%); Vms. 1701 cm'; 
OH (250 MHz) 0.93 (3H, d, J 6.5, CH3), 1.03-1.18 (1H'm ' m,
C(4)H), 1.46-1.61 (4H, m, C(3)H2 and C(5)H2), 2.75 (2H, ddd, 
J2.5, 13 and 13, C(2)Hax and C(6)Hax), 4.13 (2H, br d, J 13, 
C(2)Heq and C(6)Heq), 5.11 (2H, s, CH2Ph), 7.24-7.36 (5H, 
m, aromatic); Jc 63 MHz) 21.7 (q, CH3), 30.8 (d, C4), 33.8 
(t, C3 and CS), 44.1 (t, C2 and C6), 66.8 (d, CH2Ph), 127.7 
(d, aromatic), 127.8 (d, aromatic), 128.3 (d, aromatic), 136.9 (s, 
aromatic), 155.2 (s, C=O); m/z (El) required 233.14158, found 
233.14262, 233 (81%, Mt), 218 (4, M - CH,), 142 (78, M - 
CH2Ph), 126 (70, M - OCH2Ph), 98 (73, M - CO2CH2Ph), 
91(62, CH2Ph), 77(13, Ph). 
N-Benzyloxycarbonyl-3-methylpiperidine 3. Carbamate (3) 
was isolated as a colourless oil (2.14 g, 92%); Vmx 1701 cm'; 0H 
(250 MHz) 0.87 (3H, d, J6.5, CH3), 1.01-1.13 (1 H, in, C(3)H), 
1.39-1.81 (4H, m, C(4)H2 and C(5)H2), 2.42 (1H, dd, J 11 and 
13, C(2)Hax), 2.71-2.81 (1H, m, C(6)Hax), 4.00-4.08 (2H, m, 
C(2)Heq and C(6)Heq), 5.12 (2H, s, CH2Ph), 7.25-7.37 (SH, m, 
aromatic); O (63 MHz) 18.7 (q, CH,), 25.7 (d, C3), 30.8 (t, C4 
or CS), 32.7 (t, C4 or CS), 44.2 (t, C2 or C6), 51.1 (t, C2 or C6), 
66.7 (t, CH2Ph), 127.6 (d, aromatic), 127.7 (d, aromatic), 128.3 
(d, aromatic), 136.9 (s, aromatic), 155.1 (s, C=O); m/z (El) 
required 233.14158, found 233.14109, 233 (35%, Mt), 142 
(46, M - CH2Ph), 126 (26, M - OCH2Ph), 98 (27, M - 
CO2CH2Ph), 91(100, CH2Ph). 
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N-Benzyloxycarbonyl-cis-2,6-dimethylpiperidine 5•19  Carb-
amate (5) was isolated as a colourless oil (2.19 g, 89%); 
1693 CM-'; 6H (250 MHz) 1.20 (6H, d, J7, 2 X  CH3), 1.41-1.77 
(6H, m, C(3)H21  C(4)H2 and C(5)H2), 4.32-4.38 (2H, hr m, 
C(2)H and C(6)H), 5.13 (2H, s, CH2Ph), 7.25-7.36 (5H, in, 
aromatic); 6c 13.5 (t, C4), 20.7 (q, C7 and C8), 29.8 (t, C3 and 
CS), 45.9 (d, C2 and C6), 66.6 (t, CH2Ph), 127.5 (d, aromatic), 
127.6 (d, aromatic), 128.3 (d, aromatic), 137.0 (s, CH2Ph), 155.5 
(s, C=O); m/z (El) required 247.157229, found 247.15832, 247 
(4%, M), 32 (22, M - CH,), 156 (13, M - CH2Ph), 91(100, 
PhCH2). 
N-Benzyloxycarbonyl-2-ethylpiperidine 6. Carbamate (6) was 
isolated as a colourless oil (2.28 g, 92%); Vmx 1693 cm'; OH  (250 
MHz) 0.83 (3H, t, J 7.5, C(8)H3), 1.34-1.80 (8H, in, C(3)H2, 
C(4)H21  C(5)H2 and C(7)H2), 2.75-2.86 (lH, m, C(6)Hax), 
4.02-4.07 (1H, hr m, C(2)Heq or C(6)Heq), 4.16-4.23 (1H, br 
m, C(2)Heq or C(6)Heq), 5.17 (2H, s, CH2Ph), 7.25-7.37 (5H, 
m, aromatic); 6c (63 MHz) 10.6 (q, C8), 18.8 (t, C7), 22.4 (t, C3, 
C4 or CS), 25.5 (t, C3, C4 or CS), 27.9 (t, C3, C4 or CS), 38.9 (t, 
C6), 52.2 (d, C2), 66.7 (t, CH2Ph), 127.6 (d, aromatic), 127.6 (d, 
aromatic), 128.3 (d, aromatic), 137.0 (s, aromatic), 155.6 (s, 
C=O); mhz (El) required 247.15723, found 247.15706, 247 
(6%, Mt), 218(87%, M - CH2CH3), 156 (9, M - CH2Ph), 140 
(51  M - OCH2Ph), 112 (6, M - CO2CH2Ph), 91(67, CH2Ph). 
N-Benzyloxycarbonyl-3,3-dimethylpiperidine 7. Carbamate 
(7) was isolated as a colourless oil (2.20 g, 89%); Vms, 1701 cm; 
OH 0.89 (6H, s, C(7)H3 and C(8)H3), 1.32-1.37 (2H, m, C(4)H2 
or C(5)H2), 1.55-1.60 (2H, m, C(4)H2 or C(5)H2), 3.13 (2H, s, 
C(2)H2), 3.40 (2H, dd, J 5.5 and 5.5, C(6)H2), 5.12 (2H, s, 
CH2Ph), 7.25-7.36 (5H, m, aromatic); 6c 25.8 (q, C7 and C8), 
30.8 (s, C3), 37.6 (t, C4), 44.3 (t, C2 or C6), 55.3 (t, C2 or C6), 
66.7 (t, CH2Ph), 127.6 (d, aromatic), 127.7 (d, aromatic), 128.3 
(d, aromatic), 137.0 (s, aromatic), 155.5 (s, C=O); mhz (El) 
required 247.15723, found 247.15813, 247 (36%, MF),  156 (42, 
M - CH2Ph), 140 (20, M - OCH2Ph), 112 (17, M - CO2-
CH2Ph), 91(63, PhCH2). 
Maintenance and growth of microorganism 
Beauveria bassiana ATCC 7159 was obtained from the Ameri-
can Type Culture Collection, USA. The organism was main-
tained on malt extract agar plates at room temperature and 
these were subcultured at regular intervals. A loop of fungus 
was used to inoculate 60 ern' of sterile medium containing 7.5 g 
dm 3 corn steep solids and 10 g dm-' glucose in distilled water 
adjusted to pH 4.85 in a 250 cm' Erlenmeyer flask. After three 
days growth on an orbital shaker at 200 rpm at 25 °C, a culture 
was used to inoculate 600 cm' of the same medium in a 2 dm' 
Erlenmeyer flask. This culture was again grown for three days. 
General biotransformation procedure 
A solution of 66 mg substrate in 1 cm' ethanol was prepared 
and this was added to the three day old culture of Beauveria 
bassiana ATCC 7159. After a further three days incubation as 
above, the fungal cells were removed from the broth by centri-
fugation and the supernatant extracted into ethyl acetate. 
Purification of metabolites was routinely carried out using 
flash silica chromatography with petroleum ether-ethyl acetate 
gradients as eluent. 
Biohydroxylation of N-benzyloxycarbonylpiperidine 1 pro-
duced hydroxylated product (9) which was isolated as a colour-
less oil (100 mg, 33%). The product 9 was identical to previously 
reported material as judged by NMR spectroscopy.2° 
Biohydroxylation of N-benzyloxycarbonyl-4-methylpiperidine 
2. Hydroxylated product (10) was isolated as a pale yellow solid 
(130 mg, 45%); mp 76 °C; OH (250 MHz) 1.24 (3H, s, CH3), 
1.45-1.56 (SH, m, C(3)H21  C(5)H2 and C(4)OH), 3.34-3.23 
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(2H, dt, J 7 and 13, C(2)Hax and C(6)Hax), 3.80 (2H, br d, J 13, 
C(2)Heq and C(6)Heq), 5.11 (2H, s, CH2Ph), 7.25-7.36 (5H, 
m, aromatic); ôc (63 MHz) 30.0 (q, CH3), 38.2 (t, C3 and C5), 
40.2 (t, C2 and C6), 66.9 (t, CH2Ph), 67.7 (s, C4), 127.7 (d, 
aromatic), 127.8 (d, aromatic), 128.3 (d, aromatic), 136.7 (s, 
aromatic), 155.1 (s, C=O); m/z (El) required 249.13649, found 
249.13637, 249 (44%, Mt), 158 (14, M - PhCH2), 142 (16, 
M - PhCH2)1  91(100, PhCH2). 
Biohydroxylation of N-benzyloxycarbonyl-3-methylpiperidine 
Three products ha-c were isolated from this biohydroxyl-
ation, two of which (ha and lic) were found to be very 
closely related and thus difficult to separate. These two products 
were separated by subjecting the mixture to acetylation condi-
tions (10 mol equiv. acetic anhydride, 5 mol equiv. pyridine and 
catalytic dimethylaminopyridine) under which conditions one 
of the products was acetylated 1 ic and one was left untouched 
ha. The products were then separated by preparative HPLC. 
Product ha was isolated as a colourless oil (10 mg, 3%); oH 
(360 MHz) 1.21 (3H, s, CH01  1.49-1.79 (SH, m, C(3)OH, 
C(4)H2 and C(5)H2), 2.96-3.03 (2H, br m, C(2)Hax and 
C(6)Hax), 3.68 (1H, br s, C(2)Heq), 3.84 (1H, ddd, J 4.51  4.5 
and 13, C(6)Heq), 5.13 (2H, s, CH2Ph), 7.28-7.35 (5H, m, 
aromatic); m/z (El) required 249.13649, found 249.13725, 249 
(5%, M), 114(26, M - PhCHOCO), 91(100, PhCH2). 
Hydroxylated product lib was isolated as a colourless oil (10 
mg, 3%); 0H  (360 MHz) 0.99 (3H, d, J6.5, CH3), 1.43-1.59 (3M, 
br m, three of C(3)H, C(4)OH and C(5)H2), 1.91 (lH, br dd, 
J 3.5 and 13, C(3)H, C(4)OH or C(5)H), 2.53(1 H, br s, C(2)Hax 
or C(6)Hax), 2.90 (1H, ddd, J 3,12 and 14, C(4)H), 3.30 (1H, br 
m, C(2)Hax or C(6)Hax), 4.05-4.13 (2H, br m, C(2)Heq and 
C(6)Heq), 5.11-5.12 (2H, d, J 2, CH2Ph), 7.28-7.36 (5H, m, 
aromatic); m/z (El) required 249.13649, found 249.13616, 249 
(8%, Mt), 158 (11, M - PhCH2)1  142 (M - PhCH20), 91 
(PhCH2). 
The O-acetylated product of lic was isolated as a colourless 
oil (5 mg); O j (360 MHz) 0.88 (3H, d, J 12.5, CM01  1.67-1.93 
(3H, br m, C(3)H and C(5)H2), 2.07 (3H, s, CH3CO20.00-3.15 
(lH, br m, C(2)Hax or C(6)Hax), 3.25-3.28 (1H, br m, 
C(2)Hax or C(6)Hax), 3.70 (1H, br s, C(2)Heq or C(6)Heq), 
3.75 (1H, ddd, J4.5, 4.5 and 13.5, C(2)Heq or C(6)Heq), 5.01 
(1H, ddd, J 3, 3 and 5, C(4)Heq), 5.12 (2H, d, J 2, CH2Ph), 
7.28-7.39 (SM, m, aromatic); m/z (El) required 291.14706, 
found 291.14768; 291 (3%, M), 200(11, M - PhCH2), 91(100, 
PhCH2). 
Biohydroxylation of N-Benzyloxycarbonyl-2-methylpiperidine 
Hydroxylated product 12a was isolated as a colourless oil 
(20 mg, 7%); 0H  (250 MHz) 1.35 (3H, d, J 7, CH01  1.46-1.91 
(SH, m, C(3)H2, C(4)OH and C(5)H2), 3.34 (1H, ddd, J 51  
12.5 and 13.5, C(6)Hax), 3.90 (1H, ddd, J 3.5, 4 and 12.51  
C(6)Heq), 4.16 (lH, q, J 3, CHOH), 4.31-4.42 (1H, m, 
C(2)Heq), 5.12 (2H, s, CH2Ph), 7.25-7.36 (SM, m, aromatic); 
O (90 MHz) 19.1 (q, CH3), 32.2 (t, C3 or CS), 33.5 (t, C3 or 
CS), 36.4 (t, C6), 45.7 (d, C2), 64.7 (d, CHOH), 66.8 (t, 
CH2Ph), 127.7 (d, aromatic), 127.8 (d, aromatic), 128.4 (d, 
aromatic), 136.9 (s, aromatic), 155.2 (s, C=O); m/z (El) 
required 249.13649, found 249.136337, (FAB) 234 (4%, 
M - CH3), 158 (15, M - PhCH2), 142 (31, M - PhCH20), 
114 (2, M - PhCH2CO2)1  91(100, PhCH2). 
Hydroxylated product 12b was isolated as a colourless oil (20 
mg, 7%); OH (360 MHz) 1.12 (3H, d, J 7, CH01  1.43-1.78 (SM, 
m, C(3)OH, C(4)H2 and C(5)H2), 2.79 (1H, ddd, J 3, 13 and 
13.5, C(6)Hax), 3.74-3.80 (1H, m, CHOH), 3.95 (lH, br d, 
J 12.5, C(6)Heq), 4.51 (lH, q, J 6.5, C(2)H), 5.12 (2H, s, 
CH2Ph), 7.25-7.38 (5H, m, aromatic); O (90 MHz) 9.2 (q, CH3), 
24.0 (t, CS or C4), 27.1 (t, CS or C4), 37.6 (t, C6), 51.0 (d, C2), 
67.0 (t, CH2Ph), 69.0 (d, CHOH), 127.7 (d, aromatic), 127.9 
(d, aromatic), 128.4 (d, aromatic), 136.7 (s, aromatic), 155.3 
(s, C=O); mlz (El) required 249.13649, found 249.13637, 
(APCIt) 250 (100%, M + 1), 217 (3, M - OHCH3), 158 (7, 
M - PhCH2). 
Biohydroxylation of N-benzyloxycarbonyl-cis-2,6-dimethyl-
piperidine 5. Hydroxylated product 13 was isolated as a colour-
less oil (10 mg, 5%); OH  (360 MHz) 1.25 (6H, d, J7, 2 x CH01 
1.42-1.60 and 1.86-1.90 (5H, m, C(3)H21  C(4)OH and C(5)H2), 
4.20 (lH, tt, J 11 and 4, CHOH), 4.49-4.57 (2H, m, C(2)Heq 
and C(6)Heq), 5.14 (2H, s, CH2Ph), 7.23-7.38 (5H, m, 
aromatic); O (63 MHz, DEPT) 21.7 (q, 2 x  CH3), 39.4 (t, C3 
and CS), 47.2 (d, C2 and C6), 61.4 (d, CHOH), 66.9 (t, CH2Ph), 
127.7 (d, aromatic), 127.8 (d, aromatic), 128.4 (d, aromatic); 
m/z (El) required 263.15214, found 263.15203, (FAB) 264 
(M+ 1). 
Biohydroxylation of N-benzyloxycarbonyl-2-ethylpiperidine 
6. Hydroxylated product 14 was isolated as a colourless oil (130 
mg, 45%); OH  (360 MHz) 0.85 (3H, t, J 7.5, C(8)H3), 1.23-1.66 
(5H, m, C(3)H, C(4)OH, C(5)H and C(7)H2), 1.92 (2H, dd, 
J2.5 and 12.5, C(3)H and C(S), 2.85 (lH, ddd, J2.5, 12.5 and 
12.5, C(6)Hax), 3.91 (lH, tt, J4.S and 11. 5, CHOH), 4.16 (1H, 
br d, J 12.5, C(6)Heq), 4.33 (1H, br m, C(2)Heq), 5.12 (2H, d, 
J2, CH2Ph), 7.25-7.37 (SH, m, aromatic);O (90 MHz) 10.7 (q, 
C8), 23.8 (t, C7), 35.0 (C3 and CS), 37.6 (t, C6), 52.8 (d, C2), 
65.0 (t, CHOH), 67.0 (t, CH2Ph), 127.6 (d, aromatic), 127.8 (d, 
aromatic), 128.3 (d, aromatic), 136.8 (s, aromatic), 155.4 (s, 
C=O); m/z (El) required 263.15214, found 263.15253, (APCi) 
264 (12%, M + 1), 220 (M - CH3CH2), 172 (7, M - PhCH2), 
156 (23, M - PhCH20)1  91(100, PhCH2). 
Biohydroxylation of N-benzyloxycarbonyl-3,3-dimethyl-
piperidine 7. Hydroxylated product 15 was isolated as a colour-
less oil (134 mg, 48%); OH (250 MHz; 345 K) 0.89 (3H, s, C(7)H3 
or C(8)H3), 0.95 (3H, s, C(7)H3 or C(8)H3), 1.51-1.64 (2H, m, 
C(5)H and C(4)OH), 1.71-1.82 (lH, m, C(5)H), 2.85 (lH, d, 
J 13.5, C(2)Hax), 3.12-3.23 (lH, m, C(6)Hax), 3.40 (lH, dd, 
J 8.5 and 4.0, CHOH), 3.56 (1H, dd, J 1.5 and 13.5, C(2)Heq), 
3.81-3.91 (lH, m, C(6)Heq), 5.13 (2H, s, CH2Ph), 7.24-7.36 
(5H, m, aromatic); OH  (63 MHz) 18.4 (q, C7 or C8), 24.2 (q, C7 
or C8), 29.5 (s, 0), 35.8 (t, C5), 41.5 (t, C2 or C6), 52.6 (t, C2 
or C6), 66.9 (t, CH2Ph), 74.7 (d, CHOH), 127.7 (d, aromatic), 
127.8 (d, aromatic), 128.3 (d, aromatic), 136.7 (s, aromatic), 
155.4 (s, C=O); m/z required 263.15214, found 263.15254, 263 
(10%, M), 172 (5, M - PhCH2), 128 (3, CO2CH2Ph), 91(100, 
CH2Ph), 77 (4, Ph). 
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The biohydroxylation of a number of cyclic substrates (3-24) containing aromatic side chains 
was used to compare substrate specificity and selectivity of hydroxylation using microbial 
enzymes and whole-cell biocatalysts. In general, the regioselectivity of reaction was remarkably 
similar between the different catalysts in that little aromatic or benzylic, but significant aliphatic 
hydroxylation was observed. However, a more detailed investigation of isolated products showed 
complementary substrate specificity, functional group compatibility, and regioselectivity of 
hydroxylation. Substrate specificity and regioselectivity could be further modulated by small 
changes to the nature of the aromatic side chain, which appears to play an important role in 
substrate recognition. 	© 1999 Academic Press 
The hydroxylation of nonfunctionalized hydrocarbon centers using biological sys-
tems is recognized as an important biotransformation (1). This reaction has traditionally 
been achieved using whole-cell systems, but as more isolated enzyme systems and 
their three-dimensional structure are now becoming available, enzymes can be used 
for catalysis and are particularly important for studying substrate recognition and 
regio- and stereo selectivity of hydroxylation. The regioselectivity of hydroxylation 
is of particular importance to these biotransformations, because substrates often have 
a number of potential hydroxylation sites and thus a very high degree of selectivity 
is required. In our studies, we have looked at a particular class of cyclic substrates 
bearing aromatic side chains (3-24) and compared the selectivity of hydroxylation 
in defined enzymatic systems with that of whole-cell systems. 
BIOHYDROXYLATIONS USING ISOLATED ENZYMES 
The best studied of the cell-free hydroxylase systems is the cytochrome P450cam 
monooxygenase from Pseudomonas putida which catalyzes the hydroxylation of 
camphor 1 to 5-exo-hydroxy camphor 2 (Scheme 1). This enzyme was first reported 
in the 1960s by Gunsalus and colleagues and has been widely used as a model system 
because it is easily obtained as a soluble protein from heterologous expression (2) 
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Indicates camphor-tyrosine hydrogen bond 
FIG. 1. Active-site residues of cytochrome P450cam monooxygenase. (Left) Wild-type enzyme with 
camphor bound to the active site (3); (right) mutant Y96A with 4-hydroxydiphenyl methane bound to 
the active site (14). 
and a high-resolution crystal structure is available (3). The reaction is catalyzed with 
remarkable regio-and stereos electivity in that only 1 of 10 possible hydroxylation 
products is formed. This selectivity is due to a combination of the shape of the active 
site which provides multiple van-der-Waals interactions between enzyme and substrate 
and a single hydrogen bond between the camphor carbonyl group and tyrosine 96 of 
the enzyme. The importance of the hydrogen bond has been established by mutagenesis 
of tyrosine 96 and studies with substrate analogues lacking the carbonyl group (4). 
In the context of applications to biocatalysis, P450cam suffers from very narrow 
substrate specificity. It therefore provides an ideal target for redesign by site-directed 
mutagenesis. Our goal was to broaden the substrate specificity but at the same time 
retain regioselectivity of hydroxylation. We were particularly interested in aromatic 
substrates, such as polyaromatic compounds and substrates with aromatic side chains, 
because of potential applications in bioremediation (5) and in the synthesis of chiral 
intermediates (6-10), respectively. 
Investigation of the active site of P450cam (Fig. 1, left) suggests that removal of 
tyrosine 96 would both enlarge the substrate pocket and perhaps even provide an 
aromatic binding site, since tyrosine 96 in the wild-type structure is flanked by two 




SCHEME 1. Hydroxylation of camphor using P450cam monooxygenase from Pseudomonas putida. 
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stacking interactions. With this in mind, a number of single-site mutants at position 
96 were generated, of which the alanine mutant Y96A was the most interesting and 
hence was studied in most detail (11,12). 
First, simple aromatic compounds such as naphthalene and diphenylmethane (3) 
were tested as substrates. The hydroxylation of naphthalene was much more efficient 
with the Y96A mutant than with wild-type enzyme (13), and diphenylmethane 3 was 
almost exclusively converted to 4-hydroxy diphenylmethane (Table 1) by Y96A, 
whereas no hydroxylation was observed with wild-type enzyme (11). No benzylic 
hydroxylation was observed, which emphasizes that the mode of binding of the 
substrate to the enzyme active site can be more important for selectivity than C—H 
bond strength. 
Thus, the type of substrate binding we observed with the Y96A mutant (Table 1) 
suggested to us that removal of the tyrosine aromatic side chain had indeed created 
a binding pocket for aromatic rings as predicted, where the substrate now takes 
the place of the former protein tyrosine side chain. To verify this, we conducted 
crystallographic studies on the Y96A mutant. We have recently obtained the structure 
of the mutant Y96A with 4-hydroxy diphenylmethane bound to the active site to 1.9 
A resolution in collaboration with Malcolm Walkinshaw at Edinburgh University 
(14). These preliminary studies have revealed that, perhaps not surprisingly, some 
significant rearrangement of active-site residues occurs. Comparison of the wild-type 
with the Y96A mutant shows that most active-site residues remain in the same place, 
but very importantly that the phenylalanine 87 side chain has moved into the original 
site of tyrosine 96 (Fig. 1, right). Thus, the mutation has increased the size of the 
substrate binding pocket which now appears to be lined at the bottom, away from 
the active site, with aromatic side chains (Phe 87 and 98). Thus, rather than, as 
predicted, providing an aromatic pocket at the previous site of tyrosine 96, Phe 98 
appears to be stacking against aromatic side chains of the substrate, resulting in 
regio selectivity of hydroxylation. We are currently investigating cocrystals of Y96A 
with other substrates to see if this change of active residue orientation is generally 
observed. 
Further evidence for this aromatic stacking interaction comes from studies of the 
mutant Y96A with substrates 4-9 (Table 1), where no aromatic hydroxylation was 
observed, but good regioselectivity of hydroxylation of the aliphatic part of the 
molecule occurred. However, this can also be explained by favorable van-der-Waals 
interactions of the aliphatic part of the substrate with aliphatic protein side chains 
(Val 244, Leu 247, Val 295) closer to the active site. 
In general, substrates 3-9 in Table 1 demonstrate that the substrate range for 
hydroxylation has been greatly expanded by the single mutation of tyrosine 96, in 
particular since none of these compounds bind to wild-type enzyme. The aromatic 
side chain that is necessary for good binding to the enzyme does not need to be part 
of the desired substrate structure, but can be a protecting group as in 5-9, which 
can be cleaved off after hydroxylation. This allows for the enzyme to catalyze the 
hydroxylation of functionalized cyclohexane (5,6,9) and piperidine (7,8) derivatives, 
which themselves are not substrates. 
Another advantage for using aromatic protecting groups in these biotransformations 
is that they can be used as a further tool to manipulate regio selectivity of hydroxylation. 
FLITSCH ET AL. 
TABLE 1 
Hydroxylation Products Isolated from Incubation of Substrates with the Y96A Mutant of P450cam 
Monooxygenase from Pseudomonas putida 
SUBSTRATE 	I MAJOR PRODUCT(S) 
















No 	 N 
0  Ph 	 OO Ph 
OH 
OOPh 	 OOPh 
Ph 	
Mixture of products identified by gas 
chromatography, but not isolated 
Ph 
No products observed by gas 
chromatography 
10 
Note. The relative configuration of the stereocenters in products is as indicated. However, absolute 
configurations have not been determined. 
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For example, the benzoyl ester of cyclohexanol 5 is selectively oxidized to the 4-
hydroxyl derivative, whereas the benzyl ether 9 leads to a mixture of products, or 
the benzoyl protected cyclohexenol 6 gives the allylic hydroxylation product, whereas 
incubation of the benzyl ether 10 with Y96A resulted in recovered starting material. 
It appears that a certain distance between the aromatic side chain and the hydroxylation 
site is important in these substrates to ensure good selectivity of hydroxylation as 
comparison of 4 and 5 shows, where 4 gives 44% of 3-hydroxylated product and 5 
gives almost exclusively 4-hydroxylated material. 
A great practical problem with using isolated enzyme systems for b iotrans formations 
is the requirement for coenzymes and cofactors. For example, in the case of cytochrome 
P450cam monooxygenase discussed here, it is necessary to add the corresponding 
ferredoxin, ferredoxin reductase, and NADH as a source of electrons. These reactions 
are therefore only being conducted on a milligram scale and it would be expensive 
to scale them up much further. In the future, it may be possible to bypass electron 
transport proteins by driving the reaction electrochemically (15), but in the meantime 
the use of whole-cell systems, whether recombinant (16) or in the natural microorgan-
ism, is much more practical for preparative-scale biohydroxylations. A few whole-
cell systems which we have investigated in our group are discussed below. 
BIOHYDROXYLATIONS USING B. bassiana 
The entomopathogen Beauveria bassiana ATCC 7159 (redesignated from Sporotri-
chum sulfurescens) has been used for a number of biotransformations. Of particular 
interest to us were studies by Fonken and Johnson at Upjohn Company (6,10) on the 
selective hydroxylation of N-benzoyl alkylpiperidines to give some optically active 
hydroxy alkylpiperidines. This work led to the proposal of a stereochemical model 
for hydroxylation of these amides, which placed particular importance on the distance 
between the amide oxygen and the hydroxylation site (1). Interestingly, our studies 
with the isolated enzyme, the cytochrome P450cam mutant Y96A, had given similar 
products of hydroxylation of the Cbz protected piperidine derivatives 7 and 8 to those 
observed by Johnson, but modeling studies of the substrates at the active site of the 
mutant using the available structural data (17) would suggest that no protein side 
chain is suitably placed to form a hydrogen bond with the carbonyl oxygen of the 
Cbz group. Rather, the size and flexibility of the aromatic substrate protecting group 
appear to determine regioselectivity of hydroxylation. The comparison of N-carboxy-
benzoyl protected piperidine derivatives with benzoyl protected piperidines using the 
B. bassiana whole-cell hydroxylation system would therefore give us more information 
on the importance of the aromatic side chain, since the carbonyl group in both substrate 
classes is placed at the same distance to the different potential hydroxylation sites of 
the ring. In addition, we were interested to see if the Cbz group was more compatible 
with whole-cell b iotrans formations, since it is a much more convenient protecting 
group for amines than the N-benzoyl group. 
A comparison of the hydroxylated products from both series of substrates (Cbz 
and benzoyl protected) is shown in Table 2 (17). The protected parent piperidine 
derivatives 7 and 11 gave both 4-hydroxylated products, but with several of the alkyl 
substituted piperidines a significant change in the regio selectivity of hydroxylation 
was observed. Thus, while biohydroxylation of N-benzoyl 4-methyl piperidine 13 
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resulted in a • 2:1 mixture of the 4-hydroxylmethyl- and the 4-hydroxy-4-methyl-
piperidine derivatives, the Cbz compound 12 gave only the 4-hydroxy-4-methyl-
piperidine in 48% yield. The 3-methyl derivatives 14 and 15 and the 2-methyl deriva-
tives 16 and 17, on the other hand, resulted in the same product ratios. The most 
significant change of regioselectivity was observed with the dimethyl-piperidines 8 
and 18 and ethyl-piperidines 19 and 20. The Cbz derivatives 8 and 19 led exclusively 
to the 4-hydroxylated materials, whereas the benzoyl derivative 18 gave only 3-
hydroxylated product and 20 gave a mixture of isomers. 
One concern with whole-cell biotransformations is the lability of certain functional 
groups to other enzymes in the microorganism. Esters, for example, are likely to be 
hydrolyzed by microbial enzymes and compounds such as 5 and 6 would therefore 
not be suitable for whole-cell biotransformations. The Cbz group is potentially labile 
either to microbial carbamate hydrolases (18) or to benzylic hydroxylation (19). The 
results presented in Table 2 suggest that degradation of the Cbz group is generally 
low. However, we found one exception in substrate 8 where very little hydroxylated 
product (5%) was isolated together with a large amount (75%) of benzoic acid (19), 
indicating benzylic hydroxylation. 
BIOHYDROXYLATIONS USING Rhodoccocus spp. 
The genus Rhodococcus is a group of gram-positive bacteria that is widely distrib-
uted in both soil and aquatic environments and is known for their broad metabolic 
diversity which includes hydrocarbons, many aromatic compounds, and larger mole-
cules such as steroids. A number of Rhodococcus strains have been investigated for 
their ability to catalyze hydroxylation (20,21) and have demonstrated that this genus 
of bacteria has great potential to provide useful hydroxylases. After investigating a 
number of strains, we decided to study Rhodococcus rhodochrous ATCC 19067 and 
Rhodococcus sp NCIMB 9784 in the context of our studies described above. 
R. rhodochrous ATCC 19067 had been reported by Cardini and Jurtshuk (22,23) 
to contain an inducible P450 monooxygenase (P450oct) which performed NADH-
dependent oxidation of n-octane to 1-octanol. We have found that this whole-cell 
system can also accept a wide range of cyclic substrates such as illustrated in Table 
3. Interestingly, the substrates were again exclusively hydroxylated in the aliphatic 
rather than the aromatic ring. Cbz protected piperidine 7 was hydroxylated at the 4-
position as observed by B. bassiana and the P450cam mutant Y96A hence suggesting 
similarities in substrate recognition. However, the Rhodococcus showed complemen-
tary catalytic activity to the P450cam and the B. bassiana systems with a number of 
substrates: benzylether 9 led to a mixtures of products with the Y96A system, yet 
gave only a single product with R. rhodochrous. Compounds 10, 21, and 22 were 
hydroxylated in good yield by R. rhodochrous, yet were not substrates for the Y96A 
mutant. Cbz protected dehydropiperidine 24 was not a B. bassiana substrate but could 
be oxidized by R. rhodochrous. In only one of the cases studied (compound 23) did 
we find benzylic hydroxylation. 
The other strain we studied, Rhodococcus sp NCIMB 9784, contains a hydroxylase 
which has been reported to generate 6-endo-hydroxycamphor from camphor (24), 
although evidence for this reaction has been indirect because of further metabolism 
of the alcohol product. Because of our interest in the substrate specificity of the 
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Note. The relative configuration of the stereocenters in products is as indicated. However, absolute 
configurations have not been determined. 
cytochrome P450cam hydroxylase from P putida, we have studied this enzymatic 
activity in more detail. The hydroxylase appears to be remarkably similar in its narrow 
substrate specificity to the wild-type P putida enzyme in that they are limited to 
molecules of similar size to camphor and terpenoid substrates. Larger compounds 
such as the Cbz piperidine 7 are not hydroxylated. 
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This hydroxylase will therefore not so much be of interest as a new complementary 
hydroxylation system, but rather be useful for comparison to the P450cam from P 
putida in order to allow us to further understand factors underlying regio selectivity 
of hydroxylation. Thus, we have been able to purify a cytochrome P450 monooxygen-
ase from Rhodococcus species NCIMB 9784 which accepts camphor as a substrate. 
The first 16 N-terminal amino acids have been determined by sequencing and little 
homology was found in this short sequence to the cytochrome P450cam monooxygen-
ase of  putida. Studies toward the cloning and further characterization of this enzyme 
are currently in progress in our laboratories. 
CONCLUSIONS 
Comparison of the substrate specificity of the different monooxygenases from 
microbial sources studied here suggests some surprising similarities in selectivity of 
hydroxylation, in that the 3- and 4-positions of the aliphatic rings are the most likely 
to be hydroxylated. However, the substrate selectivity and the regio selectivity of 
hydroxylation can be fine-tuned either by change of substrate structure (e.g., using 
the Cbz instead of benzoyl-derivate) or by change of biocatalyst. With cell-free and 
purified enzyme systems becoming more and more available, we can start to rationalize 
regio selectivity of hydroxylation and redesign the active site of hydroxylases to suit 
the particular requirements of reaction selectivity. 
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